Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
KRTAP3-2	KAP3.2	ENSG00000212900	"Keratin associated protein 3-2"	Q9BYR7	17	40999193-40999894	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"esophagus: 22.1;skin 1: 42.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.2;HeLa: 2.2;SCLC-21H: 1.1;U-2197: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042992	Approved									"HPA042992: AB_2678258"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	42.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0
CAPN14		ENSG00000214711	"Calpain 14"	A8MX76	2	31173056-31233858	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"esophagus: 92.6;lymphoid tissue: 25.0"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.7"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"					"Not detected"	"Not detected"														"unprognostic (5.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.71e-4)"	"unprognostic (8.42e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.47e-4)"	0.1	0.1	0.2	0.0	0.3	0.0	0.2	0.5	0.3	1.1	0.1	0.0	0.0	0.0	0.4	0.0	92.6	0.1	0.0	0.2	0.2	0.3	0.1	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	3.2	25.0	0.2	0.4	1.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.4	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.4	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.5	0.3	0.2	0.3	0.2	0.0	0.0	0.0
KRT32	"Ha-2, KRTHA2"	ENSG00000108759	"Keratin 32"	Q14532	17	41459811-41467429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"esophagus: 12.8;skin 1: 18.0"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;HaCaT: 1.5;MCF7: 1.6;PC-3: 2.5;U-2197: 1.3;U-87 MG: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									230000000	230000000				"unprognostic (1.39e-2)"	"unprognostic (3.29e-1)"		"unprognostic (1.88e-1)"		"unprognostic (2.71e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"		"unprognostic (2.32e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.72e-9)"		"unprognostic (1.31e-2)"		"unprognostic (1.77e-1)"	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0			0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.8	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL36A	"FIL1, FIL1E, IL-1F6, IL1(EPSILON), IL1F6, MGC129552, MGC129553"	ENSG00000136694	"Interleukin 36 alpha"	Q9UHA7	2	113005461-113008044	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"esophagus: 106.0;lymphoid tissue: 87.9;tongue: 90.7"	"Group enriched"	"Detected in some"	5	"MOLT-4: 4.1;REH: 1.6;U-266/70: 4.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 8.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Not detected"	"Not detected"												"Secreted to blood"							"unprognostic (1.37e-1)"				"unprognostic (9.66e-3)"		"unprognostic (5.46e-1)"										0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	106.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.7	87.9	0.0	4.8	0.0	0.0	0.0	0.0	0.1	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	4.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.3	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PAX9		ENSG00000198807	"Paired box 9"	P55771	14	36657568-36679715	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"esophagus: 58.6;lymphoid tissue: 33.2;parathyroid gland: 34.6;salivary gland: 86.1;tongue: 27.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 8.0;HBEC3-KT: 8.0;HDLM-2: 30.0;PC-3: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	19	"T-cells: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016239, HPA038462"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB016239: AB_2159984, HPA038462: AB_10672594"	"unprognostic (3.09e-1)"	"prognostic favourable (5.38e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.71e-3)"	"unprognostic (2.96e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.31e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	0.1	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.1	3.7	0.4	0.0	0.0	0.0	0.2	0.1	58.6	0.2	0.0	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.1	0.0	0.1	0.1	34.6	1.4	0.0	0.1	2.7	0.0	0.1	86.1	0.0	0.1	0.3	0.1	0.4	0.1	0.1	0.2	0.2	0.0	11.8	0.5	27.1	33.2	0.4	3.4	0.1	0.0	0.0	0.0	0.0	2.7	0.1	3.4	0.9	0.0	1.7	1.4	2.3	1.2	0.0	0.1	0.0	0.0	0.7	1.1	0.7	0.4	0.0	8.0	1.2	8.0	0.0	30.0	5.3	0.5	0.5	0.0	0.0	0.0	2.7	0.5	3.7	0.0	1.2	0.0	2.0	0.8	0.1	4.5	0.5	0.0	0.1	12.9	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.8	4.0	0.9	3.4	0.0	0.0	0.0	0.5	1.3	0.6	0.0	0.0	3.0	0.4	0.3	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell line enriched"	"Detected in some"	14	"SiHa: 49.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"																							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	49.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMB4		ENSG00000091128	"Laminin subunit beta 4"	A4D0S4	7	108023548-108130356	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;HMC-1: 3.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA020242, HPA024247"	Approved				"Secreted to extracellular matrix"					"HPA020242: AB_2670388, HPA024247: AB_2671496"	"unprognostic (7.41e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (6.29e-4)"	"unprognostic (8.90e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-4)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.2	13.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	31.1	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	21.6	2.0	0.1	0.1	0.6	0.5	1.6	0.3	1.0	0.4	0.2	0.0	0.9	0.2	0.1	0.6	0.5	6.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.4	0.1	0.0	3.5	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.4	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	1.6	0.3	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.6	0.3	0.2	1.6	1.0	0.2	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
OTOP3		ENSG00000182938	"Otopetrin 3"	Q7RTS5	17	74935719-74949992	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"esophagus: 17.5;intestine: 42.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.2;SH-SY5Y: 1.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (9.28e-3)"				"prognostic favourable (3.86e-4)"			"unprognostic (2.77e-1)"		"unprognostic (8.60e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.03e-1)"	"unprognostic (8.36e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	34.1	0.0	0.0	42.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	2.5	29.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	1.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DMRTA2		ENSG00000142700	"DMRT like family A2"	Q96SC8	1	50417550-50423500	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.5;esophagus: 3.8;pituitary gland: 5.4;testis: 4.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HBEC3-KT: 4.2;RH-30: 15.3;SH-SY5Y: 3.2;SiHa: 3.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043098, HPA062958"	Uncertain		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA043098: AB_10796684, HPA062958: AB_2684911"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.75e-2)"		"unprognostic (1.15e-2)"	"unprognostic (3.29e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.08e-3)"	"unprognostic (4.16e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.68e-3)"	0.2	0.1	0.4	0.1	1.5	0.2	0.2	0.4	2.1	0.3	0.3	8.5	0.0	0.4	0.2	0.1	3.8	0.2	0.1	0.1	1.2	0.7	0.2	0.2	0.2	0.2	1.2	0.0	0.2	0.1	0.4	5.4	0.2	2.1	0.2	0.3	0.0	0.5	0.2	0.3	0.1	0.2	0.1	2.0	0.3	0.2	4.0	3.7	0.3	0.2	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	1.2	4.2	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.4	1.8	1.2	0.7	1.2	0.0	2.1	3.7
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 12.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced									"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Group enriched"	"Detected in some"	30	"HaCaT: 94.2;SK-BR-3: 38.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"		540000000	540000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002154: AB_563803, HPA034881: AB_2674370"	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced					14000000	14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995355-47999791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 18.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.0	0.0		0.0		0.0	5.7		0.0	0.0	0.0			0.0	0.0	0.0	4.9	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	10.3	5.0	0.0		0.0	0.0	0.0			0.0		2.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL19	"IL-10C, IL-19, MDA1, NG.1, ZMDA1"	ENSG00000142224	"Interleukin 19"	Q9UHD0	1	206798870-206842981	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 11.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.8"					"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (6.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.17e-2)"		"unprognostic (2.48e-5)"		"unprognostic (1.07e-1)"	"unprognostic (8.72e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.04e-3)"			"unprognostic (9.17e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0			0.0	0.1	0.0	6.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0		0.0	0.0	0.0	0.2	0.0		0.0	0.0		6.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	11.6	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.1	0.2	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0.0	0.2	0.6	0.0	0.0										
AC243967.1		ENSG00000267881			19	41708612-41761282	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"esophagus: 79.7;intestine: 34.3;lymphoid tissue: 77.4;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HaCaT: 1.8;MCF7: 1.9;RT4: 4.1;U-2 OS: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA011041	Approved									"HPA011041: AB_1078481"			"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.4	0.3	0.3	60.6	0.4	0.2	0.5	0.6	0.4	9.2	34.3	0.0	0.0	0.5	0.3	0.1	79.7	0.3	0.5	0.5	0.4	0.3	0.4	0.7	1.4	0.1	0.3	0.0	0.5	0.6	0.3	0.5	0.1	0.0	0.5	0.4	0.0	0.7	0.1	0.4	0.5	6.1	0.7	0.3	0.6	0.8	0.6	0.0	0.0	0.4	22.3	77.4	1.0	8.0	0.1	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.0	0.0	0.0
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333629	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"esophagus: 14.3;skin 1: 38.2;tongue: 17.3"	"Group enriched"	"Detected in some"	7	"MCF7: 2.2;T-47d: 7.9"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	2.2	0.1	0.1	3.8	0.1	0.1	0.1	0.0	0.4	0.1	14.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.1	1.4	0.1	0.2	38.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	17.3	3.5	0.1	2.2	0.6	0.4	0.4	0.2	1.0	3.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	7.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.0	3.6	0.1	3.5	1.6	0.0	0.6	2.3	2.3	0.4	1.0	0.2	0.4	2.0	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	7	"ASC TERT1: 3.9;HaCaT: 4.4"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 182.1;intestine: 64.2"	"Cell line enriched"	"Detected in single"	964	"RT4: 96.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	210000	210000	"Plasma membrane"	"Plasma membrane"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.2	0.1	2.2	8.8	3.0	0.1	0.6	0.0	2.0	12.3	64.2	2.0	0.0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0.0	0.1	0.0	0.1	3.0	1.8	38.4	0.0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5.0	0.0	0.1	8.6	21.5	9.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	2.0	2.2	0.6	3.2	1.6	3.0	5.0
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414860-7416863	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 14.3;lymphoid tissue: 8.8"	"Cell line enriched"	"Detected in single"	16	"CAPAN-2: 1.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"											"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0			0.0		8.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DYNAP	"C18orf26, FLJ39106"	ENSG00000178690	"Dynactin associated protein"	Q8N1N2	18	54587757-54599493	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 23.9;tongue: 50.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 16.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA011148	Uncertain									"HPA011148: AB_1845609"		"unprognostic (9.88e-2)"		"unprognostic (2.51e-2)"		"unprognostic (1.75e-3)"				"unprognostic (1.45e-1)"					"unprognostic (8.09e-3)"			0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.8	0.1	0.1	0.1	0.1	0.5	1.4	23.9	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.1	0.4	0.1	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	2.1	0.1	0.2	0.5	0.2	0.3	0.1	1.4	0.2	0.4	0.1	0.2	0.1	50.3	6.7	0.1	0.3	1.8	1.0	3.1	2.9	0.7	1.0	0.0	1.0	0.3	1.7	0.8	0.9	2.0	1.7	0.4	0.7	1.3	1.3	0.9	0.6	0.9	0.6	0.9	0.6	1.2	0.0	0.7	0.3	0.3	0.3	1.1	0.6	0.7	0.8	0.8	0.8	0.2	1.3	0.4	0.3	1.3	16.5	0.2	0.3	0.6	0.5	2.6	0.5	0.6	2.0	0.8	0.5	0.9	0.7	1.0	0.3	0.3	2.9	0.5	1.1	2.8	0.6	3.2	0.6	0.5	0.6	0.4	1.3	0.9	0.4	0.4	1.2	1.3	2.1	1.0	1.1	0.7	1.0	0.6	0.4	0.4	1.8	0.7	0.7	3.1	0.7	2.9	1.0	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244537	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"esophagus: 2.2;lymphoid tissue: 6.4;urinary bladder: 2.4"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"							"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.1	1.7	0.3	0.0	0.0	0.6	0.2	0.1	0.0			0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2			0.0		6.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3										
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LYPD2	"LYPDC2, RGTR430, UNQ430"	ENSG00000197353	"LY6/PLAUR domain containing 2"	Q6UXB3	8	142750150-142752534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9"	"Group enriched"	"Detected in some"	18	"EFO-21: 14.8;HaCaT: 4.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"non-classical monocyte: 76.5"	"Lineage enriched"	"Detected in many"	20	"monocytes: 76.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA028599	Uncertain				"Intracellular and membrane"					"HPA028599: AB_10603777"		"prognostic favourable (2.00e-4)"		"unprognostic (3.10e-2)"		"prognostic favourable (2.63e-4)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.11e-3)"		"unprognostic (1.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.3	0.0	77.5	0.2	0.1	1.2	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	7.7	0.0	0.5	6.5	0.0	0.0	0.0	0.1	11.6	0.0	0.0	5.7	0.0	37.9	69.2	0.0	10.1	0.2	3.7	0.0	76.5	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	14.8	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	76.5	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11 (gene/pseudogene)"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;BEWO: 2.0;hTCEpi: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"															"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	23.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	19.1	2.0	2.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0										
SERPINB13	"headpin, HUR7, hurpin, PI13"	ENSG00000197641	"Serpin family B member 13"	Q9UIV8	18	63586989-63604639	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix, uterine: 37.7;esophagus: 70.8;lymphoid tissue: 54.2;tongue: 107.2;vagina: 34.1"	"Group enriched"	"Detected in some"	132	"HaCaT: 64.1;hTCEpi: 24.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 45.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052630, HPA057129"	Enhanced		Approved	"Nuclear speckles,Cytosol"		59000	59000	"Nuclear speckles, Cytosol"	"Nuclear speckles, Cytosol"	"HPA052630: AB_2681891, HPA057129: AB_2683347"		"unprognostic (3.49e-2)"		"unprognostic (3.73e-1)"		"unprognostic (1.11e-1)"		"unprognostic (7.27e-2)"	"unprognostic (2.28e-1)"			"unprognostic (4.29e-2)"		"unprognostic (2.81e-1)"			"unprognostic (6.04e-3)"	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.1	37.7	0.1	0.0	0.0	0.1	3.1	0.1	70.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	10.9	0.1	0.2	5.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.0	0.1	107.2	54.2	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell line enhanced"	"Detected in some"		"A-431: 4.6;HaCaT: 12.4;Hep G2: 14.3;hTCEpi: 11.2;NTERA-2: 6.3;T-47d: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.2	0.2	0.0	14.3	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	2.8	1.8	4.3	3.6	0.1	0.0	4.7	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell line enriched"	"Detected in single"	142	"RT4: 106.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavourable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
ANXA8	ANX8	ENSG00000265190	"Annexin A8"	P13928	10	47460162-47484158	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"esophagus: 41.6;skin 1: 60.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 72.1;HBEC3-KT: 105.1;hTCEpi: 59.4;RT4: 26.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"					"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"											"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (8.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (6.07e-4)"	"unprognostic (5.94e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (2.68e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.55e-15)"	"unprognostic (1.04e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.39e-1)"	0.1	0.0	0.1	3.7	0.1	0.0	2.3	0.1	0.1	2.9	0.4	0.1	0.1	0.0	0.1	1.3	41.6	0.2	0.1	0.1	0.1		0.1	0.1	2.4	0.1	0.1	0.1	0.4	0.1	0.0	0.1	7.7	0.1	1.2	0.0	0.3	0.1	1.8	0.1	60.7	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	2.5	9.5	10.2	0.1	0.0	5.5	1.1	2.1	0.7	0.0	0.5	20.1	2.5	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.0	1.3	5.8	0.0	0.4	0.1	72.1	0.0	105.1	0.0	4.6	0.0	0.0	6.5	0.0	4.3	0.0	0.2	0.0	59.4	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	10.4	3.0	0.0	0.0	0.5	0.0	0.0	6.2	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5										
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		2700000	2700000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB037328: , HPA049265: AB_2680695, HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GBP6	DKFZp686G0786	ENSG00000183347	"Guanylate binding protein family member 6"	Q6ZN66	1	89364058-89386461	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 106.5;lymphoid tissue: 60.5;tongue: 61.3"	"Group enriched"	"Detected in some"	9	"A-431: 7.8;HaCaT: 17.3"	"Group enriched"	"Detected in many"	7	"cervical cancer: 21.7;head and neck cancer: 38.1;lung cancer: 14.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;T-cells: 2.7"									HPA027744	Enhanced									"HPA027744: AB_10602809"	"unprognostic (7.60e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-3)"	"unprognostic (5.85e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.34e-1)"	"unprognostic (7.99e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.04e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.91e-3)"	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	6.9	0.0	0.0	0.0	0.0	0.1	0.0	106.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	15.6	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	61.3	60.5	0.1	6.8	0.6	0.6	3.4	0.6	0.3	2.7	0.4	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.0	17.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.4	0.7	0.2	1.2	0.6	0.9	1.2	0.4	0.4	0.7	0.7	3.4	0.3	0.4	0.6	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 43.5;hTCEpi: 32.4;RT4: 50.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.3	43.5	0.0	0.2	0.0	8.6	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.4	0.5	6.0	0.0	0.0	3.2	0.0	0.4	0.3	0.0	0.1	4.3	0.0	0.0	2.4	0.0	50.5	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.2	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2
KLK13	KLK-L4	ENSG00000167759	"Kallikrein related peptidase 13"	Q9UKR3	19	51056206-51065114	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 100.5"	"Cell line enriched"	"Detected in some"	11	"HaCaT: 20.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA062136	Enhanced				"Secreted in other tissues"					"HPA062136: AB_2684694"	"unprognostic (1.99e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"		"unprognostic (3.43e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.30e-2)"	"unprognostic (7.07e-6)"	"unprognostic (7.33e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.06e-2)"	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0.0	0.5	0.1	0.2	0.1	0.0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	20.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"		580000000	580000000	"Intermediate filaments"	"Intermediate filaments"	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452126	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 135.3;tongue: 232.4"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 19.7;hTCEpi: 22.0;RPMI-8226: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1424.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB000130: , HPA045697: AB_2679422, HPA061168: "	"prognostic favourable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavourable (9.52e-4)"	0.2	0.1	0.1	0.5	0.1	0.1	3.9	0.1	0.1	33.3	0.1	0.1	0.1	0.1	0.7	0.1	135.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	17.8	0.1	0.1	34.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	232.4	15.4	0.1	26.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MAL		ENSG00000172005	"Mal, T cell differentiation protein"	P21145	2	95025677-95053996	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"esophagus: 447.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 44.8;MOLT-4: 62.7;RPTEC TERT1: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 42.0;naive CD4 T-cell: 57.9;naive CD8 T-cell: 26.4;T-reg: 40.1"	"Lineage enriched"	"Detected in many"	44	"T-cells: 57.9"	"Low region specificity"	"Detected in all"							HPA065691			Approved	"Golgi apparatus,Centrosome"				"Golgi apparatus"	"Golgi apparatus"	"HPA065691: AB_2685533"	"unprognostic (1.57e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (5.18e-6)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.89e-2)"	"prognostic favourable (3.96e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.57e-1)"	2.3	2.0	14.3	3.5	21.8	3.7	2.0	1.8	20.6	35.8	3.7	43.2	0.4	2.0	1.8	3.4	447.4	3.4	2.2	3.3	18.2	8.3	53.1	1.7	4.3	5.9	27.4	13.2	2.0	1.9	1.6	0.2	2.2	11.8	2.5	2.9	2.8	42.5	3.9	2.0	3.7	2.4	2.1	27.6	3.2	9.3	1.7	27.2	35.0	5.8	56.1	90.1	2.6	64.8	0.6	0.2	0.4	0.1	1.3	57.9	13.7	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.7	0.0	0.0	0.0	0.0	0.0	22.2	227.3	5.7	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.4	0.6	42.0	7.5	0.0	0.5	57.9	26.4	0.4	1.3	0.0	0.2	40.1	13.7	14.3	21.8	1.8	20.6	18.2	8.3	27.4	13.2	11.8	27.2
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 251.5;lymphoid tissue: 126.1"	"Cell line enriched"	"Detected in single"	14	"Karpas-707: 4.2"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.0"									HPA052028	Enhanced									"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	34.7	0.2	0.0	0.0	0.2	1.3	0.2	251.5	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.7	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	33.7	126.1	0.2	33.2	0.0	0.0	1.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUC22	PBMUCL1	ENSG00000261272	"Mucin 22"	E2RYF6	6	31010474-31035402	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"esophagus: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (2.38e-1)"			"unprognostic (1.57e-1)"	"unprognostic (1.46e-1)"		"unprognostic (1.91e-1)"		"unprognostic (4.03e-1)"			"unprognostic (1.46e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"		130000	130000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB002600: , CAB047340: , HPA062451: AB_2684767"	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	5400000	5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR2A		ENSG00000241794	"Small proline rich protein 2A"	P35326	1	153056113-153057537	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 393.4;lymphoid tissue: 173.5;tongue: 572.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.6;hTCEpi: 8.2;hTERT-HME1: 10.9;Karpas-707: 13.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 743.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.64e-2)"		"unprognostic (6.80e-3)"	"unprognostic (3.51e-1)"		"unprognostic (3.36e-3)"			"unprognostic (4.53e-2)"			"prognostic unfavourable (1.37e-5)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	82.8	0.2	0.0	0.0	0.2	3.0	0.2	393.4	0.2	0.7	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	58.3	0.2	0.2	1.3	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	572.8	173.5	0.3	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	8.2	0.0	10.9	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.7	0.3	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPRR2B		ENSG00000196805	"Small proline rich protein 2B"	P35325	1	153070224-153070840	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;SiHa: 1.2;U-2197: 1.2"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 77.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.52e-1)"				"unprognostic (1.44e-2)"			"unprognostic (3.62e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0			0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.4	0.0	0.0	0.0	0.0		0.0	0.0		3.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	3.2			0.0		11.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SRY	TDF	ENSG00000184895	"Sex determining region Y"	Q05066	Y	2786855-2787699	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 2.5;lymphoid tissue: 7.2;skin 1: 3.7;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;NTERA-2: 1.4;RT4: 6.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.34e-1)"	"unprognostic (5.53e-4)"									"unprognostic (1.61e-1)"			0.3	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.6	0.9	0.1	0.0	0.1	0.8	2.5	0.0	0.1	0.1	0.3	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.4	0.1	0.0	0.1	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0.1	0.0	5.5	0.1	7.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.5	0.1	0.1	0.4	0.1
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.8;HaCaT: 17.6;HeLa: 11.5;MCF7: 12.6;SK-BR-3: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171"	Enhanced					430000	430000			"CAB015159: AB_2202870, HPA040171: AB_2676869"	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	12.8	0.3	0.2	0.7	1.2	0.9	1.3	0.7	1.7	0.9	17.6	2.1	1.4	0.5	1.4	2.4	1.0	11.5	4.0	0.6	0.6	1.1	1.1	7.0	0.4	1.5	0.5	0.7	0.7	0.5	12.6	0.5	1.3	0.2	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.1	0.2	15.7	0.0	1.1	0.8	0.6	0.8	3.7	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2
VSIG10L		ENSG00000186806	"V-set and immunoglobulin domain containing 10 like"	Q86VR7	19	51331536-51342124	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 70.9;lymphoid tissue: 52.2;salivary gland: 72.9;tongue: 37.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 7.0;T-47d: 12.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA060453, HPA066745"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA060453: AB_2684280, HPA066745: AB_2685712"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (8.75e-4)"	"unprognostic (2.40e-3)"	"unprognostic (2.78e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.90e-4)"	"unprognostic (1.42e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.74e-2)"	"unprognostic (5.19e-3)"	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.1	9.8	0.1	0.0	2.0	0.1	0.6	0.0	70.9	0.0	0.9	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	1.2	0.1	0.0	72.9	2.6	0.2	4.9	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	37.6	52.2	0.1	10.8	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	1.4	0.1	0.6	0.6	0.1	0.3	0.1	0.1	0.0	0.2	0.4	1.1	0.9	0.1	0.1	0.1	0.0	0.0	0.1	0.8	0.8	0.2	0.2	7.0	0.0	0.0	1.2	0.0	0.8	0.2	0.0	0.0	0.6	2.0	0.0	0.6	0.0	0.1	0.9	0.7	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.0	12.8	0.0	0.1	0.0	0.2	1.1	0.0	1.7	1.1	0.1	0.8	0.2	0.4	0.0	0.6	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 59.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033311, HPA068414"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB033311: AB_781574, HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	7.7	0.0	1.9	0.0	59.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.1	0.1	0.0	0.0	7.3	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2
CDT1	"DUP, RIS2"	ENSG00000167513	"Chromatin licensing and DNA replication factor 1"	Q9H211	16	88803213-88809258	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 25.2;esophagus: 7.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017224	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA017224: "	"unprognostic (1.33e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.12e-6)"	"unprognostic (3.44e-3)"	"unprognostic (2.81e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (2.69e-6)"	"unprognostic (7.72e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.54e-2)"	0.4	0.4	0.7	2.7	0.9	25.2	0.4	0.0	1.2	1.2	2.5			2.9	0.3	0.0	7.1	0.3	0.0	0.1	0.6	2.2	0.5	0.6	0.9	3.2	1.7		0.0	0.4	0.9	2.1	2.0		0.3	1.0		0.8	0.1	0.0	3.3	3.2	0.3	0.8	3.1	1.7	3.3			0.1		2.1	0.2	1.9	3.7	2.1	3.5	0.9	1.7	4.0	0.7	9.6	10.1	4.4	7.4	0.2	0.9	17.8	6.6	1.8	5.2	3.3	20.6	10.0	14.3	7.3	1.4	12.5	5.5	4.4	1.7	5.1	23.8	13.4	8.9	17.2	0.0	7.6	5.9	0.4	0.3	5.3	1.1	1.6	21.8	4.8	1.9	23.9	31.0	39.3	11.4	8.1	33.3	6.0	12.6	1.1	7.3	10.6	7.9	11.4	3.6	5.0	11.3	15.6	1.7	7.3	11.6	10.9	9.7	17.8	15.4	19.6	5.3	19.4	8.7	0.5	0.9	3.5	2.7	0.5	1.1	1.2	2.7	2.7	1.0	3.7	4.0	2.4	2.1	1.7	0.7	2.1	3.0	0.7										
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Golgi apparatus,Cytosol"		7500000	7500000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favourable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.8	9.0	9.5	12.7	9.4	8.8	7.2	7.8	12.6	9.2	11.7	9.7	11.4	8.0	7.8	10.2	17.8	6.9	19.7	7.2	7.1	9.6	7.9	5.1	18.2	13.3	10.3	13.8	12.7	37.3	13.0	21.9	6.8	11.0	5.9	15.5	4.3	9.1	8.6	5.1	9.1	10.8	9.6	9.4	26.1	12.0	6.2	8.1	25.5	6.4	6.6	11.1	12.8	8.4	12.1	6.5	7.5	5.9	11.9	14.2	9.5	18.7	8.1	9.1	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165564-30166756	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0"	"Group enriched"	"Detected in some"	15	"HaCaT: 2.2;hTCEpi: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced									"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	24.4	2.8	0.0	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNFN	PLAC8L2	ENSG00000105427	Cornifelin	Q9BYD5	19	42387019-42390287	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 268.7;lymphoid tissue: 276.3;tongue: 323.6;vagina: 85.7"	"Cell line enhanced"	"Detected in many"		"A549: 14.4;HEK 293: 20.7;MCF7: 9.8"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 367.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"memory B-cell: 25.1;naive B-cell: 27.5"	"Lineage enriched"	"Detected in many"	11	"B-cells: 27.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA049073, HPA053997"	Enhanced		Approved	"Microtubules,Cytokinetic bridge"				Microtubules	Microtubules	"HPA049073: AB_2680620, HPA053997: AB_2682337"	"unprognostic (5.08e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.77e-3)"	"prognostic favourable (4.02e-5)"	"unprognostic (2.45e-1)"	0.4	0.3	0.2	0.2	0.8	0.2	2.5	0.2	0.2	58.9	0.5	0.2	0.2	0.2	4.4	1.4	268.7	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.3	0.2	39.0	0.3	0.5	37.3	0.4	0.2	0.2	0.3	0.2	0.2	0.2	0.9	0.2	323.6	276.3	0.2	85.7	27.5	2.4	0.5	2.0	0.0	0.7	1.0	4.6	14.4	0.3	1.3	0.7	0.7	0.2	0.8	0.3	0.3	0.3	0.8	1.2	4.0	6.5	0.2	1.9	1.2	1.8	0.1	0.0	20.7	0.3	5.4	1.5	0.0	0.0	0.0	1.5	3.2	0.8	0.0	0.0	0.8	0.2	0.0	9.8	0.0	0.1	5.3	4.3	1.7	0.2	2.2	1.4	1.8	2.2	6.3	2.7	4.0	1.9	4.9	2.0	0.0	0.0	4.4	0.1	0.0	4.7	5.6	2.6	0.0	1.7	0.2	0.0	2.0	0.0	0.7	1.5	0.2	25.1	0.5	0.5	2.4	27.5	0.2	0.4	0.5	0.0	0.3	0.5	0.0	1.0	0.2	0.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CYSRT1	"C9orf169, MGC59937"	ENSG00000197191	"Cysteine rich tail 1"		9	137224635-137226311	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"esophagus: 33.4"	"Cell line enhanced"	"Detected in many"		"A-431: 9.8;CAPAN-2: 12.4;HaCaT: 13.8;HeLa: 12.2;MCF7: 19.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021883, HPA021886"	Approved		Approved	"Nuclear speckles,Vesicles,Midbody"				"Nuclear speckles"	"Nuclear speckles"	"HPA021883: AB_1853190, HPA021886: AB_1853192"	"unprognostic (1.35e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.31e-3)"	"unprognostic (6.87e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	0.7	0.4	1.0	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1.0	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0.0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3.0	0.9	0.3	0.1	9.8	1.2	1.0	2.1	0.0	0.0	2.7	0.3	0.3	0.3	0.1	0.7	12.4	0.7	0.7	0.2	13.8	0.3	3.1	0.0	1.3	1.0	0.2	12.2	6.5	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.1	0.4	2.1	0.8	19.1	0.4	0.7	0.5	1.5	1.5	1.3	1.7	0.4	0.7	0.3	1.0	2.0	1.8	0.5	3.9	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.7	0.5	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3.0	0.4	0.2	0.1	1.0	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	13	"EFO-21: 6.7;NTERA-2: 2.5"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
IL36B	"FIL1, FILI-(ETA), IL-1F8, IL-1H2, IL1-ETA, IL1F8, IL1H2, MGC126880, MGC126882"	ENSG00000136696	"Interleukin 36 beta"	Q9NZH7	2	113022091-113052867	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 3.6;lymphoid tissue: 6.3;skin 1: 11.7"	"Cell line enriched"	"Detected in some"	21	"U-87 MG: 40.6"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035664	Uncertain				"Secreted to blood"					"HPA035664: AB_10669672"		"unprognostic (8.45e-2)"			"unprognostic (1.62e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.06e-1)"	"unprognostic (3.77e-2)"		"unprognostic (2.40e-3)"			"unprognostic (2.05e-1)"			"unprognostic (7.10e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976482-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 29.1;skin 1: 77.5;tongue: 90.2"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.6;HaCaT: 25.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	960000	960000	"Plasma membrane"	"Plasma membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	2.1	0.3	5.4	0.3	4.3	0.4	5.6	0.5	11.3	5.4	0.3	0.0	0.0	0.5	0.7	0.3	29.1	7.8	3.3	0.2	4.8	0.5	2.6	0.2	1.6	0.3	0.3	3.5	1.0	0.2	0.2	0.1	0.5	4.2	0.3	0.2	0.0	7.4	0.3	0.6	77.5	0.3	0.4	0.3	0.5	0.4	0.3	0.0	0.0	0.4	90.2	15.3	0.2	9.0	1.1	0.4	1.3	0.8	2.1	1.0	0.6	2.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	6.6	0.0	1.0	0.0	25.9	0.0	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	1.3	0.8	0.4	0.4	0.4	0.7	0.6	0.6	0.4	0.4	1.1	1.0	0.9	0.9	2.1	0.4	0.4	0.7	0.6	5.4	4.3	0.5	11.3	4.8	0.5	0.3	3.5	4.2	0.0
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		7200000000	7200000000	"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 166.3;lymphoid tissue: 128.7;tongue: 53.1"	"Group enriched"	"Detected in some"	7	"EFO-21: 9.7;RT4: 2.7;SK-BR-3: 6.8;U-87 MG: 5.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"					"Not detected"	"Not detected"			HPA039724	Enhanced					71000000	71000000			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	26.8	0.1	0.1	0.1	0.0	0.6	0.1	166.3	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	18.3	0.1	0.3	15.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	53.1	128.7	0.2	25.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.7	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 45.1;skin 1: 97.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 12.2"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"	3700000	3700000			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	8.3	0.0			0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		3.2	0.2	7.6	97.9	0.0	0.0	0.0	0.0	0.0	0.1			0.0		1.6	0.1	17.8	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.0										
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"		11000000	11000000	Cytosol	Cytosol	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;HSkMC: 2.0;SiHa: 3.1;U-2197: 10.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048341, HPA049988, HPA055992"	Supported					5700000	5700000			"HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998"		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SPRR1A		ENSG00000169474	"Small proline rich protein 1A"	P35321	1	152985231-152985500	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"esophagus: 495.3"	"Group enriched"	"Detected in some"	7	"HaCaT: 12.7;hTCEpi: 37.2;RT4: 14.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1736.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB011237	Enhanced									"CAB011237: "		"unprognostic (1.39e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.64e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"prognostic unfavourable (1.03e-4)"			"unprognostic (1.96e-1)"			"unprognostic (1.04e-1)"	0.4	0.0	0.4	0.4	0.4	0.0	0.7	0.4	0.4	72.3	0.4	0.4	0.4	0.0	0.4	0.4	495.3	0.0	3.8	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	52.5	0.4	0.4	11.7	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	70.7	47.3	0.5	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	12.7	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.1	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
SPRR2D		ENSG00000163216	"Small proline rich protein 2D"	P22532	1	153039725-153041931	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"esophagus: 246.4;tongue: 317.8"	"Group enriched"	"Detected in some"	5	"hTCEpi: 25.6;hTERT-HME1: 22.5;SK-MEL-30: 11.0"	"Group enriched"	"Detected in many"	5	"cervical cancer: 80.9;head and neck cancer: 353.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (7.50e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.17e-2)"		"unprognostic (5.14e-2)"		"unprognostic (1.49e-3)"	"unprognostic (3.58e-1)"		"unprognostic (1.37e-3)"			"unprognostic (6.85e-2)"	"unprognostic (1.90e-2)"		"prognostic unfavourable (1.62e-4)"	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.4	0.1	246.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	29.9	0.1	0.1	14.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	317.8	63.5	0.1	40.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	25.6	0.0	22.5	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.7	0.0	0.1	4.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMPRSS11D		ENSG00000153802	"Transmembrane serine protease 11D"	O60235	4	67820876-67884032	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.0;head and neck cancer: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052834	Uncertain				"Intracellular and membrane"					"HPA052834: AB_2681969"	"unprognostic (1.19e-1)"	"unprognostic (6.83e-2)"		"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.91e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.19e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.6	0.0	41.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	67.6	20.3	0.4	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
A2ML1	"CPAMD9, FLJ25179, p170"	ENSG00000166535	"Alpha-2-macroglobulin like 1"	A8K2U0	12	8822472-8887001	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 131.6;lymphoid tissue: 67.9;tongue: 54.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 12.1;hTCEpi: 6.0;SK-BR-3: 15.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 39.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038847, HPA038848"	Enhanced				"Secreted in other tissues"	34000000	34000000			"HPA038847: AB_2676236, HPA038848: AB_10672654"	"unprognostic (1.13e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.58e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.42e-2)"	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.1	0.6	31.3	0.1	0.1	0.1	0.0	0.6	0.2	131.6	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	1.3	0.1	0.2	0.1	0.1	17.3	0.1	0.1	18.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	1.2	0.1	54.7	67.9	0.3	28.7	1.0	1.2	1.8	2.0	1.5	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.0	2.7	12.1	0.0	6.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.8	0.7	0.4	0.9	1.0	0.7	0.9	0.4	0.4	0.3	1.0	0.5	0.6	1.7	1.5	2.0	1.2	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC005324.3		ENSG00000251537			17	15571491-15651653	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"esophagus: 23.3;tongue: 21.1;vagina: 17.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.5;HeLa: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023623, HPA066431"	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (3.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.81e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.80e-11)"	"unprognostic (1.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.09e-1)"	7.5	2.8	0.9	1.5	1.0	1.0	7.7	0.9	1.0	5.3	2.2	1.3	0.0	2.1	0.7	1.5	23.3	0.8	4.0	2.6	0.8	0.9	0.9	1.0	2.1	1.6	3.7	0.0	0.7	1.0	0.8	0.7	12.4	2.7	1.4	0.9	0.2	2.4	1.1	2.9	4.4	1.6	2.1	1.5	1.0	2.8	1.8	1.0	1.6	1.8	21.1	17.5	3.2	17.9	0.6	0.6	0.0	0.1	0.0	0.5	0.0	0.6	3.5	0.1	0.1	0.0	0.3	0.0	0.2	0.3	0.0	0.1	0.1	3.1	0.1	0.1	1.0	6.5	0.0	0.0	0.1	1.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.3	0.9	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.6	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.9	1.0	0.8	0.9	3.7	0.0	2.7	1.0
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 6.0;lymphoid tissue: 5.0;skeletal muscle: 4.7;skin 1: 6.0;tongue: 7.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.4;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA035507	Uncertain									"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.4	1.2	0.3	0.1	0.0	0.0	0.0	0.2	0.0	6.0	4.2	0.0	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.8	0.6	0.3	0.2	0.0	0.0	0.4	0.0	4.7	6.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	7.7	5.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.3	0.0
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.7;HaCaT: 8.7;HBEC3-KT: 13.9;hTCEpi: 21.6;RT4: 5.4;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA007131: AB_2667756, HPA007158: "	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.0	0.5	0.0	0.1	0.1	0.0	1.9	0.3	0.0	7.0	1.0	0.1	0.0	0.0	1.0	0.0	15.8	0.9	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.9	0.2	1.9	1.2	0.0	1.8	0.0	0.4	30.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	17.8	14.0	2.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.0	0.0	0.0	0.6	0.0	3.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	8.7	0.0	13.9	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in some"	82	"A549: 252.0;Hep G2: 69.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	68000000	68000000	Cytosol	Cytosol	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	252.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell line enriched"	"Detected in some"	20	"A549: 321.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: "	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favourable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	321.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	16.1	0.0	0.1	0.0	1.9	0.0	0.8	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662162-67681200	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7"	"Group enriched"	"Detected in some"	5	"MCF7: 30.9;SK-BR-3: 32.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			HPA045132	Approved									"HPA045132: AB_10795993"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.65e-2)"		"unprognostic (2.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.92e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	28.1	0.1	0.1	6.7	0.1	0.1	5.0	0.0	1.5	2.4	48.2	1.5	0.1	0.1	0.1	0.0	0.6	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.6	0.3	11.2	0.1	1.8	0.0	0.1	17.1	4.6	0.1	38.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.1	25.7	34.2	4.6	11.6	1.0	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	1.8	1.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	30.9	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.0	32.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALOX12	12S-LOX	ENSG00000108839	"Arachidonate 12-lipoxygenase, 12S type"	P18054	17	6996065-7010736	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7"	"Group enriched"	"Detected in some"	5	"A-431: 17.1;HEL: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.4"					"HPA010691, CAB019287, HPA064819"	Enhanced		Supported	"Nuclear speckles,Cytosol"		5800000	5800000	Cytosol	Cytosol	"CAB019287: , HPA010691: AB_1844756, HPA064819: "	"unprognostic (3.61e-3)"	"unprognostic (6.93e-2)"	"unprognostic (7.17e-5)"	"unprognostic (9.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.96e-5)"	"unprognostic (4.01e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.47e-2)"	0.3	0.6	0.3	1.5	0.4	2.0	0.3	0.3	1.0	28.6	0.4	0.3	0.3	0.7	3.4	0.5	28.4	0.4	1.6	0.8	0.3	0.1	0.3	0.3	0.5	1.9	0.5	0.3	0.4	0.8	0.0	0.3	0.7	0.4	0.3	0.0	0.4	8.1	0.3	0.5	12.8	0.8	0.3	0.3	1.5	0.3	0.6	0.3	0.3	0.8	22.7	9.5	1.2	42.7	1.1	1.3	4.8	0.9	0.7	0.8	14.3	17.1	2.9	1.3	1.0	0.0	0.0	1.1	1.1	0.0	0.0	0.0	2.5	0.6	0.8	0.6	0.0	2.2	0.0	0.1	0.0	1.8	2.2	27.4	3.8	1.8	0.1	0.2	4.5	0.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.2	0.3	0.6	0.9	0.6	0.9	0.5	0.4	0.0	2.2	0.1	0.6	0.5	0.5	0.2	1.0	0.7	3.2	1.5	0.8	1.4	0.7	0.5	0.2	0.5	0.8	2.0	0.7	1.8	0.9	1.7	0.7	0.5	0.5	1.1	0.5	0.8	0.7	0.7	0.2	0.4	4.8	0.7	0.4	1.3	0.3	14.3	0.3	0.4	0.3	0.6	0.3	0.1	0.5	0.3	0.4	0.3
ALOX15B	15-LOX-2	ENSG00000179593	"Arachidonate 15-lipoxygenase, type B"	O15296	17	8039017-8049134	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 12.7;hTCEpi: 26.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 91.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 6.1;myeloid DC: 6.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 6.8;monocytes: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010562	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA010562: AB_2668305"	"unprognostic (1.76e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.49e-2)"	8.9	0.6	0.4	0.7	0.6	0.3	57.4	0.1	0.4	7.6	4.6	0.1	0.0	0.2	0.3	0.7	30.6	0.8	0.5	0.2	1.3	0.0	2.9	0.7	44.0	7.1	1.8	0.3	0.8	0.8	0.2	0.9	0.7	1.3	35.9	0.3	0.1	3.6	0.2	0.3	15.4	1.9	0.2	4.1	3.1	1.6	1.0	2.0	0.5	0.8	6.6	4.1	1.1	12.9	0.0	6.8	0.2	6.1	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	12.7	26.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.7	0.0	0.2	0.0	1.7	0.4	0.6	0.1	0.4	1.3	0.0	1.8	0.3	1.3	2.0
ANKRD20A3		ENSG00000276203	"Ankyrin repeat domain 20 family member A3"	Q5VUR7	9	66106815-66153135	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;lung: 1.3;testis: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HDLM-2: 5.1;RPTEC TERT1: 1.4;WM-115: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain									"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.27e-2)"													0.1	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	1.1	0.1	0.0	0.0			0.0	0.0	1.3	0.1			0.0	0.0	0.0		0.0		0.0	0.5		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	2.0			0.2		0.4	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.1	0.0	5.1	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	77000000	77000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.57e-5)"	"prognostic unfavourable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	65.9	104.2	4.7	4.9	66.5	63.3	0.3	114.3	71.4	47.3	32.1	3.0	59.7	0.1	37.8	99.7	81.2	10.1	69.2	37.5	37.3	0.7	5.0	31.0	0.1	53.1	11.0	2.5	36.4	57.4	47.8	94.0	67.0	20.9	2.8	58.3	0.2	19.4	6.0	5.9	42.4	0.0	26.6	0.2	106.4	14.0	0.0	0.0	39.3	1.0	26.4	0.2	1.7	82.7	55.5	34.9	76.2	58.6	0.4	0.1	0.2	128.1	10.2	83.4	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1
ANXA8L1	"ANXA8L2, bA145E20.2, bA301J7.3"	ENSG00000264230	"Annexin A8 like 1"	Q5VT79	10	46375627-46391784	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 75.4;tongue: 34.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 71.2;HBEC3-KT: 108.3;hTCEpi: 28.7;SiHa: 25.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	5	"classical monocyte: 3.2;myeloid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;monocytes: 3.2"									"HPA045246, HPA047451"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045246: AB_2679271, HPA047451: AB_2680052"	"unprognostic (3.67e-3)"	"unprognostic (4.56e-3)"	"unprognostic (9.14e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.05e-2)"	"unprognostic (6.94e-3)"	"unprognostic (8.33e-5)"	"unprognostic (3.43e-1)"	"unprognostic (8.26e-10)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	4.8	0.0	0.0	5.6	0.3	0.0	0.0	0.0	0.7	1.2	35.9	1.2	0.0	0.9	0.0		0.0	0.1	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.9	0.0	0.0	1.1	0.7	0.0	75.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	34.2	13.3	6.9	0.6	0.0	5.0	0.8	3.2	0.5	0.0	0.5	14.2	3.7	0.0	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.0	71.2	0.0	108.3	0.0	6.1	0.0	0.0	6.9	0.0	2.5	0.0	0.1	0.0	28.7	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.0	0.0	16.6	0.0	0.0	25.6	2.2	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5										
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA014924: AB_2669120"	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
ARHGAP11B		ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30638805	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.6;intestine: 2.7;stomach 1: 1.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.6"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA064479: AB_2685272"																		0.2	0.0		0.0		0.3	0.0		0.0	0.0	1.1			1.1	0.0	0.0	2.6	0.1	0.0	0.0			0.0	0.1	0.1	1.6			0.0	0.0	0.0		1.0		0.0	2.7		0.0	0.0	0.0	0.3	0.1	0.0		0.3	1.9	0.4			0.0		0.9	0.3		1.0	0.8	0.0	0.0	0.0	1.3	0.0	2.8	0.4	0.0	1.7	0.6	0.6	1.6	0.2	1.0	1.3	0.5	4.6	3.0	0.0	1.4	1.0	5.2	4.1	0.1	2.4	4.0	0.4	0.0	17.6	1.4	0.4	0.8	0.2	0.4	0.1	0.5	1.1	1.5	1.3	7.6	3.8	0.2	2.4	0.6	0.9	0.2	0.8	1.8	1.1	1.3	4.5	2.7	1.0	1.1	1.3	0.6	1.5	3.3	1.3	4.7	2.6	0.1	3.0	2.9	2.1	1.4	1.1	3.6	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.3	0.9	0.8	1.0	0.3	0.6	0.0	0.0	0.0	0.3	0.2	0.0										
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;U-2197: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA059074: AB_2683897"	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.5	5.5	1.2	0.4	1.1	3.3	17.4	7.6	10.1	5.0	7.9	5.2	16.8	0.1	4.3	3.6	8.9	3.6	26.8	12.8	34.6	4.6	4.1	3.6	4.3	1.4	8.3	1.8	1.2	2.4	17.5	13.7	23.5	2.1	8.8	5.7	2.6	4.5	4.6	9.5	19.4	8.5	20.3	1.3	4.2	12.4	4.0	0.6	3.9	0.6	0.1	0.8	2.7	15.9	16.3	9.4	47.3	31.6	1.3	2.3	0.0	14.0	6.8	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;HEL: 3.2;NTERA-2: 1.0;U-266/84: 2.8;U-937: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved									"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.5	1.2	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.8	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0
B3GNT8	"B3GALT7, beta3Gn-T8, BGALT15"	ENSG00000177191	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8"	Q7Z7M8	19	41425359-41428730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;esophagus: 21.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.8;HUVEC TERT2: 5.3;K-562: 4.3;THP-1: 4.9;U-937: 7.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"eosinophil: 29.9;neutrophil: 43.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 43.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA043669	Enhanced				"Intracellular and membrane"	43000000	43000000			"HPA043669: AB_2678608"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (4.11e-4)"	"unprognostic (6.44e-3)"	"unprognostic (6.51e-3)"	"unprognostic (1.84e-2)"	"unprognostic (9.92e-3)"	"unprognostic (7.30e-2)"	"unprognostic (2.56e-2)"	"prognostic favourable (9.31e-6)"	"unprognostic (5.04e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	0.7	0.2	0.0	0.9	0.0	2.7	0.7	0.0	0.0	5.0	7.3			13.0	0.9	0.0	21.5	0.4	0.0	1.9	0.0	0.0	1.5	0.0	4.6	0.1	0.0		0.0	0.6	0.0	0.6	0.1		1.3	2.0		2.8	2.2	0.1	2.2	12.5	0.3	0.0	4.3	1.0	0.0			0.3		0.9	1.2	8.4	0.0	1.6	43.3	6.7	0.4	8.1	1.7	0.3	0.0	0.3	0.1	0.5	2.1	0.5	0.6	0.2	0.0	0.1	3.1	0.0	0.1	0.8	1.5	2.1	0.0	0.5	0.0	0.1	0.4	0.0	0.1	1.6	0.7	0.7	9.8	2.6	1.8	0.1	0.1	5.3	4.3	0.3	0.0	0.7	0.0	2.8	0.7	0.1	0.2	0.6	0.0	0.2	1.1	1.3	0.9	0.0	0.2	0.0	0.0	4.9	1.9	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	7.9	0.0	21.7	4.3	29.9	0.7	3.3	8.1	0.0	0.3	1.5	1.6	0.0	0.0	0.1	43.3	0.4	6.7	0.1	0.1	1.7										
BICDL2	CCDC64B	ENSG00000162069	"BICD family like cargo adaptor 2"	A1A5D9	16	3027682-3036926	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.1;pancreas: 54.1"	"Cell line enhanced"	"Detected in some"		"A-431: 6.3;BEWO: 11.3;CAPAN-2: 10.4;HaCaT: 16.2;MCF7: 15.7;RT4: 7.4;SK-BR-3: 8.1;T-47d: 10.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"eosinophil: 2.6;neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043251	Approved		Approved	"Intermediate filaments,Actin filaments,Cytosol"				"Intermediate filaments, Actin filaments, Cytosol"	"Intermediate filaments, Actin filaments, Cytosol"	"HPA043251: AB_10794925"	"unprognostic (2.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.06e-3)"	"unprognostic (9.65e-5)"	"unprognostic (5.79e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.32e-2)"	"prognostic favourable (9.04e-4)"	0.4	0.0	0.4	2.5	0.4	0.0	2.9	0.4	0.4	6.2	7.9	0.4	8.3	5.7	1.0	2.0	31.1	2.2	11.0	0.4	0.4	0.0	1.2	0.4	5.3	0.4	0.4	0.4	0.9	54.1	3.6	0.9	0.5	0.4	5.1	3.5	0.4	13.9	8.3	1.1	13.7	6.9	1.0	0.4	0.4	10.2	0.5	0.4	0.4	2.3	8.6	12.4	6.1	12.0	0.1	0.1	3.5	0.0	0.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	1.8	10.4	0.0	0.0	0.0	16.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	7.4	0.1	0.0	0.0	8.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.2	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.4;testis: 27.5;tongue: 20.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 15.9;HBEC3-KT: 36.3;hTCEpi: 40.8;hTERT-HME1: 39.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	12.7	0.1	0.0	1.6	0.1	0.0	0.9	0.0	0.4	2.7	1.5	0.1	0.0	0.0	0.4	10.8	13.4	0.8	0.1	1.4	0.1	0.0	0.1	0.1	0.7	1.3	0.2	0.2	0.6	0.0	0.0	0.0	1.9	0.5	0.4	0.0	0.7	1.7	0.2	0.1	7.9	0.2	0.3	0.3	0.1	0.0	27.5	0.0	6.0	0.2	20.2	3.7	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.3	2.1	0.0	0.6	0.1	6.9	9.7	0.0	0.1	0.0	0.3	4.2	15.9	0.8	36.3	12.6	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.8	40.8	6.2	39.8	6.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0
BNIPL	"BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753"	ENSG00000163141	"BCL2 interacting protein like"	Q7Z465	1	151036570-151047600	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.5;skin 1: 68.6"	"Cell line enriched"	"Detected in some"	10	"T-47d: 32.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basal ganglia: 1.4;cerebellum: 2.7"	"Low region specificity"	"Detected in many"			HPA019946			Uncertain	Cytosol				Cytosol	Cytosol	"HPA019946: AB_2732424"	"unprognostic (2.62e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.88e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.43e-11)"	"unprognostic (1.84e-2)"	"unprognostic (6.49e-2)"	"prognostic favourable (4.32e-4)"	"unprognostic (6.81e-2)"	0.1	0.1	0.2	0.1	0.2	0.3	6.4	0.2	0.2	9.7	0.1	0.1	9.4	0.1	0.6	0.6	42.5	1.0	0.1	0.2	0.2	0.0	0.5	0.2	6.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	3.2	0.1	3.4	0.1	0.3	7.1	21.0	0.7	68.6	0.2	0.8	0.1	0.1	0.6	1.0	0.1	0.2	2.7	25.8	23.2	5.0	18.2	1.8	0.8	3.2	0.6	0.5	1.7	0.4	0.3	0.2	0.5	0.6	0.3	0.3	0.6	0.3	0.0	0.2	0.1	1.1	0.4	0.6	0.5	0.0	1.2	0.7	0.2	0.4	0.8	0.8	0.9	0.5	0.2	0.1	0.5	0.6	0.0	2.3	0.1	0.2	0.0	0.5	0.5	0.2	1.4	0.5	0.9	0.5	0.4	0.3	0.2	0.3	0.5	0.3	1.1	0.5	0.4	0.7	0.2	32.4	0.2	0.7	0.6	0.4	0.2	0.1	1.4	1.1	3.1	0.0	0.2	0.6	2.7	0.6	0.7	1.7	0.6	1.4	0.5	1.0	1.2	0.3	1.8	1.0	0.6	3.2	0.5	0.6	0.8	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.1	0.1	0.1	0.1
BX255925.3		ENSG00000284976			9	137217452-137219361	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"esophagus: 30.6;pancreas: 25.2"	"Low cell line specificity"	"Detected in all"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"																																			0.6	3.0	0.4	1.6	0.3	5.0	1.2	0.3	0.8	3.8	7.1	0.3	0.8	5.3	0.6	3.5	30.6	1.1	12.4	2.1	0.3		1.7	1.2	1.5	2.3	0.3	0.3	0.5	25.2	0.7	0.3	1.5	0.3	3.1	0.5	0.3	14.6	1.4	1.1	6.2	8.9	0.9	0.3	1.9	7.0	15.0	0.3	0.3	0.5	15.0	15.1	1.0	0.3	1.8	4.9	3.7	2.3	2.0	2.9	5.6	5.5	9.0	5.3	6.9	2.5	2.4	20.9	6.4	3.5	6.7	4.8	8.3	6.3	8.0	4.6	2.3	19.9	3.3	4.7	1.4	8.8	9.4	4.7	21.3	7.4	4.2	6.8	15.7	3.2	4.4	7.7	2.0	3.1	11.4	6.8	2.3	15.3	6.0	19.8	9.2	31.3	15.3	7.2	9.3	2.8	5.4	6.9	7.9	5.7	7.0	4.9	18.1	10.8	3.7	10.4	11.9	16.7	7.9	5.4	9.2	6.9	5.9	7.9	7.8	0.0	1.9	3.7	1.8	2.3	2.9	1.5	1.4	1.1	1.2	1.8	0.8	0.8	3.3	2.0	1.2	4.9	1.4	5.6										
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Cell line enriched"	"Detected in some"	5	"RT4: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"					"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C15orf62	LOC643338	ENSG00000188277	"Chromosome 15 open reading frame 62"	A8K5M9	15	40770080-40772449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 19.5;SK-BR-3: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Low region specificity"	"Detected in all"			HPA044636	Approved									"HPA044636: AB_10794052"	"unprognostic (9.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.40e-1)"	1.5	0.9	0.8	1.5	1.1	1.5	1.1	4.0	1.7	1.7	1.0	0.8	0.8	2.0	1.1	0.8	22.8	0.9	1.4	0.8	0.8	0.6	0.9	1.9	1.6	2.1	1.1	0.8	1.3	0.9	0.0	1.3	0.8	0.9	1.1	0.0	0.8	5.4	1.8	1.9	11.9	1.8	0.8	0.8	1.5	1.2	0.9	0.8	1.8	1.0	18.8	21.9	0.9	3.8	0.4	0.7	0.0	0.1	0.4	1.0	0.1	0.6	0.5	1.8	2.2	0.7	0.2	0.4	0.8	0.2	0.0	0.2	2.0	2.4	1.1	2.0	0.0	4.4	0.8	0.0	0.0	1.6	1.8	1.1	4.0	0.6	0.0	0.9	1.4	0.2	1.0	0.0	0.1	0.6	0.9	1.3	0.0	0.5	1.4	1.7	0.7	0.8	1.5	0.3	0.5	19.5	1.6	3.9	0.9	0.6	6.2	0.2	2.2	1.4	0.9	2.2	1.0	2.0	0.7	1.5	1.0	1.0	0.7	3.3	0.7	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.9	0.6	0.0	0.4	1.0	1.0	0.0	0.4	0.0	0.7	0.8	0.1	0.8	1.1	4.0	0.9	0.8	0.6	1.1	0.8	0.9	0.8
C18orf25	"ARKL1, MGC12909, RNF111L1"	ENSG00000152242	"Chromosome 18 open reading frame 25"	Q96B23	18	46173553-46266991	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 54.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051314, HPA051899"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051314: AB_2681438, HPA051899: AB_2681657"	"unprognostic (1.44e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (5.77e-3)"	"unprognostic (4.46e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.97e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	5.3	4.9	5.8	6.4	8.2	18.6	6.5	10.1	10.1	6.1	4.9	5.5	6.5	4.4	7.7	5.3	54.0	6.2	3.8	11.4	4.8	4.9	5.4	6.2	5.9	6.8	5.3	6.5	5.9	5.0	15.3	6.3	7.3	8.3	5.2	5.7	9.5	11.3	4.8	13.1	6.2	5.5	5.7	4.7	6.3	5.1	7.8	5.7	8.2	7.4	10.2	11.8	7.2	12.7	8.1	11.0	19.0	11.0	2.8	11.1	5.5	11.2	11.3	9.5	10.7	6.8	6.2	12.2	16.4	8.7	17.6	15.0	8.6	13.0	8.7	15.6	11.0	25.7	17.5	11.1	19.1	14.4	5.6	7.6	9.6	6.5	11.8	14.2	10.3	5.7	13.0	20.4	17.0	6.9	8.5	10.4	9.7	8.5	10.8	7.3	8.4	4.4	9.8	11.3	12.7	16.8	20.3	13.3	6.9	12.0	8.5	8.5	5.6	8.8	10.0	16.0	11.5	3.9	15.0	13.7	11.6	14.0	8.3	15.1	17.1	4.2	7.5	15.4	5.7	8.4	9.9	5.9	11.1	8.6	7.4	8.1	8.0	6.3	19.0	2.8	11.0	11.0	7.1	5.5	5.8	8.2	10.1	10.1	4.8	4.9	5.3	6.5	8.3	5.7
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;CAPAN-2: 31.8;HaCaT: 39.2;HBEC3-KT: 37.7;hTCEpi: 20.0;RPTEC TERT1: 18.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		7900	7900	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favourable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	17.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	31.8	0.0	2.1	0.0	39.2	0.0	37.7	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.0	0.0	11.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	18.4	4.7	0.0	0.1	0.3	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2
C2orf54	FLJ22671	ENSG00000172478	"Chromosome 2 open reading frame 54"	Q08AI8	2	240886048-240896889	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5"	"Group enriched"	"Detected in some"	6	"CACO-2: 21.1;HaCaT: 15.8;SK-BR-3: 56.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.4"	"Not detected"	"Not detected"							HPA052722			Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA052722: "	"unprognostic (5.86e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (2.77e-4)"		"unprognostic (1.43e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.05e-1)"	0.3	0.0	0.3	1.5	0.3	0.0	0.9	0.3	0.3	8.9	3.9	0.3	0.3	6.3	0.7	0.4	63.8	0.3	0.3	0.3	0.3	0.0	2.8	2.8	5.5	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.7	0.3	0.5	1.1	0.3	7.6	0.3	0.3	18.6	3.6	0.3	0.3	0.3	1.0	0.3	0.3	1.0	0.3	35.5	28.6	0.8	19.1	0.8	0.1	0.7	0.2	3.4	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.1	1.3	0.1	0.1	0.0	15.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	3.1	1.0	0.0	0.0	56.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.3	0.5	0.0	0.1	0.8	0.1	0.2	0.1	3.4	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
C3orf67	"FLJ42117, FLJ42930"	ENSG00000163689	"Chromosome 3 open reading frame 67"	Q6ZVT6	3	58717365-59050084	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.4;testis: 28.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.2;T-reg: 2.2"	"Group enriched"	"Detected in many"	13	"B-cells: 2.2;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069696			Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA069696: AB_2686174"	"unprognostic (4.59e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-5)"	"unprognostic (1.91e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (6.68e-3)"	"unprognostic (8.95e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.81e-2)"	0.5	1.8	1.2	1.0	4.3	0.3	0.6	0.5	2.0	1.5	0.7	0.5	0.0	0.1	0.6	1.6	10.4	3.4	0.7	0.4	0.9	0.9	0.7	1.9	0.6	1.8	0.5	0.9	0.7	0.8	1.3	8.4	1.3	1.3	1.0	0.9	1.6	2.6	0.4	0.2	0.4	0.3	0.5	0.6	0.4	0.5	28.4	0.5	0.4	0.4	2.0	3.6	0.3	2.9	2.2	0.0	0.0	0.1	0.1	2.2	0.3	10.4	1.7	2.9	0.0	1.8	5.7	0.0	5.0	1.6	2.2	1.8	0.9	3.4	10.9	1.7	1.2	1.1	4.7	2.4	4.0	1.7	0.3	0.0	1.8	0.0	0.9	0.0	0.0	1.1	2.4	4.7	3.8	4.5	8.3	0.1	3.0	1.4	0.5	0.0	3.7	7.4	10.5	0.0	4.4	2.3	0.1	7.6	3.6	1.4	1.0	3.1	3.4	0.0	0.1	0.2	3.4	5.4	2.2	4.5	9.3	2.1	2.6	0.0	6.9	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.7	0.0	0.0	2.2	0.1	0.7	0.0	0.1	0.0	0.0	2.2	0.3	1.2	4.3	0.5	2.0	0.9	0.9	0.5	0.9	1.3	0.5
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101118-42142619	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3"	"Cell line enhanced"	"Detected in many"		"A-431: 27.2;CACO-2: 24.8;CAPAN-2: 20.6;HaCaT: 18.4;SK-BR-3: 16.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	1.3	0.5	0.2	3.7	0.2	0.2	4.2	0.3	0.3	13.3	20.9	0.2	1.4	15.7	0.7	1.2	66.1	2.6	15.5	0.5	0.2	0.1	6.2	0.6	5.9	0.2	0.2	0.2	1.4	20.8	1.1	2.2	3.1	0.2	6.8	5.3	0.2	16.6	4.0	1.2	24.8	37.2	0.7	0.2	0.2	16.2	0.4	0.2	0.6	12.5	49.3	54.3	4.8	17.5	2.1	1.9	3.5	1.3	0.9	1.2	0.7	27.2	0.3	0.0	0.1	0.1	3.2	13.5	1.6	2.0	3.8	4.0	24.8	20.6	0.0	2.9	2.7	18.4	0.0	8.3	2.5	2.2	3.8	1.3	2.4	5.5	1.0	0.0	0.1	1.9	15.4	2.9	4.3	0.0	0.7	0.2	0.7	9.5	0.3	0.1	1.8	0.7	0.1	0.0	0.1	2.9	12.3	1.5	0.0	2.4	16.6	0.0	12.1	0.1	0.4	0.2	1.8	6.9	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.9	1.3	1.7	0.8	0.8	0.6	1.0	0.8	0.8	1.4	2.1	0.9	1.2	3.5	0.9	0.5	1.9	0.5	0.7	0.2	0.2	0.3	0.3	0.2	0.1	0.2	0.2	0.2	0.2
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524009-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 108.7;skin 1: 40.8;vagina: 42.4"	"Group enriched"	"Detected in some"	6	"A-431: 16.5;hTCEpi: 6.5;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	15	"cervical cancer: 150.9;head and neck cancer: 196.3;lung cancer: 59.9;melanoma: 47.8;urothelial cancer: 43.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved					500000	500000			"CAB010070: , HPA044999: AB_2679177"	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	24.5	0.0			0.0	0.0	0.0	108.7	0.2	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		29.8	0.0	0.1	40.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		9.0	0.0	42.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CAPNS2	"MGC12536, MGC14804"	ENSG00000256812	"Calpain small subunit 2"	Q96L46	16	55566672-55567687	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 56.0;skin 1: 44.1;tongue: 45.6"	"Cell line enriched"	"Detected in some"	10	"hTCEpi: 69.8"	"Group enriched"	"Detected in many"	15	"cervical cancer: 19.6;head and neck cancer: 26.3;lung cancer: 10.2;melanoma: 5.8;urothelial cancer: 21.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.9;intermediate monocyte: 2.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 2.1"	"Not detected"	"Not detected"							"HPA059749, HPA076768"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA059749: AB_2732639, HPA076768: AB_2732322"	"unprognostic (3.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (3.32e-2)"		"unprognostic (1.79e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	0.1	0.0	0.1	0.1	0.4	0.2	3.4	0.1	0.1	5.8	0.1	0.1	0.1	0.0	0.4	0.1	56.0	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.2	6.7	0.1	0.6	44.1	0.1	1.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1	45.6	14.6	12.3	10.8	0.0	0.5	6.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	69.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	6.9	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CARD14	"BIMP2, CARMA2, PSORS2"	ENSG00000141527	"Caspase recruitment domain family member 14"	Q9BXL6	17	80169992-80209331	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.1;skin 1: 17.3;tongue: 12.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 7.1;SK-BR-3: 9.7;T-47d: 21.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.79e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.05e-5)"	"unprognostic (2.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.92e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-8)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-1)"	0.4	1.9	0.4	0.9	0.4	0.1	3.2	0.4	0.7	4.0	0.4	0.4	0.4	2.1	0.8	1.0	12.1	0.3	0.6	0.4	0.4	0.3	0.7	1.1	0.7	1.0	0.4	0.4	1.0	0.4	0.0	0.4	3.0	0.6	2.1	0.0	0.4	6.2	3.6	0.6	17.3	1.6	0.4	1.5	1.8	0.5	0.8	0.4	0.4	0.4	12.3	10.7	1.3	5.8	2.0	0.0	0.0	0.5	0.0	0.4	0.1	3.8	0.5	0.6	0.2	0.0	0.0	3.8	0.2	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	2.0	0.2	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	1.2	0.0	7.1	0.0	0.0	0.1	0.4	0.0	1.6	0.4	0.0	3.0	0.5	0.1	0.0	9.7	1.5	21.6	0.0	0.2	0.1	0.5	0.3	0.0	2.1	0.2	0.1	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.4	0.3	2.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.4	0.4	0.7	0.4	0.3	0.4	0.4	0.6	0.4
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;HUVEC TERT2: 4.9;LHCN-M2: 7.5;TIME: 17.0;U-2197: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	4.9	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.4	0.0	9.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.3;HaCaT: 28.1;HeLa: 9.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA013332: , HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.3	6.7	0.2	1.9	0.2	0.7	0.1	0.5	1.5	0.2	0.7	5.0	15.3	0.1	0.4	1.3	28.1	0.4	0.3	0.4	2.3	0.3	0.1	9.5	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.0	1.2	0.8	0.1	0.4	0.2	0.2	0.8	0.0	0.4	0.0	1.8	3.7	0.1	0.2	2.2	2.0	0.1	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0										
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 17.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	19000000	19000000	"Plasma membrane"	"Plasma membrane"	"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.4	1.4	0.3	0.0	0.1	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CEACAM6	"CD66c, NCA"	ENSG00000086548	"Carcinoembryonic antigen related cell adhesion molecule 6"	P40199	19	41750977-41772208	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 81.4;gallbladder: 75.7;lung: 129.1"	"Cell line enriched"	"Detected in some"	8	"A549: 57.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.6;monocytes: 1.3"									"CAB008370, HPA011041"	Enhanced					79000000	79000000			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-4)"	"unprognostic (4.08e-1)"	"unprognostic (8.71e-3)"	"unprognostic (2.85e-1)"	"unprognostic (7.68e-2)"	0.3	0.3	0.3	7.4	0.3	29.7	0.3	0.3	0.3	16.8	35.3	0.2	0.1	5.8	0.9	0.2	81.4	1.1	75.7	2.3	0.3	0.3	0.3	0.8	129.1	0.1	0.3	0.1	0.3	1.7	0.0	0.3	32.1	0.2	0.9	43.1	0.2	50.1	0.1	0.3	2.1	12.8	0.9	0.3	0.8	2.6	0.3	0.1	1.0	0.3	25.3	58.1	2.3	21.0	0.1	0.3	2.6	1.3	0.1	0.3	5.2	0.0	57.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	1.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	1.5	0.0	0.2	0.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.6	0.1	0.5	0.3	0.0	5.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
CERS3	"LASS3, MGC27091"	ENSG00000154227	"Ceramide synthase 3"	Q8IU89	15	100400395-100544995	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.6;skin 1: 29.0;testis: 37.9"	"Cell line enriched"	"Detected in some"	6	"hTCEpi: 37.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 14.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006092, HPA024356"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006092: AB_1079236, HPA024356: AB_1852721"	"unprognostic (5.01e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.47e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.84e-3)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-5)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-3)"	0.4	0.0	0.4	0.4	0.4	0.0	1.9	0.4	0.4	6.0	0.4	0.4	0.4	0.0	0.4	0.4	25.6	0.3	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.0	0.4	3.6	0.4	0.4	29.0	0.4	0.4	0.4	0.4	0.0	37.9	0.4	0.4	0.4	0.4	8.5	0.4	11.2	0.0	0.0	1.5	0.6	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	0.2	0.2	0.0	0.7	0.3	0.0	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.2;esophagus: 19.9;intestine: 25.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 42.6;hTCEpi: 19.3;SCLC-21H: 15.1;SK-BR-3: 33.5;T-47d: 29.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043491	Uncertain				"Intracellular and membrane"	2100000	2100000			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	0.0	0.7	4.8	1.9	6.3	0.0	2.1	17.2	12.6	1.8	25.5			24.7	0.0	0.0	19.9	0.4	3.0	0.0	5.6	7.9	0.9	0.0	0.0	0.0	5.0		0.0	0.1	2.1	1.4	2.5		0.5	24.1		7.2	0.0	0.0	13.0	21.7	0.9	1.1	0.0	7.8	0.0			0.6		4.4	1.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	0.0	10.6	0.0	0.0	0.0	0.0	2.2	7.3	0.0	0.4	0.0	42.6	6.1	12.5	0.0	0.0	4.7	0.0	0.7	0.2	0.0	0.0	2.0	0.0	19.3	0.0	3.3	0.0	1.9	0.0	0.0	9.9	0.0	0.0	3.0	2.3	0.0	0.0	1.9	2.0	1.5	15.1	5.9	0.0	33.5	2.2	29.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell line enriched"	"Detected in some"	5	"hTCEpi: 67.0"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	66000	66000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	12.3	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	10.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	67.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;MCF7: 30.4;SK-BR-3: 12.7;T-47d: 29.0;TIME: 23.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005963	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.4	0.0	0.0	0.0	0.1	0.3	66.8	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.4	4.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.1	12.7	0.0	29.0	0.0	23.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein like 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;esophagus: 9.5"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;AF22: 15.1;TIME: 9.5;WM-115: 25.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	22	"neutrophil: 10.6"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.6"									HPA047731	Uncertain				"Intracellular and membrane"					"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.9	0.1	1.2	0.3	4.8	1.0	2.6	0.4	2.5	0.8	2.4			0.6	0.2	0.2	9.5	1.6	1.1	4.1	1.2	1.3	1.1	0.0	0.8	0.0	0.8		0.0	0.0	0.0	0.3	1.7		1.6	1.4		2.8	1.7	0.0	8.3	1.0	2.5	1.1	2.4	0.1	1.9			1.3		0.3	0.5	1.9	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.7	12.4	15.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	3.1	1.2	2.9	0.0	0.0	1.1	0.0	3.3	0.3	0.1	0.1	0.0	0.4	2.8	0.0	1.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	2.6	3.8	0.0	0.4	3.4	0.3	0.5	1.4	0.5	4.4	0.0	2.4	0.0	2.1	9.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0										
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	480000	480000	Nucleoplasm	Nucleoplasm	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CRABP2	CRABP-II	ENSG00000143320	"Cellular retinoic acid binding protein 2"	P29373	1	156699606-156705816	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 154.2;tongue: 80.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 160.3;MCF7: 61.1;T-47d: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA004135	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA004135: AB_1846516"	"unprognostic (1.17e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (2.11e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.23e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.19e-13)"	"unprognostic (3.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.25e-2)"	4.9	1.1	1.0	1.7	3.2	0.7	16.8	1.3	2.1	66.8	1.3	1.2	38.5	0.0	13.9	2.8	154.2	13.1	2.8	1.2	0.9	2.1	1.4	0.2	0.7	0.4	0.8	2.9	5.9	0.8	2.7	5.0	7.0	3.7	6.7	0.7	7.9	10.6	28.0	0.5	25.7	0.9	8.8	1.1	0.8	0.5	1.1	0.9	2.1	2.2	80.5	33.5	10.0	66.6	0.1	0.0	0.4	0.0	0.0	1.3	0.5	10.2	0.5	11.7	0.1	15.3	22.9	0.0	21.8	160.3	1.7	2.2	18.2	37.8	0.1	10.8	23.1	13.3	2.8	0.0	0.5	0.2	0.8	0.0	1.4	0.1	3.0	0.0	0.2	7.2	1.0	2.5	0.0	0.0	0.0	0.2	0.1	61.1	0.1	0.1	14.1	5.7	0.1	0.0	0.3	0.2	0.4	29.2	2.1	0.3	37.8	0.1	124.2	0.0	0.0	0.4	6.7	3.6	1.3	0.9	2.2	0.1	3.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.2	0.0	0.1	1.3	1.2	0.4	0.0	0.0	0.0	0.0	0.5	1.0	3.2	1.3	2.1	0.9	2.1	0.8	2.9	3.7	0.9
CRCT1	"C1orf42, NICE-1"	ENSG00000169509	"Cysteine rich C-terminal 1"	Q9UGL9	1	152514502-152516010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 212.8;lymphoid tissue: 82.6;tongue: 126.1;vagina: 69.4"	"Cell line enriched"	"Detected in single"	11	"CAPAN-2: 10.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 68.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (3.01e-2)"				"unprognostic (6.92e-2)"		"unprognostic (2.86e-2)"	"unprognostic (3.30e-1)"		"prognostic unfavourable (7.03e-4)"			"unprognostic (1.56e-2)"			"unprognostic (1.46e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.7	0.1	0.1	46.9	0.1	0.1	0.1	0.2	2.3	0.1	212.8	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.1	22.9	0.1	0.7	38.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	126.1	82.6	0.1	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CRNN	"C1orf10, SEP53"	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HaCaT: 1.1;HL-60: 1.2;K-562: 2.0;TIME: 1.2;U-266/84: 1.0;U-698: 1.5;U-937: 1.7"	"Group enriched"	"Detected in many"	18	"cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024343, CAB026182"	Enhanced					36000	36000			"CAB026182: , HPA024343: AB_1847162"		"unprognostic (1.96e-2)"		"unprognostic (1.74e-6)"		"unprognostic (4.20e-2)"			"unprognostic (3.43e-1)"	"unprognostic (6.43e-3)"								0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	57.1	0.2	0.0	0.0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	49.6	0.2	0.2	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.2	139.6	187.9	0.3	81.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	1.0	1.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Not detected"	"Not detected"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules, Cytosol"	"Nucleoplasm, Microtubules, Cytosol"	"CAB026378: , HPA030948: AB_2673670, HPA030949: "	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.4	0.0	0.0	0.0	8.8	31.7	3.2	1.5	11.6	3.4	3.2	0.7	3.7	16.4	0.7	7.2	16.9	0.1	39.6	1.6	22.3	0.7	0.0	0.4	5.1	4.2	10.0	0.0	15.8	23.1	6.4	30.7	14.4	0.5	2.3	9.1	1.2	2.8	4.0	0.1	6.9	4.9	0.1	0.1	5.3	24.9	0.7	0.0	6.4	11.0	0.1	5.4	7.6	4.2	3.8	0.5	0.0	10.5	1.8	1.4	17.9	18.1	12.6	8.2	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5
CRYBG2	"AIM1L, FLJ38020"	ENSG00000176092	"Crystallin beta-gamma domain containing 2"	Q8N1P7	1	26321698-26360080	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.9;placenta: 55.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.0;BEWO: 15.1;CACO-2: 24.6;CAPAN-2: 16.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029629			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029629: AB_10601331"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (5.11e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.39e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.83e-9)"	"unprognostic (9.12e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.63e-2)"	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	8.0	4.4	0.0	0.0	4.9	0.9	0.6	43.9	0.2	2.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	55.0	0.0	0.8	1.4	0.1	5.1	0.0	0.0	13.8	10.4	0.0	0.0	0.0	0.9	1.2	0.0	0.1	0.0	22.0	19.8	4.9	16.1	0.7	0.0	2.4	0.1	0.2	1.7	0.3	7.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	24.6	16.5	0.1	5.0	0.0	6.1	0.0	4.4	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.3	1.6	0.3	0.0	0.0	2.9	0.0	4.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.1	0.5	0.7	1.7	0.7	0.0	0.6	0.5	0.5	2.4	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol		39000000	39000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favourable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.6	0.1	0.0	0.3	3.8	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.6	10.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	13.3	0.2	3.7	146.6	0.3	14.4	0.0	0.0	3.5	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.6	0.8	1.1	0.1	91.6	0.0	0.2	2.4	0.0	0.1	0.0	0.1	58.3	3.2	29.1	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		6100000	6100000	Cytosol	Cytosol	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CXCL17	"Dcip1, DMC, UNQ473, VCC1"	ENSG00000189377	"C-X-C motif chemokine ligand 17"	Q6UXB2	19	42428288-42443048	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.0;lung: 83.0;stomach 1: 79.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 2.1;RT4: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (2.74e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.03e-2)"		"unprognostic (4.46e-3)"	"unprognostic (3.77e-1)"	"prognostic favourable (4.92e-5)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.29e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.7	0.1	0.1	17.4	0.1	0.4	0.1	0.0	1.0	5.1	68.0	6.3	1.3	0.1	0.1	0.0	0.7	0.4	83.0	0.1	0.1	0.1	2.8	11.4	0.0	2.3	0.1	0.3	6.8	0.0	0.3	39.2	0.5	0.1	0.0	0.1	0.3	0.1	0.1	79.9	0.3	0.1	0.5	1.2	8.8	40.1	5.5	10.0	0.0	0.0	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271464-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;esophagus: 24.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.3;Karpas-707: 7.4;NB-4: 15.9;RPMI-8226: 24.1;THP-1: 14.9;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010546	Approved									"HPA010546: AB_1078268"	"unprognostic (9.48e-2)"	"unprognostic (6.01e-5)"	"unprognostic (4.72e-3)"	"unprognostic (3.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.41e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.94e-2)"	7.3	2.0	1.7	7.8	1.7	2.8	5.4	0.8	2.2	3.0	3.3	1.7	2.9	2.2	2.3	4.4	24.6	2.3	5.6	3.1	2.3	1.9	4.8	2.7	6.9	19.5	3.8	0.8	1.7	2.0	1.7	1.5	3.3	2.9	3.7	4.8	3.1	5.4	0.8	1.7	3.1	7.1	4.2	5.1	22.8	5.2	2.3	4.0	4.7	4.5	4.8	11.3	9.8	3.5	8.1	7.4	33.9	11.9	4.1	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	15.9	0.0	0.0	3.2	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	16.4	0.0	5.8	6.3	33.9	0.0	10.9	0.0	8.1	2.4	0.1	4.8	5.8	3.7	0.0	18.4	4.1	11.9	7.4	0.5	2.8	1.7	1.7	0.8	2.2	2.3	1.9	3.8	0.8	2.9	4.0
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9"	"Group enriched"	"Detected in all"	7	"cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"				"Nucleoplasm, Nuclear bodies, Microtubules"	"Nucleoplasm, Nuclear bodies, Microtubules"	"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	0.3	14.7	1.4	0.4	1.3	0.0	7.4	0.4	1.0	11.7	1.0	0.8	1.6	0.0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0.0	5.6	0.2	1.5	2.3	0.0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2.0	21.1	1.4	4.0	2.9	2.6	2.8	1.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.0	0.3	5.5	0.0	0.0	0.0	0.6	0.6	1.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	2.9	2.6	1.6	0.5	1.9	1.0	1.2	0.8	0.4	1.0	1.4	0.4	0.5	2.2	2.8	0.6	4.0	1.3	0.5	1.4	1.3	0.4	1.0	1.5	3.6	2.8	0.3	1.5	0.8
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.7;skeletal muscle: 31.1"	"Cell line enhanced"	"Detected in many"		"U-2197: 10.1;U-266/70: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 6.1;eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA054955	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	1.9	0.7	1.5	0.7	1.5	0.8	1.7	1.4	1.1	8.6	1.1	0.5	0.8	0.6	4.2	1.7	28.7	1.0	1.1	1.5	1.3	0.5	0.8	2.1	1.7	1.7	0.6	0.3	1.1	4.0	2.4	3.6	0.3	1.9	2.5	0.6	1.6	3.0	1.4	31.1	10.6	0.6	2.4	0.6	0.5	0.8	4.5	0.2	0.0	1.3	16.0	10.4	6.2	6.6	0.6	0.1	6.1	0.2	0.3	0.5	0.3	1.7	0.0	0.1	1.2	1.5	1.6	0.3	0.5	0.9	0.6	0.9	0.2	0.0	0.0	0.8	3.4	6.3	1.1	3.9	0.6	0.0	1.5	1.0	0.3	0.1	0.5	0.0	1.6	1.6	3.8	2.3	2.0	0.2	0.1	0.3	2.0	5.0	0.2	0.1	0.8	0.9	0.0	5.4	0.1	0.1	4.8	0.0	0.0	3.9	0.1	0.4	0.8	0.3	0.2	0.9	1.3	10.1	0.1	22.1	3.9	0.0	0.9	0.0	0.7	6.1	0.2	2.1	0.5	0.0	0.5	0.6	0.1	0.4	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.1	0.2	0.3	1.5	1.5	1.4	1.1	1.3	0.5	0.6	0.3	1.9	0.2
DKK4		ENSG00000104371	"Dickkopf WNT signaling pathway inhibitor 4"	Q9UBT3	8	42374068-42377232	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.6;gallbladder: 9.9"	"Cell line enriched"	"Detected in single"	11	"Hep G2: 6.7"	"Cancer enriched"	"Detected in many"	20	"endometrial cancer: 174.4"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052916	Uncertain				"Secreted in other tissues"					"HPA052916: AB_2681987"	"unprognostic (1.64e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.73e-2)"		"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"		"unprognostic (8.11e-2)"	0.2	0.0	0.1	0.1	0.1	0.2	1.6	2.8	0.1	2.3	0.1	0.1	0.1	5.1	1.6	2.3	10.6	0.7	9.9	0.1	0.1	1.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	2.0	0.1	0.5	1.4	0.0	0.1	1.7	1.9	0.2	0.2	0.9	0.5	0.1	0.1	2.2	2.9	0.1	1.8	0.1	5.9	1.6	2.5	4.3	0.7	0.7	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.1	0.1	2.8	0.1	0.1	1.0	0.1	0.1	0.5	0.1
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102415	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;CAPAN-2: 20.5;HaCaT: 29.6;hTCEpi: 32.0;SK-BR-3: 18.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.4;neutrophil: 5.7"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 20.4"	"Not detected"	"Not detected"							"HPA011911, HPA012615"	Enhanced					14000000	14000000			"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (3.01e-4)"	3.3	1.1	1.1	9.8	1.1	0.0	6.3	0.7	0.9	38.1	23.6	0.6	0.2	12.1	3.0	2.4	127.5	1.5	1.1	9.5	1.0	0.9	4.7	4.3	3.3	6.3	1.1	0.6	1.0	3.8	11.8	0.7	20.0	1.1	4.5	13.3	1.3	22.4	0.0	0.7	4.4	33.5	0.8	1.7	6.1	12.6	0.9	0.7	4.8	2.5	163.9	68.2	1.0	39.6	0.0	0.0	20.4	1.5	0.0	0.0	0.3	7.3	0.7	1.2	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	3.8	20.5	0.0	0.3	0.0	29.6	4.9	2.1	0.0	0.0	2.9	11.0	3.6	6.6	0.1	0.0	0.2	0.1	32.0	0.0	3.1	0.0	5.3	0.0	0.0	5.9	0.0	0.4	4.8	7.3	5.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	18.8	0.0	5.0	7.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	20.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	1.1	1.1	0.7	0.9	1.0	0.9	1.1	0.6	1.1	0.7
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447795-31478702	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9"	"Group enriched"	"Detected in some"	7	"HaCaT: 41.1;hTCEpi: 101.8"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046864, HPA056863, CAB069880"	Enhanced									"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.90e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.1	35.9	1.1	0.0	0.0	1.6	2.3	0.0	156.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	10.6	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.0	158.9	50.7	0.4	24.8	0.2	0.1	9.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.8	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.5;HaCaT: 49.1;HBEC3-KT: 35.3;hTCEpi: 111.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		110000000	110000000	"Cell Junctions"	"Cell Junctions"	"CAB037324: , HPA045840: AB_2679468, HPA054950: "	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favourable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.6	6.2	0.0	0.0	0.9	1.4	45.5	4.0	3.5	2.0	2.0	17.7	5.4	0.0	5.8	6.5	49.1	7.5	35.3	0.3	0.0	8.7	0.0	3.5	23.8	0.0	0.1	0.1	0.3	111.4	1.8	20.4	0.0	0.0	0.0	3.6	9.7	0.0	0.1	0.9	3.1	0.0	0.0	5.2	7.5	5.6	2.1	0.0	4.6	9.8	0.0	11.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell line enhanced"	"Detected in all"		"A549: 28.0;CAPAN-2: 46.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"	"Nucleoplasm, Nuclear membrane"	"HPA042931: AB_2678227"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.7	28.0	4.2	6.1	2.4	2.3	9.0	2.7	2.4	3.1	4.2	7.8	46.2	4.0	2.0	2.7	9.6	2.2	13.3	1.9	8.9	4.7	2.3	5.7	6.8	3.2	3.3	5.8	4.1	8.1	7.9	4.3	2.3	6.9	6.0	3.7	6.2	5.0	11.5	6.0	4.2	5.6	3.8	7.1	1.4	10.0	1.6	3.4	4.5	7.7	3.7	7.7	8.8	2.4	17.3	8.2	5.8	11.0	4.5	5.3	4.5	3.7	3.5	8.8	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4										
DUOXA1	"FLJ32334, mol, NIP, NUMBIP"	ENSG00000140254	"Dual oxidase maturation factor 1"	Q1HG43	15	45117367-45129938	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 48.0"	"Cell line enriched"	"Detected in some"	7	"HaCaT: 47.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"MAIT T-cell: 2.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041578	Approved									"HPA041578: AB_10795691"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.36e-2)"	0.5	1.2	0.4	0.9	0.5	0.0	1.4	0.4	0.6	8.5	0.4	0.7	18.8	0.1	2.0	18.9	48.0	1.9	1.8	0.4	0.4	0.0	0.6	0.4	23.7	0.4	0.4	0.4	0.4	0.4	1.0	0.4	1.0	0.5	5.7	0.0	1.6	7.5	9.5	0.4	32.8	0.5	1.7	0.4	0.4	9.1	0.6	0.4	0.4	30.3	34.1	26.2	10.0	17.9	0.1	0.0	0.0	0.1	0.1	2.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.5	0.4
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	12000000000	12000000000	Cytosol	Cytosol	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.5;HaCaT: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	102	"T-cells: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042292	Approved									"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.3	0.2	0.3	1.9	0.4	0.5	1.8	0.4	0.3	2.8	2.9	0.1	0.0	2.2	1.1	2.6	9.2	0.4	6.8	0.5	0.3	0.4	1.9	1.9	2.4	6.6	0.3	0.0	0.3	0.5	0.0	0.2	0.2	0.3	1.6	4.5	0.1	3.2	0.1	0.3	3.5	2.5	1.3	1.2	0.5	1.8	0.6	0.2	3.2	0.3	1.7	11.3	4.6	3.5	0.0	0.0	0.0	0.0	0.0	10.2	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.5	0.0	14.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.2	4.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.4	0.4	0.3	0.3	0.4	0.3	0.0	0.3	0.2
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234337-31269447	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.4;esophagus: 29.1"	"Cell line enhanced"	"Detected in many"		"BJ: 25.1;BJ hTERT+: 62.1;HEL: 24.1;U-266/70: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 17.8;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	9	"B-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"		41000000	41000000	"Plasma membrane"	"Plasma membrane"	"HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713"	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.7	7.1	15.0	5.6	16.3	2.0	3.3	10.6	37.4	5.6	2.2	7.3	0.0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15.0	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6.0	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3.0	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1.0	1.9	0.6	1.7	7.8	0.5	2.6	1.4	1.2	2.5	3.8	0.2	25.1	62.1	2.4	2.2	0.0	0.3	0.1	0.9	8.2	0.2	0.0	1.6	1.7	1.0	2.2	24.1	0.1	0.0	8.6	0.0	0.0	6.0	0.7	2.4	1.0	0.0	0.0	0.1	1.8	3.9	0.3	0.0	5.6	1.3	0.8	0.1	0.5	1.9	2.8	0.7	3.9	0.2	0.4	0.0	0.3	0.0	0.0	1.8	1.7	0.1	2.0	15.6	1.9	0.0	4.8	0.0	3.9	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1.0	0.6	1.9	0.0	0.4	7.8	15.0	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6
EMP1	"CL-20, TMP"	ENSG00000134531	"Epithelial membrane protein 1"	P54849	12	13196716-13219939	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 240.9;lymphoid tissue: 129.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 129.3;fHDF/TERT166: 89.9;HaCaT: 80.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 28.6"	"Cell type enriched"	"Detected in some"	7	"myeloid DC: 7.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051931, HPA056250"			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051931: , HPA056250: "	"unprognostic (1.40e-2)"	"unprognostic (7.30e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (2.26e-8)"	"prognostic unfavourable (7.46e-4)"	"unprognostic (2.98e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (9.69e-8)"	63.3	5.0	2.7	8.0	10.4	2.1	20.8	0.8	3.9	51.3	11.6	5.5	4.0	4.6	14.0	10.4	240.9	9.9	25.2	16.1	7.3	2.8	8.9	4.4	18.1	5.9	5.3	0.9	5.7	10.2	2.9	2.8	10.6	28.6	6.3	6.9	17.8	45.4	2.8	12.0	16.8	10.7	17.6	9.7	8.5	6.0	5.2	3.0	0.6	22.5	99.1	129.3	14.1	80.6	0.0	7.0	0.0	0.5	0.1	0.1	0.0	38.1	2.0	0.9	0.2	61.8	129.3	0.1	28.3	51.9	14.6	18.7	0.2	64.6	0.2	20.2	89.9	80.4	1.1	3.7	19.8	0.7	0.0	0.1	6.7	0.0	14.9	0.2	0.2	40.5	5.4	46.4	13.6	33.3	0.2	0.6	34.3	0.1	0.0	0.8	0.7	6.5	0.1	3.9	0.3	42.6	0.4	0.0	0.0	12.6	1.8	21.0	0.3	0.2	36.5	32.8	11.5	30.8	15.2	0.1	0.4	0.2	47.8	0.2	38.5	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	2.7	10.4	0.8	3.9	7.3	2.8	5.3	0.9	28.6	3.0
ENDOU	"P11, PP11, PRSS26"	ENSG00000111405	"Endonuclease, poly(U) specific"	P21128	12	47709734-47725567	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 42.1;placenta: 86.0;tongue: 28.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.3;SK-BR-3: 9.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA012388, HPA067448"	Enhanced				"Secreted in other tissues"					"HPA012388: AB_1854860, HPA067448: AB_2685843"	"unprognostic (2.61e-2)"	"unprognostic (4.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (6.29e-4)"	"unprognostic (6.50e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	0.6	0.1	1.3	0.2	1.4	0.2	1.2	0.2	1.1	7.5	0.2	0.2	0.2	0.1	0.3	0.8	42.1	0.6	0.4	0.4	0.7	0.1	0.2	0.2	0.2	0.2	0.4	0.3	0.9	0.2	0.1	0.2	86.0	0.5	0.2	0.1	0.2	9.3	0.2	0.2	13.5	0.2	0.4	0.3	0.2	0.1	0.2	0.2	0.5	0.4	28.8	21.6	0.2	10.9	0.2	0.2	0.8	0.2	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	2.4	1.5	0.3	1.9	1.6	1.4	0.2	0.1	4.3	1.0	0.2	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	1.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	9.6	0.1	0.2	0.0	0.3	0.4	0.1	1.2	0.2	2.4	2.3	0.8	0.2	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	1.3	1.4	0.2	0.7	0.7	0.1	0.4	0.3	0.5	0.2
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Group enriched"	"Detected in some"	6	"hTCEpi: 61.2;U-2197: 27.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA014420: "	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavourable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.1	0.0	61.2	1.0	4.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.2	1.1	0.0	0.1	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 41.9;EFO-21: 40.4;PC-3: 48.0;U-251 MG: 49.2;WM-115: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.4	31.3	8.7	4.2	0.6	0.7	5.1	9.3	13.3	17.0	10.8	13.0	41.9	0.0	40.4	5.3	6.3	2.0	21.6	5.9	0.0	1.4	0.0	9.1	8.3	11.1	0.0	0.0	1.0	8.1	9.2	20.5	18.1	0.0	0.0	10.7	4.9	0.0	0.0	4.2	48.0	0.0	7.9	0.0	18.0	8.0	0.0	1.3	18.2	4.4	1.2	0.6	0.1	22.3	6.1	16.3	0.4	49.2	0.0	0.1	0.1	4.7	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;NTERA-2: 5.9;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 2.8;monocytes: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.2	0.1	0.1	0.2	0.3	0.1	1.0	0.1	0.3	12.5	0.2	0.2	0.4	0.1	0.9	0.3	34.8	1.1	1.7	0.1	0.5	0.1	1.6	0.2	1.6	0.0	0.2	0.0	0.6	0.0	2.2	2.4	0.2	0.4	1.5	0.1	0.6	3.4	0.6	0.2	33.1	0.2	0.2	0.2	1.2	0.5	2.7	0.2	2.4	0.2	39.6	29.6	2.8	13.6	0.0	2.8	0.2	4.9	0.0	0.0	0.5	0.2	0.6	1.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.7	0.8	0.5	6.3	0.2	0.3	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.0	0.5	0.0	0.5	0.0	0.3	0.6	0.0	0.0	0.3	0.4	0.0	1.0	0.1	0.8	5.9	0.8	0.0	0.0	0.1	0.2	1.3	2.6	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.8	0.1	0.3	0.1	0.6	0.8	0.1	0.2	0.2	0.0	1.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	4.9	2.8	0.0	0.5	0.1	0.3	0.1	0.3	0.5	0.1	0.2	0.0	0.4	0.2
EPS8L1	"DRC3, FLJ20258, MGC23164, MGC4642"	ENSG00000131037	"EPS8 like 1"	Q8TE68	19	55072020-55087923	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.9;placenta: 45.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.1;BEWO: 31.9;SK-BR-3: 9.8;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041851, HPA043545"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA041851: AB_2677706, HPA043545: AB_2678544"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (7.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.43e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.65e-2)"	"unprognostic (3.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.63e-1)"	1.2	0.0	0.2	2.1	0.3	0.0	1.7	0.3	0.4	7.6	2.1	0.2	1.5	2.0	1.3	1.8	40.9	6.2	6.9	0.2	0.2	0.0	4.1	0.2	1.8	0.2	0.2	0.2	1.6	4.0	1.1	1.1	45.0	0.3	2.9	0.5	0.3	6.6	2.5	0.4	18.7	1.5	0.7	0.2	0.4	23.2	0.9	0.2	1.0	6.2	12.1	16.9	1.9	12.1	0.1	3.5	5.1	0.4	1.7	0.8	0.5	9.1	0.4	0.3	0.2	0.0	0.0	31.9	0.8	0.0	0.0	0.0	2.9	7.6	0.1	1.9	0.0	4.6	0.2	0.5	0.0	0.2	0.9	0.7	0.3	0.2	0.1	1.4	6.4	0.0	1.4	0.0	0.0	0.0	3.4	0.0	0.0	4.2	0.5	1.4	0.5	0.0	0.1	0.0	3.0	0.7	0.7	0.1	2.3	0.6	9.8	0.4	15.5	1.8	0.7	0.0	0.4	0.0	0.0	1.4	1.7	0.9	2.0	0.5	1.2	2.6	0.4	5.1	0.8	0.1	0.7	0.0	0.4	0.8	0.0	0.1	0.1	0.0	0.0	1.7	0.0	3.5	0.7	0.5	0.2	0.3	0.3	0.4	0.2	0.0	0.2	0.2	0.3	0.2
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639916-52695900	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 98.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	75000	75000			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavourable (7.59e-4)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	12.4	3.9	4.7	8.2	5.7	18.1	6.8	6.3	7.4	27.8	8.1	3.6	8.2	7.6	5.3	6.9	98.4	4.4	8.3	6.9	4.3	5.8	6.6	16.2	8.3	8.9	4.0	5.5	7.0	9.0	6.1	5.8	20.0	5.8	7.1	7.9	7.0	20.3	7.3	4.1	7.1	10.0	5.9	5.4	8.2	12.2	3.3	3.7	4.4	6.7	31.0	28.2	27.5	28.3	4.5	4.2	14.9	7.5	6.1	10.5	2.1	32.1	7.5	6.4	7.0	17.9	20.7	11.8	14.0	16.7	11.0	18.5	10.5	50.3	8.5	17.3	8.8	20.0	8.5	26.5	27.8	7.1	4.3	1.1	7.6	13.0	15.5	18.9	23.3	18.0	17.7	14.1	14.5	15.2	5.2	16.3	14.6	4.9	11.3	11.6	3.7	5.2	6.9	20.1	11.3	17.0	30.7	5.7	15.4	9.4	5.7	12.5	7.9	7.0	13.2	20.0	9.9	16.3	12.1	8.4	9.0	7.2	29.1	9.7	9.2	14.9	5.5	9.6	4.8	6.1	10.4	4.5	9.2	6.1	4.2	3.1	5.5	5.4	13.4	6.1	7.5	3.3	10.5	2.1	4.7	5.7	6.3	7.4	4.3	5.8	4.0	5.5	5.8	3.7
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (2.01e-5)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favourable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.4	12.7	13.7	11.2	0.3	1.2	8.4	8.2	4.2	14.1	9.0	6.9	11.0	22.5	4.6	3.3	10.4	15.8	4.8	7.4	7.0	16.0	15.1	11.5	5.3	0.0	9.4	12.5	0.4	0.3	8.2	4.0	7.2	20.2	20.4	4.2	13.0	14.8	8.1	11.0	6.9	13.9	14.6	9.3	2.0	5.2	9.8	7.6	6.9	10.2	5.3	16.8	6.3	3.3	7.1	13.8	6.0	11.2	15.1	14.0	15.2	4.1	8.9	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3
EVPL	EVPK	ENSG00000167880	Envoplakin	Q92817	17	76004502-76027452	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 24.1;MCF7: 15.8;RT4: 34.9;SK-BR-3: 17.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002220, HPA053969"	Enhanced		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"CAB002220: AB_563701, HPA053969: AB_2682326"	"unprognostic (2.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.47e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.09e-2)"	0.2	0.0	0.0	2.3	0.1	1.1	1.2	0.0	0.3	11.6	5.7	0.1	2.8	4.8	1.9	1.3	69.9	0.9	4.1	0.0	0.0	0.0	4.8	0.0	5.7	0.2	0.0	0.0	0.4	2.4	1.8	1.1	2.3	0.1	3.2	0.7	0.7	10.9	4.5	0.5	43.7	7.8	2.1	0.2	0.1	1.9	0.3	0.1	0.4	6.3	43.1	46.1	5.0	21.6	0.4	1.7	1.9	0.3	1.6	1.4	0.0	11.0	9.3	0.0	0.1	0.1	0.0	3.9	0.1	0.0	0.0	0.0	1.2	6.7	0.0	0.0	0.0	24.1	0.0	3.1	0.0	0.0	0.0	0.2	6.9	7.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	0.0	0.0	0.4	0.0	15.8	0.4	1.5	0.0	4.2	4.5	0.0	0.1	7.3	34.9	0.4	0.0	4.6	17.4	0.0	22.0	0.4	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.0	1.0	0.3	0.7	0.6	0.3	0.7	0.2	0.2	0.5	0.1	0.4	1.4	0.6	1.9	1.6	0.2	1.7	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1
EVPLL		ENSG00000214860	"Envoplakin like"	A8MZ36	17	18377662-18389647	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.2;lymphoid tissue: 10.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.9;HeLa: 3.2;hTCEpi: 11.3;RT4: 3.9;SiHa: 2.1;T-47d: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045728	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA045728: AB_10960394"	"unprognostic (1.34e-1)"	"unprognostic (4.88e-2)"				"unprognostic (2.06e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.08e-2)"		"unprognostic (1.64e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.60e-4)"	"unprognostic (5.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.06e-2)"	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	3.3	0.5	0.0	0.7	0.4	0.8	0.9	22.2	0.4	0.8	0.0	0.0	0.0	0.9	2.0	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	1.7	0.2	0.0	2.1	3.1	0.1	7.8	0.4	1.4	0.0	0.1	1.7	2.5	0.0	0.1	2.2	9.5	10.4	3.5	7.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	2.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP12		ENSG00000197416	"Fatty acid binding protein 12"	A6NFH5	8	81524981-81531378	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.7;testis: 13.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.2;RT4: 1.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044041	Enhanced									"HPA044041: AB_10962213"		"unprognostic (1.18e-1)"			"unprognostic (7.31e-3)"	"unprognostic (3.07e-1)"									"unprognostic (2.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.8	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0		0.0	0.0	0.0	0.5	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2			0.0		0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	28000000	28000000	Cytosol	Cytosol	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		1200000	1200000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.5	30.3	24.0	44.0	40.9	24.3	15.1	8.0	24.5	0.0	17.5	49.7	36.9	4.4	32.6	8.0	4.2	4.7	3.7	37.5	8.3	30.7	0.1	10.8	33.2	20.5	40.0	14.1	36.6	7.1	0.2	46.1	26.1	0.2	6.2	5.3	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	35.9	25.6	15.6	16.8	1.2	47.3	25.0	10.9	31.4	36.3	0.4	0.8	0.0	70.5	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2
FAM25A	bA96C23.5	ENSG00000188100	"Family with sequence similarity 25 member A"	B3EWG3	10	87020306-87024730	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 85.5;skin 1: 30.9;tongue: 61.1;vagina: 30.8"	"Group enriched"	"Detected in some"	6	"A-431: 13.3;SK-BR-3: 39.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 53.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"	"unprognostic (9.94e-2)"	"unprognostic (2.57e-1)"				"unprognostic (7.62e-2)"		"unprognostic (1.03e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.05e-5)"						"unprognostic (1.21e-1)"	0.2	0.1	0.2	0.2	0.2	0.0	1.9	0.2	0.2	21.6	0.2	0.2	0.2	0.0	1.1	0.2	85.5	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.0	0.2	19.9	0.2	0.3	30.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2	61.1	16.9	0.2	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	39.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.4;RT4: 2.8;T-47d: 2.3;U-266/70: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	8200	8200			"HPA013844: AB_2668897"	"prognostic favourable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	3.4	0.3	0.0	0.0	1.3	0.3	1.4	0.7	0.0	0.3	0.5	1.0	0.1	2.8	0.2	1.3	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.7	0.9	0.6	1.8	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2
FAM46B	MGC16491	ENSG00000158246	"Family with sequence similarity 46 member B"	Q96A09	1	27005020-27012836	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 55.8;tongue: 42.0"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 31.9;hTERT-HME1: 16.4;NTERA-2: 16.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 87.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;intermediate monocyte: 2.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (1.67e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.28e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.44e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-2)"	3.3	0.6	0.6	3.9	0.3	0.1	10.4	0.3	0.4	20.6	13.4	0.4	3.6	0.8	8.0	2.8	55.8	5.5	4.0	9.1	0.2	0.0	3.8	0.5	11.6	0.7	0.4	0.9	3.8	1.2	1.0	0.7	7.4	0.9	6.8	1.2	1.5	23.5	11.1	0.9	36.3	3.5	21.5	0.3	0.4	6.8	4.6	0.1	0.6	3.1	42.0	18.7	23.0	13.6	0.0	0.4	1.3	2.5	0.0	0.0	0.0	1.9	0.3	3.9	1.2	0.5	0.6	0.9	2.7	0.9	11.1	4.4	7.6	2.5	0.0	4.7	1.5	6.2	0.6	10.1	3.0	0.0	0.6	0.1	1.5	1.3	5.6	0.0	0.1	2.5	31.9	3.4	16.4	0.1	0.2	0.0	1.4	1.4	0.0	0.6	16.7	0.7	0.2	0.0	0.1	10.8	0.0	0.4	0.3	5.3	11.9	6.9	9.4	0.1	0.2	2.7	9.2	0.3	0.5	0.1	0.4	0.0	0.5	0.0	1.6	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.4	0.2	0.0	0.4	0.9	0.9	0.1
FAM83A	"BJ-TSA-9, MGC14128"	ENSG00000147689	"Family with sequence similarity 83 member A"	Q86UY5	8	123178960-123210079	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.8;lymphoid tissue: 28.6"	"Group enriched"	"Detected in some"	5	"A-431: 23.7;HBEC3-KT: 37.0;hTCEpi: 19.9;K-562: 58.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 52.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052615			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052615: AB_2797244"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (3.85e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (2.98e-9)"	"unprognostic (2.62e-1)"	"unprognostic (2.81e-1)"	"prognostic unfavourable (4.99e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.22e-16)"	"unprognostic (2.76e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.07e-2)"	0.1	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.6	0.4	0.0	8.3	0.6	0.8	2.0	44.8	2.8	1.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	2.7	0.0	1.3	0.0	0.0	3.1	13.6	0.1	4.4	2.5	0.2	0.0	0.1	0.1	0.3	0.0	0.1	0.3	13.4	28.6	3.1	18.4	0.4	0.3	0.7	0.2	0.3	0.4	0.0	23.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	3.2	0.0	7.6	0.0	37.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	19.9	0.0	5.1	0.0	58.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	4.2	2.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.4	0.1	0.3	0.1	0.2	0.1	0.0	0.4	0.1	0.2	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54942022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.7;intestine: 24.6;tongue: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 12.3;HaCaT: 13.8;HBEC3-KT: 7.5;hTCEpi: 13.9;hTERT-HME1: 18.3;RT4: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031464, HPA031465"	Enhanced									"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavourable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.86e-5)"	0.4	0.4	0.4	6.9	0.4	0.0	1.6	0.4	0.4	8.8	16.4	0.0	1.9	6.5	0.4	2.9	32.7	1.4	7.0	1.6	0.4	0.4	6.3	0.5	0.5	0.0	0.4	0.0	0.5	3.7	0.0	0.4	15.6	0.0	5.5	8.2	0.0	5.5	1.7	3.5	22.3	24.6	1.3	0.4	0.4	3.6	0.9	0.0	4.3	11.0	30.1	8.5	4.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	5.3	2.8	0.0	0.0	0.0	13.8	0.0	7.5	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	18.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.7	15.8	0.1	0.0	2.4	0.4	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292401	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain									"CAB034227: AB_1562876, HPA049978: AB_2680979"		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.1	29.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	22.3	12.1	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.4	0.2	0.3	2.0	0.0	0.5	0.0	0.0	0.4	0.2	0.5	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.8	0.1	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Mitotic spindle"	"Mitotic spindle"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.44e-6)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.2	19.3	15.3	12.8	1.7	1.9	27.4	14.1	8.8	27.9	17.1	29.4	14.4	7.9	14.0	9.2	26.9	20.8	24.1	26.2	2.6	8.2	9.2	14.8	21.2	1.4	4.0	4.8	1.0	1.2	16.0	9.3	15.3	8.1	11.5	15.8	16.8	6.2	5.9	12.6	24.6	6.0	28.1	4.4	8.0	8.0	7.1	11.8	41.1	34.3	6.1	21.4	4.2	7.3	18.5	22.7	21.0	30.9	3.5	5.3	8.2	8.3	6.0	13.5	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2
FAM83G	"FLJ41564, PAWS1"	ENSG00000188522	"Family with sequence similarity 83 member G"	A6ND36	17	18968789-19004804	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.0;skin 1: 33.8;tongue: 28.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023369, HPA023940"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA023369: AB_1848415, HPA023940: AB_1848416"	"unprognostic (2.12e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (8.29e-4)"	"unprognostic (1.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.65e-2)"	"prognostic favourable (7.58e-6)"	"unprognostic (9.68e-2)"	"unprognostic (5.13e-2)"	"unprognostic (3.74e-2)"	1.8	1.0	0.5	5.1	0.8	0.6	2.2	1.0	0.8	6.2	5.5	0.4	1.3	6.6	1.4	0.9	36.0	0.8	13.4	8.7	0.9	0.6	2.6	26.5	2.3	1.5	0.4	0.4	1.1	7.0	4.7	2.2	2.6	1.6	1.7	3.2	1.5	5.7	3.0	3.4	33.8	10.1	1.6	0.4	1.0	5.9	0.8	0.3	3.2	3.3	28.9	19.1	2.4	6.9	1.5	0.2	3.4	0.7	0.0	2.6	0.7	12.7	11.8	0.1	0.0	0.4	1.1	19.6	13.5	5.9	11.4	8.6	15.1	4.7	8.4	8.3	8.8	15.2	1.9	11.3	5.3	6.9	4.3	0.2	5.8	8.2	8.5	1.5	4.3	1.5	21.2	7.4	12.3	4.1	4.0	0.3	3.2	7.8	0.3	3.1	6.0	0.0	0.0	0.0	4.1	5.6	3.3	6.1	0.0	4.6	2.9	0.8	5.0	1.9	7.6	7.1	11.9	3.3	15.5	1.2	2.0	2.1	5.5	0.0	4.6	3.4	0.0	0.0	2.6	0.1	1.4	1.1	1.5	0.8	0.2	1.5	1.4	0.2	0.0	0.0	0.7	0.2	1.8	0.7	0.5	0.8	1.0	0.8	0.9	0.6	0.4	0.4	1.6	0.3
FAM83H	FLJ46072	ENSG00000180921	"Family with sequence similarity 83 member H"	Q6ZRV2	8	143723933-143733801	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.2;lymphoid tissue: 30.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 19.5;MCF7: 26.8;RT4: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA024505, HPA024604"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA024505: AB_1848417, HPA024604: AB_1848418"	"unprognostic (3.80e-2)"	"unprognostic (3.75e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (9.69e-3)"	"prognostic favourable (4.42e-4)"	"unprognostic (5.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	0.8	1.9	1.2	4.1	1.0	0.2	2.9	0.2	1.6	8.8	12.5	0.9	6.1	6.3	1.1	3.0	42.2	3.0	17.7	0.3	1.1	0.4	5.0	10.4	3.9	0.5	0.3	0.6	1.3	6.7	5.9	2.8	8.9	0.9	5.6	2.7	2.6	8.3	2.9	0.1	17.7	17.9	1.8	0.7	0.7	9.1	1.3	0.2	1.1	6.9	27.9	30.7	5.1	9.5	0.3	0.2	0.5	0.3	0.1	0.2	0.0	13.7	6.5	0.0	0.0	0.0	0.0	12.1	0.9	0.0	0.4	0.1	5.9	12.4	0.0	10.0	0.2	19.5	0.8	12.0	0.2	1.0	2.1	0.3	12.9	4.1	1.0	0.3	0.9	0.7	14.2	0.0	3.6	0.0	7.2	0.0	0.0	26.8	0.2	0.0	2.5	5.9	0.0	0.0	1.3	3.8	16.1	3.7	0.0	10.8	12.6	2.1	13.6	1.8	0.0	0.0	3.9	0.9	0.0	1.9	2.0	0.0	0.0	0.0	0.6	0.3	0.3	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	1.2	1.0	0.2	1.6	1.1	0.4	0.3	0.6	0.9	0.2
FGFBP1	"FGFBP, HBP17"	ENSG00000137440	"Fibroblast growth factor binding protein 1"	Q14512	4	15935569-15938740	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 106.6;lymphoid tissue: 56.8;tongue: 133.1"	"Group enriched"	"Detected in some"	4	"HaCaT: 77.2;HBEC3-KT: 133.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA004332	Enhanced				"Secreted in other tissues"					"HPA004332: AB_1078856"	"unprognostic (2.87e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.99e-2)"		"unprognostic (1.86e-2)"		"unprognostic (1.97e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.31e-3)"	0.2	0.0	0.2	0.6	0.2	0.0	4.1	0.2	0.2	27.1	5.1	0.2	0.2	0.4	1.1	0.2	106.6	0.1	0.3	0.2	0.2	0.0	0.3	0.2	1.9	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.7	0.2	0.3	4.6	0.4	14.1	0.2	0.2	14.6	1.3	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.3	133.1	56.8	1.8	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	20.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	1.5	0.0	77.2	0.0	133.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;NTERA-2: 4.4;TIME: 3.0;U-2 OS: 3.4;U-2197: 3.6"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		500000	500000	"Cytoplasmic bodies"	"Cytoplasmic bodies"	"CAB002210: AB_563731, HPA027505: , HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	14.0	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	3.0	1.2	3.4	3.6	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FMO2		ENSG00000094963	"Flavin containing monooxygenase 2"	Q99518	1	171185208-171211230	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;esophagus: 35.3;lung: 53.0"	"Group enriched"	"Detected in some"	57	"ASC diff: 24.0;ASC TERT1: 10.9;HSkMC: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			HPA028261	Approved									"HPA028261: AB_10601012"	"unprognostic (1.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-2)"	40.0	11.8	1.2	1.7	4.4	0.0	22.5	1.5	0.6	7.6	5.0	0.6	2.9	0.3	1.9	3.5	35.3	6.7	2.0	17.4	1.8	1.2	9.4	1.8	53.0	5.7	3.9	1.2	6.1	2.1	1.8	7.0	0.0	2.4	6.0	0.7	8.3	14.0	1.3	7.6	1.7	1.5	2.5	1.9	0.4	2.4	3.3	1.3	0.4	5.8	6.8	5.5	5.0	10.2	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	28.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	4.4	1.5	0.6	1.8	1.2	3.9	1.2	2.4	1.3
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 92.9;U-2197: 62.3;WM-115: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.80e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.0	5.3	0.6	2.4	5.4	5.4	5.2	33.8	31.0	29.3	16.4	1.6	30.1	0.0	7.4	23.4	6.8	2.2	27.2	25.2	1.1	0.0	2.2	0.5	4.0	6.8	1.4	0.8	2.3	2.7	22.9	34.7	9.4	5.2	0.2	38.4	1.5	0.0	3.0	2.5	92.9	0.1	2.9	0.1	13.6	2.4	0.0	0.0	2.0	0.0	25.4	0.1	1.3	23.3	34.7	7.1	62.3	49.5	0.0	0.1	0.1	48.8	0.6	140.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.5;intestine: 24.0;retina: 58.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.2;HEK 293: 13.1;U-2197: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.4	0.4	3.5	3.4	4.4	0.1	2.2	1.7	3.9	1.3	24.0	2.3	0.0	7.6	0.2	1.2	28.5	0.4	2.0	0.5	2.8	2.4	0.2	0.3	13.6	0.6	3.7	3.2	0.2	0.7	0.8	5.5	11.5	2.2	13.2	12.3	58.7	0.8	1.0	0.6	0.9	15.8	4.8	2.1	0.2	12.6	0.8	1.4	0.0	2.5	2.7	2.4	9.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.6	0.4	1.8	2.9	0.0	8.2	39.2	3.6	1.6	0.1	0.0	0.0	1.8	2.5	6.4	6.8	0.3	1.6	0.0	13.1	0.0	3.1	0.0	3.5	0.0	0.2	0.5	2.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	2.0	0.0	2.7	0.0	0.1	0.0	3.3	6.1	16.0	1.4	0.2	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.4	1.7	3.9	2.8	2.4	3.7	3.2	2.2	1.4
FOXN1	"FKHL20, RONU, WHN"	ENSG00000109101	"Forkhead box N1"	O15353	17	28506243-28538896	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.1;lymphoid tissue: 37.0;skin 1: 27.9;tongue: 18.4"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 15.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 7.0;head and neck cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.60e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (2.68e-3)"	"unprognostic (5.98e-6)"		"prognostic favourable (5.00e-4)"		"unprognostic (2.85e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.08e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.68e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.6	0.0	15.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	1.6	0.2	0.1	27.9	0.0	0.0	0.0	0.0	0.1	0.2	0.1	37.0	0.1	18.4	11.3	0.7	6.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.9	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	4	"A-431: 30.2;RH-30: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											HPA046966	Supported									"HPA046966: AB_2679879"	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	30.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.2	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 14.6;RPMI-8226: 5.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favourable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.2	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	5.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.9;lymphoid tissue: 18.6"	"Group enriched"	"Detected in some"	4	"AF22: 8.4;BEWO: 9.7;hTCEpi: 5.6;RPTEC TERT1: 2.9;RT4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"thalamus: 7.6"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favourable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	1.1	0.4	1.0	0.5	1.9	0.2	1.5	5.4	2.1	11.6	0.6	2.1	1.6	0.4	5.1	3.4	26.9	2.2	7.1	0.5	1.0	1.0	0.4	0.2	2.0	0.9	1.6	1.2	3.4	1.1	0.2	1.4	9.2	1.9	3.7	0.6	3.0	5.4	3.1	1.2	10.2	0.7	0.9	1.2	0.3	1.0	0.7	2.0	0.6	1.7	9.0	18.6	5.1	7.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	1.5	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.9	4.7	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.9	5.4	2.1	1.0	1.0	1.6	1.2	1.9	2.0
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor pi subunit"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.0;lymphoid tissue: 57.7"	"Cell line enhanced"	"Detected in many"		"A-431: 44.6;EFO-21: 52.2;HeLa: 31.3;PC-3: 71.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 10.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 10.1;monocytes: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB014883	Uncertain									"CAB014883: "	"unprognostic (3.98e-3)"	"prognostic favourable (3.37e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.97e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.92e-3)"	"unprognostic (6.52e-3)"	1.5	0.5	0.5	1.3	0.5	1.1	31.6	0.5	1.1	18.5	1.7	0.6	2.6	2.6	30.4	9.9	37.0	2.2	8.6	1.0	0.5	0.4	6.9	3.8	2.5	0.5	0.5	0.5	1.1	4.3	0.0	2.4	5.5	0.6	6.8	0.4	0.8	25.5	3.2	2.0	10.0	3.9	0.5	0.5	0.8	5.0	1.0	0.5	2.5	0.6	3.1	57.7	1.2	20.0	0.9	1.1	10.1	6.1	0.2	1.3	3.1	44.6	2.0	2.2	1.5	0.1	0.9	5.2	0.8	0.3	0.1	0.1	8.0	5.1	0.7	52.2	0.2	16.2	1.3	0.1	0.1	0.7	1.6	2.9	31.3	1.1	0.1	1.0	2.5	0.3	0.6	0.6	0.4	0.3	12.0	5.7	0.1	1.4	1.9	1.0	18.4	71.4	2.8	1.4	1.7	3.0	2.4	1.8	0.8	16.5	0.8	0.5	0.9	0.5	1.9	4.1	15.2	3.4	3.3	2.2	1.3	1.3	0.5	2.9	0.6	10.1	2.3	6.8	0.5	1.7	1.3	0.3	0.5	0.4	0.7	0.9	0.7	0.6	5.4	0.2	6.1	1.1	0.7	3.1	0.5	0.5	0.5	0.6	0.5	0.4	0.5	0.5	0.6	0.5
GDPD3	MGC4171	ENSG00000102886	"Glycerophosphodiester phosphodiesterase domain containing 3"	Q7L5L3	16	30104810-30113856	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6"	"Group enriched"	"Detected in many"	6	"MCF7: 13.7;SK-BR-3: 48.5"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 21.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"eosinophil: 1.6;neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	"Not detected"	"Not detected"			"HPA041148, HPA041470"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA041148: AB_10794545, HPA041470: AB_10795121"	"unprognostic (4.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.59e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (5.89e-9)"	"unprognostic (3.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.79e-3)"	3.0	0.9	1.2	10.5	1.2	0.5	2.5	5.7	1.3	9.4	11.3	1.2	1.2	4.0	2.8	3.4	30.8	2.1	3.6	1.7	1.2	0.7	5.9	1.2	3.7	2.3	1.2	1.2	3.3	1.2	0.4	2.3	12.9	2.5	2.4	7.4	1.2	4.9	1.2	1.3	5.3	8.6	2.4	1.2	4.1	8.3	1.2	1.2	1.9	2.3	36.6	40.8	2.7	9.2	0.1	0.0	5.1	0.2	0.0	0.2	0.0	5.3	0.0	1.8	0.5	0.5	2.8	1.6	0.5	0.4	0.5	0.6	0.6	3.7	0.6	0.7	0.3	0.5	0.5	0.2	0.5	1.0	1.5	0.1	0.8	2.5	0.5	0.2	0.4	0.1	0.7	1.5	0.1	2.1	0.4	0.9	0.7	13.7	0.4	0.9	1.1	0.2	2.5	0.6	2.9	1.1	2.4	0.5	0.9	0.0	48.5	0.3	0.9	1.0	1.5	0.5	0.5	1.1	0.5	1.6	0.3	0.6	1.4	0.8	0.3	0.1	0.0	1.6	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	5.1	0.0	0.1	0.0	0.1	0.0	1.2	1.2	5.7	1.3	1.2	0.7	1.2	1.2	2.5	1.2
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A-431: 25.9;CAPAN-2: 36.9;HaCaT: 30.0;HBEC3-KT: 25.6;hTCEpi: 42.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"				"Vesicles, Cell Junctions"	"Vesicles, Cell Junctions"	"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	3.5	0.0	30.0	0.0	25.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.1	0.0	10.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	6.7	0.0	0.0	0.0	12.5	9.9	0.0	0.0	3.9	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0
GJB5	CX31.1	ENSG00000189280	"Gap junction protein beta 5"	O95377	1	34755047-34758512	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.7;HaCaT: 31.1;HBEC3-KT: 13.9;hTCEpi: 51.5;RT4: 17.3"	"Group enriched"	"Detected in many"	5	"cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038146	Uncertain									"HPA038146: AB_10697242"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.71e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.67e-3)"	0.0	0.1	0.7	0.0	0.5	0.1	2.6	0.6	2.3	7.5	0.1	0.0	0.5	0.0	0.1	2.1	39.0	0.4	3.3	0.1	0.8	0.1	0.1	0.1	0.3	0.0	0.2	0.5	0.1	0.6	0.0	0.4	7.0	0.2	3.0	0.1	0.0	5.6	2.1	0.2	37.7	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.6	0.6	28.0	26.1	3.4	11.7	0.0	0.0	0.0	0.8	0.0	0.1	0.8	9.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	31.1	0.0	13.9	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	51.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	1.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.8	0.7	0.5	0.6	2.3	0.8	0.1	0.2	0.5	0.2	0.0
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232395	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.5;esophagus: 97.1;tongue: 43.6"	"Cell line enriched"	"Detected in some"	9	"RT4: 63.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Lineage enhanced"	"Detected in many"		"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA014846: "	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	1.2	1.0	15.3	1.1	17.0	50.5	3.3	9.0	15.9	16.9	1.0	1.9	0.0	1.0	1.6	1.1	97.1	1.2	1.8	1.0	16.3	7.9	1.0	1.0	1.1	1.4	11.1	11.3	1.0	1.0	1.0	0.7	1.0	9.2	1.1	1.1	0.0	8.7	1.0	1.0	18.7	1.0	1.0	3.7	1.1	1.2	1.7	6.0	7.9	4.1	43.6	15.7	6.3	30.9	1.4	0.0	1.2	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.4	2.7	1.5	1.2	0.0	0.0	0.0	5.7	0.6	15.3	17.0	9.0	15.9	16.3	7.9	11.1	11.3	9.2	6.0
GLTP		ENSG00000139433	"Glycolipid transfer protein"	Q9NZD2	12	109850943-109880488	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.0;lymphoid tissue: 78.0;skin 1: 84.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056461	Approved		Supported	Cytosol		280000	280000	Cytosol	Cytosol	"HPA056461: AB_2683138"	"unprognostic (1.18e-1)"	"prognostic favourable (2.01e-5)"	"unprognostic (7.46e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (6.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (4.17e-6)"	"unprognostic (3.28e-2)"	7.0	5.8	11.4	6.1	16.4	6.6	10.5	4.7	19.3	21.8	13.2	31.3	6.6	5.4	5.4	13.4	82.0	4.9	5.4	6.4	15.9	9.7	13.7	4.5	9.2	7.0	22.4	8.9	5.9	7.7	5.7	3.4	7.9	14.8	8.0	11.8	4.0	21.2	8.0	6.1	84.3	8.2	7.1	48.7	7.4	7.6	4.0	24.7	6.2	8.9	60.6	78.0	10.8	38.5	11.8	23.2	16.7	32.3	21.2	26.7	17.2	14.0	10.0	5.8	6.2	13.9	16.0	4.3	17.4	21.7	13.6	11.4	4.0	5.4	12.4	9.4	21.4	17.3	9.0	20.6	19.3	12.6	8.0	8.1	6.1	6.0	12.2	8.6	9.6	11.8	25.9	24.2	17.2	22.7	3.7	8.6	19.8	19.5	11.7	7.1	10.5	13.6	10.5	13.8	13.0	7.6	42.3	7.4	7.4	11.0	28.6	9.3	13.3	3.1	31.0	15.5	8.3	22.8	13.1	11.4	9.4	8.5	31.3	9.1	9.6	16.7	32.3	16.5	26.7	30.8	16.2	11.8	16.1	23.3	23.2	11.4	10.5	18.8	15.8	21.2	24.8	3.7	17.6	17.2	11.4	16.4	4.7	19.3	15.9	9.7	22.4	8.9	14.8	24.7
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136193-3163769	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.4;HMC-1: 45.9;MOLT-4: 45.9;NB-4: 17.2;REH: 34.3;THP-1: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043113	Approved									"HPA043113: AB_10967343"	"prognostic favourable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	4.9	1.7	1.6	7.2	2.3	37.4	3.9	1.1	2.0	7.9	1.3	1.6	1.0	1.0	0.8	1.8	46.0	1.3	2.8	2.6	1.6	1.1	1.3	1.2	7.6	3.7	3.1	1.3	1.0	0.7	0.2	0.8	4.5	2.7	5.9	1.1	1.3	9.2	1.7	0.8	20.0	1.1	1.8	2.8	5.6	2.5	1.1	2.2	42.2	0.7	29.0	25.3	10.4	16.2	0.0	31.0	6.2	12.6	2.1	3.9	5.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	10.7	0.0	19.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	7.8	45.9	0.0	12.1	0.0	8.0	0.0	0.0	0.1	0.0	0.0	45.9	17.2	0.0	0.0	34.3	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	5.8	12.6	6.2	0.0	9.7	0.5	0.0	1.0	0.1	13.0	0.0	0.0	0.0	3.1	2.1	6.5	31.0	3.9	5.1	1.6	2.3	1.1	2.0	1.6	1.1	3.1	1.3	2.7	2.2
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316952	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 24.8;skin 1: 19.7;tongue: 21.9"	"Cell line enhanced"	"Detected in some"		"A-431: 30.8;HaCaT: 24.6;HBEC3-KT: 32.8;hTCEpi: 43.8;hTERT-HME1: 18.4;RT4: 12.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"				"Lipid droplets, Mitochondria"	"Lipid droplets, Mitochondria"	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.4	6.5	0.0	0.0	2.8	0.0	0.4	2.1	24.8	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	11.1	5.1	4.5	0.0	0.0	9.5	4.0	0.0	19.7	0.0	0.4	0.0	0.0	0.2	0.7	0.0	2.0	0.0	21.9	13.5	6.2	13.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	24.6	0.0	32.8	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	43.8	0.0	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.7	0.0	0.0	0.0	1.1	12.9	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.1	0.0
GRB7		ENSG00000141738	"Growth factor receptor bound protein 7"	Q14451	17	39737927-39747291	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9"	"Cell line enriched"	"Detected in some"	9	"SK-BR-3: 89.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.4"	"Cell type enriched"	"Detected in single"	20	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Region enhanced"	"Detected in some"		"cerebellum: 9.3"	"Low region specificity"	"Detected in all"			"CAB005226, HPA057084, CAB073538"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330"	"unprognostic (8.46e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (6.60e-7)"	"unprognostic (7.06e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (3.10e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (2.59e-2)"	"prognostic favourable (8.23e-5)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (5.49e-3)"	"unprognostic (4.01e-2)"	2.9	0.1	0.1	2.8	0.6	0.0	16.1	7.4	1.2	6.7	12.7	0.3	25.0	6.7	2.6	8.1	53.9	14.5	16.3	0.8	0.2	0.1	23.4	5.2	12.3	0.1	0.1	0.4	3.1	20.5	5.8	3.7	42.6	1.6	10.2	6.4	0.7	14.0	25.5	0.5	19.1	12.4	2.0	0.1	0.3	7.2	2.3	0.3	0.5	8.5	6.5	17.2	7.2	11.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.4	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.0	0.1	10.4	5.9	0.0	0.9	0.1	5.6	0.0	3.9	0.0	0.0	0.5	0.0	1.3	9.0	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.2	0.8	0.0	0.0	4.1	4.6	3.3	2.3	0.0	4.5	89.5	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	7.4	1.2	0.2	0.1	0.1	0.4	1.6	0.3
GRHL1	"LBP-32, MGR, TFCP2L2"	ENSG00000134317	"Grainyhead like transcription factor 1"	Q9NZI5	2	9951693-10002277	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.3;skin 1: 34.4"	"Group enriched"	"Detected in some"	4	"BEWO: 64.8;SK-BR-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 4.8;neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005798, HPA006420"	Enhanced		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA005798: AB_1079026, HPA006420: AB_1079025"	"unprognostic (2.26e-3)"	"unprognostic (5.80e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.33e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.14e-1)"	1.7	0.6	1.5	0.2	2.4	2.8	15.9	2.0	1.6	10.2	0.9	0.2	10.8	0.3	0.9	3.8	40.3	0.7	1.0	1.6	1.9	1.2	2.5	4.9	2.3	0.2	0.7	1.4	0.5	1.5	12.9	2.6	31.0	0.8	6.1	0.2	1.8	17.5	9.7	0.9	34.4	0.7	5.1	0.6	0.6	1.3	1.6	0.4	0.4	2.8	22.3	25.3	6.7	16.9	0.1	0.2	4.8	0.2	0.5	0.6	4.5	3.1	0.0	0.3	0.9	0.1	0.1	64.8	0.3	0.4	0.2	0.3	0.2	2.2	0.4	0.1	0.0	1.9	3.9	0.4	0.9	0.9	1.7	0.1	0.6	1.2	0.0	0.2	0.3	0.1	1.7	1.8	0.0	0.3	0.6	1.2	0.0	4.1	0.6	0.5	0.2	0.7	0.2	0.3	0.5	0.4	12.3	0.7	0.5	0.6	34.1	0.7	4.1	0.1	0.3	0.2	0.8	1.0	0.3	0.8	0.4	0.4	0.1	0.5	0.5	0.0	0.2	4.8	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.6	4.5	1.5	2.4	2.0	1.6	1.9	1.2	0.7	1.4	0.8	0.4
GRHL3	"SOM, TFCP2L4"	ENSG00000158055	"Grainyhead like transcription factor 3"	Q8TE85	1	24319322-24364482	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.5;HaCaT: 16.9;MCF7: 26.0;RT4: 29.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 28.9"	"Region enhanced"	"Detected in some"		"pons and medulla: 3.6"	"Group enriched"	"Detected in some"	12	"eosinophil: 1.0;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA059960	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA059960: AB_2684180"	"unprognostic (8.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.95e-2)"	"unprognostic (7.83e-3)"	"unprognostic (7.58e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.97e-3)"	"unprognostic (7.42e-2)"	0.1	0.1	0.1	0.1	0.9	0.0	1.0	0.2	0.9	9.0	0.1	0.2	0.0	0.2	0.6	0.8	59.0	0.2	0.6	0.1	1.1	0.3	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.9	0.1	1.1	3.6	3.6	0.1	0.0	5.9	0.9	0.2	21.7	0.1	0.5	3.0	0.0	0.2	1.1	0.1	0.5	0.1	51.5	60.1	12.3	11.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.5	1.2	0.4	0.0	0.0	0.0	21.5	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	16.9	0.0	1.5	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	1.3	0.0	0.1	0.0	0.0	26.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	2.1	29.7	0.1	0.0	0.0	2.9	0.0	1.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.2	0.1	1.1	0.3	0.1	0.0	3.6	0.1
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Uncertain		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (3.87e-5)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	7.4	5.1	5.4	6.5	6.4	5.3	9.8	10.9	8.9	13.3	4.8	3.7	3.9	6.0	5.4	5.8	43.1	5.1	4.3	6.3	5.5	5.6	7.5	5.7	10.2	8.1	5.1	5.2	7.5	6.8	7.2	6.5	8.5	8.4	5.1	4.8	3.7	7.2	6.7	7.8	5.4	5.8	4.3	4.4	5.9	6.1	4.9	5.1	7.4	7.9	14.4	12.8	6.1	11.5	3.5	3.8	8.2	2.5	3.7	13.5	4.6	9.0	4.9	7.1	25.5	4.5	4.7	14.3	8.0	6.8	7.8	11.0	12.0	6.1	9.4	8.5	4.2	7.0	11.3	11.7	10.0	5.0	9.5	11.9	9.4	6.8	13.6	11.1	6.0	6.9	14.4	9.7	15.2	4.7	10.3	23.2	5.8	6.4	7.2	9.5	9.4	17.9	9.1	9.9	12.4	5.0	8.4	14.7	12.2	8.1	15.0	23.9	13.1	13.3	5.3	8.5	9.4	6.1	11.8	8.6	11.4	9.1	8.6	16.2	7.7	8.2	2.5	3.3	5.1	2.4	6.2	3.5	7.7	5.7	3.8	1.9	10.3	7.7	1.9	3.7	2.5	1.0	13.5	4.6	5.4	6.4	10.9	8.9	5.5	5.6	5.1	5.2	8.4	5.1
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Cell line enhanced"	"Detected in some"		"A-431: 8.2;HaCaT: 5.8;hTCEpi: 3.0;HUVEC TERT2: 3.2;TIME: 8.5"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA023670, HPA024767, HPA026317"	Supported		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA023670: , HPA024767: , HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
HAS3		ENSG00000103044	"Hyaluronan synthase 3"	O00219	16	69105564-69118719	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;urinary bladder: 22.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.1;PC-3: 75.1;RT4: 29.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031554, CAB033850"	Supported		Approved	Microtubules				Microtubules	Microtubules	"CAB033850: AB_2116418, HPA031554: AB_10670703"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.59e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.40e-3)"	0.4	0.2	0.4	0.4	1.0	0.3	5.5	1.1	1.3	3.3	3.7	0.4	0.4	1.9	0.8	1.1	22.6	0.7	3.5	2.4	0.6	0.6	1.2	0.7	18.0	0.4	0.4	0.4	0.9	2.2	0.1	1.0	3.3	1.1	3.5	2.3	0.6	7.6	2.1	0.6	5.7	2.1	1.4	0.4	0.4	9.0	2.0	0.4	0.5	4.0	11.7	11.1	22.9	13.6	1.5	1.2	2.2	1.4	0.4	2.0	1.1	0.9	4.7	0.2	0.2	0.1	0.1	1.8	0.3	0.1	0.2	0.1	1.0	2.4	0.2	0.5	0.1	14.1	0.7	8.4	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	2.3	0.3	0.8	0.1	0.0	0.1	0.0	0.5	0.3	0.1	4.2	75.1	0.5	0.0	0.0	7.7	29.7	5.3	0.2	0.5	0.0	0.0	0.2	0.2	0.1	0.2	0.2	8.2	0.4	0.3	0.2	0.0	0.3	0.0	0.1	0.8	1.4	2.2	1.4	0.7	1.3	0.7	1.1	0.5	1.2	1.5	2.0	0.7	0.5	0.4	1.1	1.0	1.5	1.1	0.4	1.0	1.1	1.3	0.6	0.6	0.4	0.4	1.1	0.4
HES2	bHLHb40	ENSG00000069812	"Hes family bHLH transcription factor 2"	Q9Y543	1	6412418-6424670	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.6;placenta: 60.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.7;HaCaT: 19.9;HBEC3-KT: 17.1;hTCEpi: 9.9;TIME: 29.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039462	Uncertain									"HPA039462: "	"unprognostic (1.96e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.56e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-2)"	0.8	0.0	0.2	0.7	0.2	0.2	0.7	0.2	0.3	6.7	6.0	0.2	0.2	0.1	0.4	0.4	22.6	2.5	0.2	0.2	0.2	0.0	1.0	0.4	3.8	0.2	0.2	0.2	0.5	0.2	0.2	0.4	60.9	0.3	1.2	4.6	0.5	2.9	0.6	0.2	14.5	0.9	0.2	0.2	0.2	0.0	1.8	0.2	0.7	0.2	8.6	6.0	0.3	11.9	0.6	0.6	4.9	0.4	0.5	0.6	0.2	0.9	0.3	0.0	0.1	0.2	0.0	10.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.9	0.1	19.9	0.5	17.1	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	9.9	0.0	0.4	5.2	0.1	0.2	0.0	1.5	0.0	0.8	0.0	7.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	1.0	5.6	0.2	0.7	0.3	29.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.6	0.5	0.3	0.3	0.4	0.5	0.4	0.1	0.6	0.4	0.6	3.9	0.5	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
HILPDA	"C7orf68, FLJ21076, HIG-2, HIG2"	ENSG00000135245	"Hypoxia inducible lipid droplet associated"	Q9Y5L2	7	128455849-128458418	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4;esophagus: 71.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 44.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010515	Approved		Supported	"Nucleoplasm,Lipid droplets"	"Intracellular and membrane"			"Lipid droplets"	"Lipid droplets"	"HPA010515: AB_1850710"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.30e-11)"	"unprognostic (9.20e-3)"	"unprognostic (4.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.06e-3)"	"unprognostic (2.15e-2)"	"prognostic unfavourable (2.05e-7)"	"unprognostic (2.23e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	24.5	5.2	25.3	5.5	34.2	14.1	16.2	8.6	53.9	15.7	14.4	6.4	2.8	4.7	9.1	6.3	71.4	7.9	7.2	16.7	25.1	8.5	10.4	10.3	13.2	4.9	22.4	3.1	22.9	5.0	3.0	4.2	25.7	46.5	7.0	6.2	2.8	7.7	6.1	5.2	14.4	4.4	6.9	66.4	3.0	6.4	10.1	21.1	1.7	5.6	6.9	6.0	60.5	18.6	9.2	5.9	31.7	3.6	6.9	3.3	2.0	11.0	23.2	12.7	13.8	17.4	6.4	23.9	4.0	5.0	8.5	9.4	5.8	10.1	7.5	3.2	6.0	7.1	7.1	8.6	10.9	4.1	6.5	4.6	4.9	5.2	3.9	7.2	6.3	10.6	7.5	6.7	4.5	6.9	6.6	3.1	8.4	13.5	21.7	13.2	15.7	10.3	16.4	5.9	11.7	4.7	16.4	12.2	11.2	6.3	44.1	7.8	35.9	7.1	5.0	10.9	5.4	8.2	5.0	3.1	2.2	9.6	20.6	11.2	9.4	9.2	3.5	31.7	2.3	3.6	3.3	7.8	2.9	2.8	3.4	9.2	3.0	2.9	1.4	6.9	2.7	5.9	1.9	2.0	25.3	34.2	8.6	53.9	25.1	8.5	22.4	3.1	46.5	21.1
HOXB1	"HOX2, HOX2I"	ENSG00000120094	"Homeobox B1"	P14653	17	48528526-48531001	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.2;testis: 1.9;urinary bladder: 1.5"	"Cell line enhanced"	"Detected in single"		"T-47d: 1.9"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA044576	Uncertain									"HPA044576: AB_10794501"	"unprognostic (1.80e-2)"	"unprognostic (9.50e-3)"		"unprognostic (8.22e-2)"		"unprognostic (1.22e-1)"		"unprognostic (6.26e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.03e-1)"			"unprognostic (1.96e-1)"	"unprognostic (6.74e-2)"		"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.1	0.1	2.2	0.8	0.1	0.1	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.0	1.9	0.1	0.1	0.1	0.1	0.1	1.5	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HS3ST6	HS3ST5	ENSG00000162040	"Heparan sulfate-glucosamine 3-sulfotransferase 6"	Q96QI5	16	1911463-1918440	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.8;skin 1: 15.0"	"Group enriched"	"Detected in some"	5	"A549: 2.8;HaCaT: 2.7;U-2 OS: 1.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (5.72e-2)"	"prognostic favourable (3.73e-4)"		"unprognostic (1.30e-1)"		"unprognostic (1.20e-2)"		"unprognostic (1.19e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.99e-3)"		"unprognostic (2.10e-2)"		"unprognostic (6.55e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.26e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.1	0.1	6.6	0.4	0.0	0.4	0.0	0.3	0.9	18.8	1.2	0.0	0.1	0.1	0.1	0.2	0.1	1.9	0.1	0.1	0.0	0.5	0.1	0.0	0.2	1.9	0.0	3.6	0.0	0.6	0.4	0.1	0.3	15.0	0.1	1.0	0.1	0.1	0.1	0.1	0.0	2.1	0.1	2.7	3.2	6.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
IGFL1	UNQ644	ENSG00000188293	"IGF like family member 1"	Q6UW32	19	46229752-46231243	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 51.5;tongue: 29.7"	"Group enriched"	"Detected in some"	7	"HaCaT: 6.2;RT4: 22.8;SK-BR-3: 7.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 47.6;head and neck cancer: 60.7;melanoma: 23.3;urothelial cancer: 84.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA014001	Uncertain				"Secreted in other tissues"					"HPA014001: AB_2668919"	"unprognostic (1.35e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.01e-1)"		"unprognostic (1.64e-2)"		"unprognostic (2.67e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.50e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.80e-1)"		"unprognostic (1.64e-1)"	"unprognostic (3.23e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.1	14.7	0.1	0.0	0.0	0.1	0.3	0.1	51.5	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	11.0	0.1	0.1	1.8	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.9	0.1	29.7	14.4	0.4	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.2	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.1	7.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988750-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 7.4;HDLM-2: 11.2;SK-BR-3: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	7	"B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.7"	"Low region specificity"	"Detected in some"			HPA001886	Uncertain				"Secreted to blood"					"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.7	1.4	3.4	1.6	6.2	3.3	2.0	2.6	5.6	0.5	1.6	1.0	0.0	1.5	1.2	0.8	10.1	5.7	0.6	1.4	3.1	2.2	1.2	0.6	5.2	2.9	3.2	1.7	1.6	1.1	0.1	1.0	0.4	5.4	0.9	1.3	0.2	2.1	1.1	0.4	0.2	1.5	0.8	2.7	2.8	1.2	0.9	4.1	0.0	0.5	0.5	2.1	0.9	1.1	5.1	0.1	1.3	0.3	0.0	1.6	0.3	2.7	0.3	0.4	2.3	0.0	0.1	0.2	3.1	1.9	3.5	7.4	1.2	0.1	0.0	0.2	0.5	0.3	0.8	0.5	3.3	11.2	3.9	0.1	0.1	0.8	2.5	0.6	5.2	0.6	0.9	6.3	2.4	1.1	0.0	1.9	2.2	0.0	0.1	0.0	0.3	1.6	2.2	0.0	0.4	0.4	0.2	0.1	1.1	0.0	16.8	0.4	0.8	1.2	0.8	0.9	0.8	2.1	5.7	1.2	0.0	0.0	1.4	5.1	0.7	0.0	0.1	1.3	0.9	0.3	1.4	1.3	0.4	1.6	0.1	5.1	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.3	3.4	6.2	2.6	5.6	3.1	2.2	3.2	1.7	5.4	4.1
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell line enhanced"	"Detected in many"		"A-431: 26.0;CAPAN-2: 41.2;HaCaT: 37.8;HBEC3-KT: 28.4;hTCEpi: 43.5;PC-3: 25.2;U-2 OS: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"			"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.0	9.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.0	41.2	0.0	6.0	0.0	37.8	0.0	28.4	0.0	0.0	0.2	3.9	9.3	2.1	0.9	2.0	7.6	0.0	43.5	0.0	10.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	25.2	0.0	0.0	0.0	18.6	5.6	0.0	0.0	17.9	11.9	0.1	7.1	5.7	0.0	0.1	49.0	0.3	8.0	0.1	0.0	0.1	0.0	15.1	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 84.8;hTCEpi: 41.9;hTERT-HME1: 55.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.41e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.6	0.0	84.8	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	41.9	0.7	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"			Nucleoplasm	Nucleoplasm	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
IL20RB	"DIRS1, FNDC6, IL-20R2, MGC34923"	ENSG00000174564	"Interleukin 20 receptor subunit beta"	Q6UXL0	3	136946230-137011085	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 64.5;skin 1: 61.2"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 104.1"	"Group enriched"	"Detected in many"	5	"cervical cancer: 54.5;head and neck cancer: 50.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 0.6"	"Not detected"	"Not detected"			HPA063914			Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA063914: AB_2732709"	"unprognostic (1.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.43e-4)"	"unprognostic (2.48e-4)"	"unprognostic (2.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.43e-4)"	"unprognostic (4.08e-3)"	"unprognostic (7.64e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.57e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.55e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.57e-2)"	1.6	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	13.2	0.2	0.0	0.0	0.0	1.3	0.3	64.5	0.1	0.1	0.3	0.0	0.0	0.1	2.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.2	2.8	0.0	1.6	0.3	0.4	4.1	0.2	0.4	61.2	0.1	0.1	0.3	0.0	0.1	0.9	0.0	0.5	0.2	22.6	17.1	0.9	19.2	0.1	0.4	0.0	0.3	0.0	0.6	0.0	4.8	0.0	0.0	0.0	2.9	12.6	0.4	0.1	0.3	0.0	0.1	0.4	0.5	0.0	2.7	1.7	15.7	0.0	25.8	0.1	0.0	0.0	0.0	3.2	0.0	17.4	0.0	0.0	2.1	104.1	0.8	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"		8000000	8000000	Cytosol	Cytosol	"CAB002243: AB_563785, HPA055211: AB_2682739"	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		61000000	61000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favourable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	30.2	25.1	2.5	2.1	0.0	0.0	39.3	1.7	10.4	0.7	0.6	37.9	33.5	0.6	18.7	1.1	126.0	3.6	28.0	0.1	0.0	8.9	1.3	20.0	8.3	4.2	0.8	13.4	0.0	63.6	0.1	5.2	11.2	11.1	11.0	0.0	38.8	0.2	10.9	4.9	4.2	35.4	0.0	22.7	19.4	77.4	6.2	4.6	3.9	76.5	0.2	63.8	0.9	17.6	0.0	1.8	0.8	0.5	0.9	3.4	0.6	0.1	1.4	0.3	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in many"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.7	8.1	0.0	0.1	0.3	0.4	9.2	3.4	7.9	1.5	1.9	7.4	29.8	0.1	18.1	3.0	34.2	10.4	29.8	2.4	0.2	2.7	0.1	17.0	0.7	2.1	2.7	0.5	2.2	42.6	0.4	16.7	0.0	0.4	0.6	6.8	2.0	0.5	0.2	0.3	11.5	0.5	7.6	0.6	23.6	36.0	0.7	0.3	30.4	4.9	2.1	0.6	0.6	0.0	2.1	6.2	0.0	1.4	0.9	0.4	1.0	2.9	0.5	2.5	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4
KLK10	"NES1, PRSSL1"	ENSG00000129451	"Kallikrein related peptidase 10"	O43240	19	51012739-51020175	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 52.5;HaCaT: 79.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	4	"hippocampal formation: 1.7"	"Not detected"	"Not detected"								"Secreted in other tissues"	670000	670000				"prognostic favourable (8.32e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-6)"	"unprognostic (9.34e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.52e-2)"	1.5	0.5	0.2	1.7	0.3	0.3	2.4	0.7	0.4	20.8	0.9	0.3	0.5	0.2	2.9	0.8	78.6	7.8	36.0	0.7	0.2	0.5	0.2	0.3	4.3	0.2	0.2	0.3	7.2	0.2	0.0	0.2	0.8	0.6	1.6	0.4	0.3	11.0	0.6	0.4	17.7	0.4	0.4	0.4	0.2	0.5	1.6	0.2	1.0	0.3	136.3	58.6	0.5	33.4	0.4	0.5	2.1	0.4	0.4	0.3	0.1	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.5	0.0	2.9	0.0	79.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.1	0.4	0.3	0.3	2.1	0.4	0.4	0.5	0.3	0.1	0.2	0.3	0.7	0.4	0.2	0.5	0.2	0.3	0.6	0.2
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 9.4;HaCaT: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"	320000	320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	9.4	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2
KLK12	KLK-L5	ENSG00000186474	"Kallikrein related peptidase 12"	Q9UKR0	19	51029092-51035230	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 27.6;esophagus: 53.9;lymphoid tissue: 24.7;tongue: 33.3;vagina: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HaCaT: 2.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025473	Uncertain				"Secreted in other tissues"					"CAB025473: "	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.15e-1)"		"unprognostic (5.80e-3)"		"unprognostic (4.99e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.56e-1)"		"prognostic favourable (8.01e-4)"	"unprognostic (8.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.6	2.0	0.0	0.0	3.6	1.2	0.2	53.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.7	0.0	16.6	0.0	0.0	0.4	4.3	0.1	0.2	0.0	0.4	0.5	0.0	0.2	0.0	33.3	24.7	0.0	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Group enriched"	"Detected in some"	14	"A-431: 68.4;CAPAN-2: 163.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"	6800000	6800000	Nucleoplasm	Nucleoplasm	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavourable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	163.7	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	7	"A-431: 31.5;CAPAN-2: 41.3;HaCaT: 30.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	950000	950000	Vesicles	Vesicles	"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavourable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	41.3	0.0	0.8	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Group enriched"	"Detected in some"	100	"A-431: 211.8;HaCaT: 141.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		1100000000	1100000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 118.0;HBEC3-KT: 211.3;hTCEpi: 483.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		6500000000	6500000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favourable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	118.0	0.0	211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	483.0	0.0	42.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavourable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"A-431: 37.3;CAPAN-2: 33.1;HaCaT: 48.1;HBEC3-KT: 36.6;hTCEpi: 35.6;MCF7: 40.9;RT4: 35.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"			"Actin filaments"	"Actin filaments"	"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	24.2	33.1	0.0	2.1	0.0	48.1	0.0	36.6	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	35.6	0.0	7.3	0.0	0.0	0.1	0.0	40.9	0.0	0.1	0.9	0.4	0.0	1.7	0.4	24.7	35.1	1.9	0.0	0.0	57.6	0.6	8.7	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
LEXM	"C1orf177, FLJ40201, LEM"	ENSG00000162398	"Lymphocyte expansion molecule"	Q3ZCV2	1	54806063-54842252	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 7.0;esophagus: 14.2;testis: 5.2"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.5;HaCaT: 1.6;Karpas-707: 1.8;U-266/84: 2.0;U-87 MG: 1.2"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in many"		"gdTCR: 7.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035889, HPA035890"	Uncertain									"HPA035889: AB_2674844, HPA035890: AB_10669535"	"unprognostic (1.61e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.69e-2)"		"unprognostic (1.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.5			2.3	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.5		0.6	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.2	5.2			0.0		0.6	0.0	3.8	0.0	0.2	1.6	0.0	3.0	7.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.2	0.8	0.2	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.7	0.0	1.0	2.0	0.0	1.2	0.3	0.1	0.0	0.0	1.6	7.0	0.0	0.4	0.0	1.5	3.4	0.0	0.0	0.3	4.6	0.0	3.0	0.0	0.2	0.3	1.4										
LGALS9B		ENSG00000170298	"Galectin 9B"	Q3B8N2	17	20449395-20467539	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 13.4;esophagus: 13.6;stomach 1: 23.2"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 13.3;U-937: 4.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	15	"NK-cell: 13.4"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 13.4"									"HPA046876, HPA047218"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.05e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.05e-1)"	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	1.2	5.7			2.3	0.0	0.0	13.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0		0.0	0.0	0.0	0.0	0.0		0.4	8.4		1.8	0.0	0.0	0.3	2.6	0.0	0.0	0.4	23.2	0.0			0.0		1.0	0.0	3.4	0.3	0.4	0.2	0.3	13.4	0.9	1.7	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.2	0.2	0.0	0.4	0.3	0.2	0.4	0.2	13.4	0.3	0.2	0.0	1.7										
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.5;U-937: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 3.2;NK-cell: 8.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 8.9"									"HPA046876, HPA047218"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	2.1	8.3	0.2	0.0	1.6	0.0	0.0	15.8	0.0	4.7	1.0	0.0	0.0	0.0	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	1.6	1.0	0.0	0.2	5.1	0.1	0.0	1.5	15.4	0.0	0.0	0.4	0.0	3.0	7.5	0.0	2.1	0.0	0.4	3.2	1.2	8.9	0.6	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.9	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.5	0.5	0.6	1.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.2	3.2	8.9	1.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LPAR5	"GPR92, GPR93, KPG_010, LPA5"	ENSG00000184574	"Lysophosphatidic acid receptor 5"	Q9H1C0	12	6618835-6636447	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 28.4;brain: 20.3;esophagus: 21.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.5;HEL: 13.7;HMC-1: 19.9;K-562: 10.2;U-698: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 28.4;T-cells: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013170	Approved									"HPA013170: AB_1849314"	"unprognostic (1.94e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.27e-2)"	"unprognostic (7.99e-3)"	"unprognostic (5.43e-1)"	"prognostic favourable (6.56e-5)"	"unprognostic (7.43e-2)"	2.1	3.2	11.2	5.6	12.4	1.1	1.6	1.3	8.9	5.8	10.2	20.3	0.5	11.2	0.7	3.2	21.1	2.0	1.9	3.6	10.9	4.0	1.3	1.5	2.1	9.2	9.3	4.0	0.9	0.8	0.9	1.4	7.2	9.2	1.7	9.7	1.7	6.3	1.6	0.3	6.8	9.3	1.3	11.7	10.6	8.3	1.7	13.6	2.2	2.0	1.1	13.5	3.4	9.0	28.4	5.5	2.5	1.8	1.3	23.9	6.5	4.0	0.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	7.5	3.2	1.0	0.0	5.2	0.0	2.2	0.0	0.0	0.0	13.7	0.4	0.3	0.0	0.0	19.9	0.0	2.5	0.1	1.1	0.0	10.2	0.0	0.0	0.3	0.4	4.3	0.0	0.7	3.5	0.0	0.0	0.0	2.4	0.1	0.1	2.0	0.0	0.0	0.0	1.6	0.1	0.0	3.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	2.5	0.1	0.0	23.9	1.0	18.0	28.4	4.0	14.1	5.5	27.8	4.0	8.9	0.2	1.3	1.8	0.3	5.4	6.5	11.2	12.4	1.3	8.9	10.9	4.0	9.3	4.0	9.2	13.6
LTB4R2	"BLT2, BLTR2, JULF2, NOP9"	ENSG00000213906	"Leukotriene B4 receptor 2"	Q9NPC1	14	24305734-24312053	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB022689, HPA029680, HPA072921"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.05e-11)"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.19e-1)"	1.5	1.2	0.4	1.8	0.5	4.8	1.1	0.4	0.6	7.9	0.4	0.6	0.8	2.4	1.0	4.7	38.9	0.8	0.7	0.4	0.5	0.1	6.1	0.5	1.1	1.8	0.4	0.7	0.7	0.5	0.3	0.7	0.8	0.5	1.8	0.3	0.5	4.7	1.1	0.9	21.4	1.8	0.4	0.4	3.5	1.0	1.4	0.4	3.1	0.9	43.6	26.8	0.6	9.0	0.3	2.2	1.4	2.0	0.9	2.7	1.1	2.4	4.3	1.8	1.8	0.4	0.6	7.6	0.9	0.4	1.3	0.9	3.4	1.5	3.2	1.6	0.6	15.7	1.3	2.7	0.9	3.9	4.8	2.2	3.5	1.6	0.5	3.6	4.1	0.5	3.6	1.9	2.3	0.6	2.7	3.5	0.6	4.8	1.9	3.8	1.0	5.4	7.8	1.7	1.8	0.4	3.1	3.4	1.6	1.6	2.0	1.3	3.7	2.7	1.6	2.6	3.2	4.0	1.3	7.9	2.2	5.2	0.5	6.0	2.0	0.0	2.0	1.4	2.7	1.6	1.6	0.1	2.2	2.0	2.2	0.3	1.7	0.9	1.3	0.9	0.8	0.6	0.4	1.1	0.4	0.5	0.4	0.6	0.5	0.1	0.4	0.7	0.5	0.4
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784880-142786592	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 236.9;skin 1: 111.6;tongue: 316.2"	"Cell line enriched"	"Detected in some"	20	"A-431: 55.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced					92000	92000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	0.2	3.7	0.2	0.2	0.2	0.1	3.7	0.2	0.2	23.0	0.2	0.2	0.2	0.1	2.1	0.2	236.9	0.1	0.5	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	1.2	0.1	0.2	18.1	0.2	0.4	111.6	0.2	0.9	0.2	0.2	2.0	0.2	0.2	0.9	0.2	316.2	61.8	6.3	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LYNX1-SLURP2		ENSG00000284505	"LYNX1-SLURP2 readthrough"		8	142764334-142778224	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 13.1;esophagus: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.2;BJ: 3.6;EFO-21: 2.9;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.6"									"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.7;non-classical monocyte: 4.1"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.1"														"Intracellular and membrane"																							3.8	2.4	3.7	0.8	4.1	0.3	1.1	1.2	13.1	1.1	1.4	2.1	0.0	1.1	1.9	1.4	13.6	2.1	1.2	7.0	3.0		1.6	6.5	1.1	0.6	2.3	4.2	1.6	1.0	1.2	0.0	0.7	6.7	3.6	0.9	1.9	2.0	5.0	2.0	8.6	1.5	3.5	1.2	1.5	1.2	0.8	1.4	0.0	0.5	0.5	1.1	4.2	0.8	0.0	0.2	0.0	4.1	0.0	0.6	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.4	0.3	0.0	0.0	2.9	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.4	0.2	0.0	1.1	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.7	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	4.1	0.0	0.0	0.1										
LYPD3	C4.4A	ENSG00000124466	"LY6/PLAUR domain containing 3"	O95274	19	43460787-43465660	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 29.4;MCF7: 32.8;RT4: 31.5;SK-BR-3: 47.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 235.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041529, HPA041797, HPA077859"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		9700000	9700000	"Endoplasmic reticulum, Vesicles"	"Endoplasmic reticulum, Vesicles"	"HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: "	"unprognostic (1.07e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.96e-3)"	0.3	0.4	0.3	0.4	0.3	0.8	5.8	0.3	0.3	28.0	0.3	0.3	0.3	0.0	2.1	0.7	110.5	0.5	0.3	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.8	0.3	0.0	0.3	7.4	0.3	1.4	0.0	0.5	21.7	0.3	0.6	86.4	0.4	0.8	0.3	0.3	0.1	0.3	0.3	1.9	0.3	70.6	75.2	4.1	48.3	0.2	3.5	3.0	0.4	0.1	7.9	1.9	11.0	0.1	0.0	0.2	0.1	0.0	4.6	0.4	1.1	0.4	0.5	0.1	12.5	0.0	0.5	0.3	29.4	0.0	1.3	0.2	0.0	0.0	0.2	1.5	0.2	0.1	0.0	0.2	0.5	11.1	0.0	0.1	0.0	0.0	0.0	0.0	32.8	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.3	31.5	0.0	0.0	0.1	47.3	0.5	5.2	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	1.6	0.2	4.2	1.6	3.5	0.0	7.9	6.7	3.0	0.1	0.0	0.4	1.2	1.9	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.9;skin 1: 8.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.3;RT4: 14.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039551, HPA046187"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039551: AB_2676565, HPA046187: AB_10964208"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.3	0.0	0.3	2.7	0.3	0.8	0.5	0.3	0.3	2.8	2.1	0.3	0.3	0.2	0.3	0.3	9.9	0.0	0.3	0.3	0.3	0.2	2.0	3.1	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	2.2	0.3	1.1	1.8	0.3	1.3	0.7	0.6	8.7	3.4	0.3	0.3	0.3	0.4	0.7	0.3	0.3	0.3	2.5	1.7	2.1	4.2	2.6	1.3	5.5	1.2	4.4	0.7	0.0	3.4	0.1	0.7	0.6	0.1	0.0	5.2	0.6	0.2	0.0	0.0	0.3	1.2	2.0	15.3	0.1	2.8	0.1	0.1	0.1	0.7	0.1	0.9	0.4	2.7	0.0	0.9	0.5	0.0	0.4	0.0	0.3	0.0	0.9	2.4	0.0	0.3	0.5	0.5	2.2	1.0	0.8	0.8	0.4	0.6	14.8	0.5	0.8	2.3	1.9	0.6	2.4	0.4	0.5	1.0	2.4	0.7	0.6	2.2	3.9	0.9	0.5	0.3	1.0	2.6	1.2	0.3	0.6	0.6	0.5	0.8	0.4	0.5	0.3	2.6	0.7	0.7	5.5	4.4	0.7	1.3	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3
MAL2		ENSG00000147676	"Mal, T cell differentiation protein 2 (gene/pseudogene)"	Q969L2	8	119165034-119245673	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.4"	"Cell line enhanced"	"Detected in some"		"A-431: 108.8;HaCaT: 48.6;RPTEC TERT1: 42.2;SK-BR-3: 157.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043831	Uncertain									"HPA043831: "	"prognostic unfavourable (4.57e-6)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavourable (8.44e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.00e-3)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.39e-5)"	"unprognostic (5.48e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.33e-1)"	"unprognostic (9.27e-3)"	3.3	1.3	7.8	5.5	21.1	0.0	17.4	17.4	26.4	13.1	25.5	1.6	19.2	16.0	1.5	5.4	70.4	13.9	16.2	1.9	8.6	4.0	22.8	11.5	20.4	0.0	2.2	11.8	1.3	19.0	9.3	22.7	6.6	1.2	6.8	24.3	0.6	21.1	16.9	1.1	31.0	18.3	0.5	1.8	1.2	33.8	3.3	1.6	0.5	43.8	30.4	31.5	13.3	28.5	0.0	0.0	0.0	0.0	0.0	0.6	0.1	108.8	0.0	0.1	0.0	0.0	0.0	10.2	0.0	0.2	0.1	0.1	9.3	35.4	0.0	6.2	0.0	48.6	0.0	3.5	0.0	0.1	0.2	0.0	1.6	9.0	0.0	0.0	0.0	0.0	24.8	0.0	3.8	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.8	33.5	0.0	0.0	0.0	42.2	27.4	6.2	0.0	1.9	157.0	0.3	20.8	0.3	0.0	0.0	0.3	0.1	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	21.1	17.4	26.4	8.6	4.0	2.2	11.8	1.2	1.6
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116566	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 107.7;intestine: 142.1;lung: 72.9"	"Cell line enhanced"	"Detected in some"		"A-431: 40.0;A549: 39.2;CAPAN-2: 54.2;fHDF/TERT166: 59.5;HaCaT: 42.2;PC-3: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Low region specificity"	"Detected in single"							HPA051410	Uncertain									"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	5.5	1.0	0.9	11.1	2.1	0.1	7.7	0.4	1.1	22.5	46.4	0.2	1.3	41.2	6.0	2.7	107.7	2.8	6.7	10.8	1.7	1.0	1.9	1.1	72.9	3.7	1.1	0.2	1.6	2.9	49.8	1.0	3.7	3.6	5.5	19.0	1.6	11.2	1.5	2.1	11.1	142.1	5.1	4.2	2.0	1.8	2.2	0.4	0.6	5.6	45.8	63.8	7.8	35.4	0.9	0.7	9.3	0.7	2.1	1.0	0.5	40.0	39.2	0.0	0.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	6.4	54.2	0.1	19.7	59.5	42.2	0.0	2.3	0.0	0.1	0.0	0.3	1.1	0.0	0.3	0.0	0.1	0.9	2.1	0.1	0.0	19.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	23.9	0.0	0.0	0.1	5.1	2.2	0.1	0.0	0.0	1.4	0.1	0.0	0.2	19.9	0.0	0.1	0.1	0.1	0.0	0.0	4.6	0.0	0.0	0.0	9.3	0.7	1.0	0.4	0.4	0.4	0.7	0.8	0.7	0.3	0.9	0.5	1.0	4.4	2.1	0.2	0.7	0.6	0.5	0.9	2.1	0.4	1.1	1.7	1.0	1.1	0.2	3.6	0.4
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.9;esophagus: 2.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;SiHa: 1.7;U-138 MG: 6.1;U-2 OS: 1.4;U-2197: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042365	Approved									"HPA042365: AB_2677961"	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0			0.0	0.0	7.9	2.7	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	1.6			0.0		0.2	0.0	0.4	0.1	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	6.1	1.4	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0										
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253403-118264536	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 24.8;EFO-21: 27.3;HaCaT: 34.1;RT4: 64.9;TIME: 71.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA060740	Approved		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (2.08e-2)"	11.7	1.7	1.5	2.8	1.5	0.0	17.1	1.5	1.6	31.0	8.5	1.0	26.3	4.4	6.8	17.8	103.8	13.4	12.3	4.7	2.4	1.5	11.7	7.9	21.7	1.8	2.4	0.6	7.4	4.6	10.2	9.2	1.5	4.0	17.8	8.7	6.2	21.6	32.8	7.8	11.4	4.4	5.6	4.3	1.3	10.0	3.7	1.3	5.7	21.7	52.3	41.1	29.4	37.4	0.0	13.4	10.9	9.3	0.3	1.0	2.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	24.8	0.0	27.3	0.0	34.1	0.0	7.9	0.0	0.0	1.9	0.0	0.3	7.1	0.0	0.0	0.0	0.0	18.8	0.0	0.6	17.8	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.0	0.0	0.0	1.2	3.1	64.9	0.0	0.0	1.1	12.7	0.0	5.4	0.1	71.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.3	2.3	0.1	7.2	1.0	0.0	0.5	0.4	13.4	0.0	0.6	0.7	10.9	0.3	1.0	0.2	0.2	2.8	1.5	1.5	1.5	1.6	2.4	1.5	2.4	0.6	4.0	1.3
MSGN1	pMesogenin1	ENSG00000151379	"Mesogenin 1"	A6NI15	2	17816496-17817101	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.2;esophagus: 2.9;tongue: 2.1"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 1.3;REH: 1.1;RH-30: 1.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.0;hippocampal formation: 2.2"	"Cell type enriched"	"Detected in single"	14	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (3.63e-2)"				"unprognostic (3.25e-2)"									"unprognostic (1.66e-1)"			0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.0	2.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	2.9	0.6	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.1	0.1	0.0	1.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.1	0.4	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.0	2.2	0.1	0.0	0.0	0.4	0.0
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.4	1.5	2.2	1.6	4.9	2.4	8.2	3.8	2.2	1.9	1.3	4.9	2.7	2.0	2.0	1.5	12.3	4.2	7.7	2.0	1.1	5.0	4.1	4.4	4.8	16.4	4.9	4.1	2.8	13.0	4.3	20.0	2.4	7.1	7.9	1.2	2.8	2.4	9.9	0.6	2.5	1.1	2.2	4.9	2.5	4.1	7.1	3.0	5.1	6.8	2.7	1.0	2.9	9.4	2.7	0.7	2.9	3.6	5.4	9.1	0.7	2.8	8.7	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7
MYEOV	OCIM	ENSG00000172927	"Myeloma overexpressed"	Q96EZ4	11	69294138-69367726	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.4;breast: 16.9;esophagus: 17.3"	"Cell line enhanced"	"Detected in some"		"A-431: 57.8;A549: 27.8;CAPAN-2: 8.5;U-2 OS: 12.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA012949: AB_1854241"	"unprognostic (1.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.28e-3)"	"unprognostic (7.58e-3)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.49e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (1.54e-7)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.69e-2)"	29.4	0.2	0.0	2.4	0.0	0.2	16.9	0.1	0.0	2.6	1.1	0.0	0.4	0.4	0.5	8.1	17.3	0.0	1.3	0.1	0.0	0.2	0.2	8.6	0.1	0.2	0.0	0.1	0.1	2.1	0.0	0.1	0.0	0.0	0.1	0.6	0.9	2.0	0.0	0.6	4.9	0.8	0.1	0.0	0.3	10.7	0.4	0.0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0.0	0.0	0.1	1.0	0.3	2.1	57.8	27.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.2	8.5	0.2	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	1.0	0.1	0.8	0.0	12.8	0.0	0.6	0.1	0.6	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5"	"Cell line enriched"	"Detected in some"	28	"HSkMC: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Low region specificity"	"Detected in some"			HPA021808	Enhanced					17000000	17000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.0	0.5	0.7	0.8	1.0	0.6	0.8	1.9	0.8	2.2	4.1	0.6	3.5	0.9	1.9	13.2	21.1	1.0	0.6	0.6	0.9	0.6	0.8	1.8	0.6	1.0	0.9	0.6	1.4	1.3	0.5	0.7	1.1	0.6	25.6	0.9	0.6	0.7	16.2	18.5	1.5	1.4	16.5	1.2	1.6	0.8	2.8	0.6	1.8	2.3	1.7	2.0	8.5	2.6	1.0	0.1	0.0	0.1	0.9	0.7	0.0	0.1	0.6	0.4	0.6	0.6	0.2	0.6	0.4	0.2	0.3	0.3	0.6	0.1	0.4	0.2	0.2	0.6	0.3	0.1	0.6	0.4	0.5	0.5	0.1	0.9	0.2	0.3	0.8	37.0	0.2	0.4	0.4	0.0	0.2	0.0	0.1	0.4	0.5	1.3	0.5	0.4	0.5	0.5	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.1	0.0	0.8	0.6	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.1	0.6	0.0	0.7	1.0	1.9	0.8	0.9	0.6	0.9	0.6	0.6	0.6
NCCRP1	"FBXO50, LOC342897, NCCRP-1"	ENSG00000188505	"Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)"	Q6ZVX7	19	39196961-39201884	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 101.7;lymphoid tissue: 113.1;skin 1: 49.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 26.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 2.0"	"Not detected"	"Not detected"			HPA052812	Approved					1200000	1200000			"HPA052812: AB_2681960"	"unprognostic (3.56e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (4.59e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.37e-6)"	"unprognostic (2.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.57e-1)"	0.1	0.1	0.0	3.1	0.0	0.3	2.1	0.0	0.4	21.5	0.8	0.0	0.4	0.6	2.1	0.3	101.7	0.4	0.3	0.1	0.0	0.0	0.9	0.1	0.8	2.4	0.0	0.0	0.1	2.9	0.1	0.0	7.5	0.0	0.4	0.6	20.2	10.5	0.4	0.3	49.6	2.4	0.2	0.0	0.4	0.1	0.1	0.0	4.3	0.2	42.7	113.1	1.2	31.2	0.7	0.8	3.4	0.6	0.9	0.6	0.1	0.2	0.2	1.0	0.2	0.1	0.7	2.1	0.1	0.0	0.1	0.1	0.5	0.5	0.6	2.0	0.4	0.9	1.4	0.5	0.4	0.0	0.4	0.2	0.8	0.2	0.1	0.4	0.3	0.5	0.4	0.0	0.3	0.2	0.3	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.2	0.4	0.4	0.1	0.5	0.6	1.0	2.5	26.2	0.2	0.3	0.9	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.5	0.2	0.5	3.4	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.3	0.2	0.7	0.5	0.4	2.0	0.9	0.5	0.8	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
NDUFA4L2	"FLJ26118, NUOMS"	ENSG00000185633	"NDUFA4, mitochondrial complex associated like 2"	Q9NRX3	12	57234903-57240715	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 82.5;skin 1: 93.4"	"Cell line enriched"	"Detected in many"	7	"AN3-CA: 54.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 356.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4;T-reg: 2.8"	"Group enriched"	"Detected in many"	24	"B-cells: 2.4;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055323			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA055323: "	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.23e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (9.10e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.74e-2)"	24.5	9.6	8.3	4.9	15.5	1.3	11.5	7.7	10.4	19.1	4.4	8.3	1.1	4.6	4.6	5.4	82.5	3.6	11.0	30.9	9.8	7.3	5.4	4.2	12.7	4.6	10.9	10.7	6.1	6.7	4.6	6.2	42.7	13.2	6.8	2.4	13.7	10.3	7.4	19.0	93.4	4.7	5.6	5.6	29.9	4.3	3.0	8.9	0.7	12.0	14.8	11.9	10.2	31.4	2.4	0.1	0.0	0.0	0.0	2.8	0.3	0.3	0.5	0.1	54.1	2.2	1.3	0.1	0.8	0.6	0.2	0.5	0.0	0.6	2.1	2.3	0.8	0.4	0.3	0.4	0.0	1.1	0.1	0.2	0.1	0.0	7.8	1.6	0.8	5.0	1.0	0.1	1.9	0.0	0.2	2.9	0.1	1.0	0.4	0.0	0.1	0.9	0.8	0.4	4.1	0.0	0.0	2.9	1.0	0.1	0.1	1.8	0.6	5.7	0.2	0.5	0.0	0.4	0.2	4.1	1.3	0.9	2.0	3.8	0.3	0.0	0.0	0.0	0.6	0.0	0.0	2.4	0.7	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.3	8.3	15.5	7.7	10.4	9.8	7.3	10.9	10.7	13.2	8.9
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729084	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.3;skin 1: 73.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 58.1;hTCEpi: 36.2;RT4: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	97000000	97000000			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	3.1	3.0	7.7	3.0	11.1	11.9	5.3	8.4	20.8	6.6	7.3	27.3	2.4	9.6	2.3	2.0	55.3	2.9	2.5	3.0	16.1	8.2	3.0	2.4	2.5	1.7	12.7	10.6	1.8	10.8	2.4	4.1	8.2	10.1	5.9	7.8	6.3	8.7	4.4	1.6	73.5	6.9	3.1	14.3	2.2	3.2	1.3	12.4	2.5	1.8	25.3	20.8	17.3	14.8	0.1	4.8	1.0	1.5	0.1	0.1	0.2	4.0	3.4	3.2	4.6	1.7	0.5	22.7	1.6	1.5	1.4	1.0	7.1	13.9	5.4	6.7	1.9	58.1	8.2	29.6	0.6	12.7	1.2	0.7	1.1	3.3	0.7	3.6	9.1	0.5	36.2	4.4	16.2	4.1	0.1	28.9	1.8	10.6	0.0	2.2	10.6	4.7	0.3	19.4	6.5	1.3	39.4	7.8	17.7	5.5	14.6	0.5	13.3	0.5	2.2	1.2	4.6	10.0	1.4	5.3	6.6	0.0	0.4	3.0	2.8	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	1.0	0.1	1.5	4.8	0.0	0.2	7.7	11.1	8.4	20.8	16.1	8.2	12.7	10.6	10.1	12.4
NECTIN4	"LNIR, nectin-4, PRR4, PVRL4"	ENSG00000143217	"Nectin cell adhesion molecule 4"	Q96NY8	1	161070995-161089599	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;placenta: 46.6;skin 1: 39.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA010775	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	11000	11000	"Plasma membrane"	"Plasma membrane"	"HPA010775: AB_1079720"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-8)"	"unprognostic (2.98e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.97e-2)"	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0.0	0.1	0.0	0.5	4.4	0.0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2.0	0.1	0.1	4.5	0.2	0.0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0.0	5.1	0.1	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.1	0.0	18.0	0.0	0.6	0.1	0.0	0.2	0.0	0.4	5.2	0.0	0.0	0.3	0.0	7.2	1.5	1.8	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.1	23.4	0.0	15.2	0.0	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.1	1.2	0.2	0.0	0.1	0.2	0.2	0.0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
NKX6-1	"Nkx6.1, NKX6A"	ENSG00000163623	"NK6 homeobox 1"	P78426	4	84491987-84498450	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 6.0;esophagus: 11.0;pancreas: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 5.5;HAP1: 8.0;HEK 293: 7.0;HMC-1: 5.4;PC-3: 4.7;U-2197: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.7"	"Low region specificity"	"Detected in some"			"HPA036774, CAB070169"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB070169: AB_10011794, HPA036774: AB_10673664"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"		"unprognostic (9.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.68e-1)"	0.2	0.0	0.3	0.2	2.2	0.0	6.0	1.0	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	11.0	0.0	0.2	0.2	0.4	1.3	0.2	0.2	0.2	0.2	2.5	0.2	0.2	10.8	0.0	0.2	0.2	0.9	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	1.3	0.2	1.5	2.1	0.2	0.2	3.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.5	0.9	0.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.2	0.0	8.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.1	0.0	0.0	4.7	0.0	2.3	0.0	0.0	0.3	1.5	0.0	0.7	0.0	0.0	0.0	0.7	0.1	0.0	2.4	8.8	2.2	0.0	0.0	0.0	1.5	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	1.0	1.1	0.4	1.3	2.5	0.2	0.9	0.2
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		35000	35000	Mitochondria	Mitochondria	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favourable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.0	12.0	1.3	9.6	4.1	4.8	1.9	5.4	6.3	2.7	4.7	0.6	10.1	7.3	16.7	6.9	10.2	3.7	3.1	0.9	9.4	3.9	9.6	4.1	6.5	6.3	3.3	5.6	5.3	13.0	3.5	6.9	5.5	0.1	4.9	2.8	10.8	5.6	8.1	5.9	6.8	11.1	1.6	2.4	6.5	5.2	1.8	6.3	8.0	4.3	3.5	13.9	9.9	6.4	5.4	4.9	4.8	2.8	1.7	1.9	2.4	0.8	10.3	3.8	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3
NMU		ENSG00000109255	"Neuromedin U"	P48645	4	55595229-55636698	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.9;skin 1: 28.3;tongue: 28.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 79.5;K-562: 62.4;Karpas-707: 28.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.4"	"Group enriched"	"Detected in some"	10	"MAIT T-cell: 7.2;memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	51	"T-cells: 7.2"	"Region enhanced"	"Detected in single"		"pons and medulla: 4.7"	"Low region specificity"	"Detected in single"			HPA025926	Uncertain				"Secreted in other tissues"					"HPA025926: AB_1854539"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.08e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.29e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.07e-10)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.55e-2)"	0.1	0.3	0.2	2.0	1.1	5.9	1.3	0.1	3.4	5.4	1.1	0.2	2.5	0.6	0.5	0.0	42.9	0.2	0.3	0.3	0.2	0.9	0.1	0.0	1.0	0.4	0.4	0.5	0.0	0.0	0.0	2.8	2.1	0.3	0.1	0.6	0.0	6.6	1.5	0.1	28.3	1.7	0.2	1.2	0.1	3.1	1.3	0.0	0.7	17.2	28.4	8.5	0.1	12.2	0.1	0.0	0.0	0.0	0.0	7.2	0.1	8.3	0.0	4.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	12.8	18.4	1.8	0.0	79.5	9.6	0.7	0.5	1.1	5.2	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	62.4	28.7	0.0	2.0	0.2	0.0	2.4	2.4	0.0	0.0	0.1	0.4	0.0	4.1	10.4	6.4	0.1	0.0	4.4	0.0	0.5	0.0	6.0	0.0	11.1	8.3	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.0	2.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.1	3.4	0.2	0.9	0.4	0.5	0.3	0.0
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492202-137494250	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.7;esophagus: 1.4;placenta: 1.8"	"Group enriched"	"Detected in some"	4	"AF22: 2.9;NTERA-2: 4.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA018303, CAB024865"	Uncertain									"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	1.8	3.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.7	0.0
OR10K1		ENSG00000173285	"Olfactory receptor family 10 subfamily K member 1"	Q8NGX5	1	158461574-158470857	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;esophagus: 2.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA059125	Uncertain									"HPA059125: AB_2683913"																		0.2	0.4	0.2	0.8	0.3	2.0	0.2	0.2	0.4	0.7	0.3			0.2	0.3	0.8	2.9	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.2	0.3	0.2		0.3	0.3	0.1	0.3	0.0		0.2	0.0		0.2	0.0	1.6	0.4	0.3	0.0	0.3	0.5	0.3	0.9			0.2		1.0	0.8	0.3	1.4	0.5	2.4	0.6	0.9	1.2	0.1	1.2	1.0	1.1	1.0	0.7	0.6	1.3	0.7	0.5	0.1	0.4	0.6	0.9	1.2	1.8	0.3	1.0	0.4	0.4	1.5	1.7	0.4	1.3	1.1	0.8	0.3	0.9	1.6	0.1	0.1	0.9	0.4	0.1	1.0	3.8	0.1	0.4	1.3	1.6	2.2	0.2	1.0	0.5	0.8	0.0	0.9	0.8	1.2	0.8	0.4	2.0	0.9	1.1	0.4	1.2	2.2	2.1	0.9	2.1	1.7	1.0	0.7	1.0	1.9	1.6	0.6	0.2	1.2	0.5	1.2	0.7	0.9	1.0	0.3	1.4	0.9	1.0	2.4	0.9	0.4	0.5	0.8	0.1										
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188803-4226889	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA035599	Uncertain									"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0			0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.8			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OVOL1	HOVO1	ENSG00000172818	"Ovo like transcriptional repressor 1"	O14753	11	65787022-65797219	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;tongue: 37.4"	"Cell line enhanced"	"Detected in some"		"A-431: 9.9;BEWO: 28.5;CACO-2: 7.2;HaCaT: 16.8;RT4: 16.6;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA003984	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003984: AB_1854854"	"unprognostic (4.26e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.00e-13)"	"unprognostic (4.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.04e-3)"	0.2	0.1	0.2	3.3	0.3	0.0	2.2	0.4	0.2	7.2	11.5	0.0	3.0	9.6	0.4	0.7	42.6	0.3	4.2	0.1	0.2	0.2	4.7	0.2	1.7	0.0	0.2	0.0	0.1	5.6	5.0	0.2	14.4	0.0	2.3	5.1	1.1	13.9	6.1	0.5	24.1	14.2	0.8	0.2	0.2	0.8	17.3	0.0	0.6	1.8	37.4	25.3	8.3	9.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	28.5	0.0	0.0	0.0	0.0	7.2	2.7	0.0	0.1	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	16.6	0.1	0.0	0.0	13.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205126-17246005	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 48.7;lymphoid tissue: 60.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.3;EFO-21: 4.5;HaCaT: 2.8;LHCN-M2: 3.6;RPTEC TERT1: 4.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Low region specificity"	"Detected in some"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.3	0.0	48.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.1	0.0	4.6	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	60.2	1.3	6.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.9	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.2	0.0	0.1	9.3	0.0	4.5	0.4	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.3	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;RT4: 15.8;T-47d: 11.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.2	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	15.8	0.0	0.0	0.0	2.3	0.1	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"PERP, TP53 apoptosis effector"	Q96FX8	6	138088505-138107511	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 250.2;skin 1: 157.9;tongue: 230.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.2;hTCEpi: 139.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.3"	"Group enriched"	"Detected in many"	9	"granulocytes: 21.3;T-cells: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA022269	Enhanced									"HPA022269: AB_1855219"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	4.2	1.6	1.0	2.7	1.2	0.0	25.5	1.3	0.9	51.9	12.5	0.5	7.1	6.3	6.4	11.7	250.2	7.7	15.6	14.7	1.2	1.5	4.4	28.0	8.4	1.7	1.3	0.3	3.3	11.5	5.0	3.3	31.5	1.6	17.5	5.0	2.4	46.6	7.9	1.4	157.9	23.4	7.1	1.3	0.6	8.4	1.9	0.6	6.7	8.7	230.6	113.6	14.0	57.8	1.4	0.0	21.3	0.0	0.0	5.6	0.8	10.0	11.3	0.0	1.1	7.9	8.4	23.6	16.4	18.5	2.3	1.7	9.2	20.8	0.0	5.9	4.1	37.2	2.0	29.6	0.5	15.8	9.2	0.0	11.3	8.7	5.7	0.0	0.0	6.3	139.5	0.2	15.2	9.2	0.1	4.4	0.2	6.9	0.0	0.5	4.8	6.0	0.0	3.7	0.0	15.8	11.7	3.9	0.0	17.3	9.3	7.9	5.2	2.0	11.0	4.1	1.6	4.4	0.0	1.3	1.7	0.0	3.3	0.0	8.7	21.3	0.0	0.0	3.0	0.0	5.2	1.4	3.8	2.6	0.0	0.4	0.4	1.7	0.2	0.0	0.0	0.0	5.6	0.8	1.0	1.2	1.3	0.9	1.2	1.5	1.3	0.3	1.6	0.6
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell line enhanced"	"Detected in all"		"A549: 177.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"		59000000	59000000	"Intermediate filaments, Cytosol"	"Intermediate filaments, Cytosol"	"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	22.6	177.4	44.2	47.5	67.3	41.7	9.6	15.3	27.2	21.2	29.1	26.0	26.1	22.2	18.9	15.7	19.2	32.3	27.5	14.3	15.3	28.2	30.0	31.9	54.6	20.5	49.6	33.4	29.7	13.8	33.5	8.3	50.1	40.1	19.7	27.2	25.7	40.9	24.8	26.6	15.6	31.8	40.6	40.9	29.7	12.2	23.8	20.8	13.1	20.8	18.1	22.9	42.6	46.9	11.2	20.0	13.3	16.9	14.9	27.3	39.9	24.5	53.9	10.1	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4
PGLYRP3	"PGLYRPIalpha, PGRP-Ialpha, PGRPIA"	ENSG00000159527	"Peptidoglycan recognition protein 3"	Q96LB9	1	153297862-153310718	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 21.3;skin 1: 39.1;vagina: 10.9"	"Group enriched"	"Detected in some"	15	"HaCaT: 8.6;HDLM-2: 3.5;hTCEpi: 3.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.5"					"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030369	Uncertain				"Secreted in other tissues"					"HPA030369: AB_10603984"		"unprognostic (6.34e-2)"	"unprognostic (1.60e-1)"			"unprognostic (7.09e-2)"		"unprognostic (2.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.88e-3)"			"unprognostic (1.28e-1)"	"unprognostic (1.82e-1)"		"unprognostic (2.25e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.8	0.0			0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.9	0.0	0.0	39.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		3.8	0.0	10.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	2100000	2100000	"Plasma membrane"	"Plasma membrane"	"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.6;HeLa: 32.4;K-562: 31.6;T-47d: 47.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	16.9	10.4	0.0	14.0	0.5	0.2	4.3	3.4	4.9	1.6	0.6	39.6	10.0	19.0	5.4	0.2	5.7	2.3	8.1	0.1	0.2	14.8	4.7	32.4	10.9	5.1	1.7	0.0	0.4	5.9	0.0	1.9	0.0	31.6	0.0	0.5	5.2	0.1	3.8	0.0	9.3	5.6	0.3	0.3	0.2	5.3	6.5	0.0	14.8	8.0	0.0	47.1	1.1	0.6	1.8	4.7	1.0	5.2	0.0	0.0	12.5	2.4	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in some"	5	"HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		2700000	2700000	"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	44.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.0	1.0	25.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	5	"HL-60: 4.4;NB-4: 1.4;SK-BR-3: 1.2;U-698: 4.9;U-937: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.2	0.1	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	4.9	0.4	4.7	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5										
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Group enriched"	"Detected in some"	5	"AF22: 13.9;AN3-CA: 14.0;NTERA-2: 7.1;SCLC-21H: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favourable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	14.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.9	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1
PLEKHN1	DKFZP434H2010	ENSG00000187583	"Pleckstrin homology domain containing N1"	Q494U1	1	966497-975865	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2"	"Cell line enhanced"	"Detected in many"		"A-431: 11.1;HaCaT: 19.5;SK-BR-3: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA031742	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA031742: AB_10670704"	"unprognostic (2.72e-3)"	"unprognostic (8.05e-3)"	"unprognostic (9.03e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (4.97e-5)"	"unprognostic (9.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	0.4	0.6	0.0	1.8	0.2	0.4	1.4	0.0	0.1	7.7	0.9	0.0	0.0	0.8	1.1	2.7	31.5	0.3	5.0	0.5	0.3	0.0	2.3	0.8	1.1	0.3	0.0	0.0	0.1	0.5	0.3	0.0	1.5	0.0	3.7	0.2	0.3	5.3	1.2	1.5	31.3	0.7	0.6	0.6	0.5	1.7	0.8	0.0	0.2	0.7	20.2	21.2	6.0	10.6	0.0	0.3	2.0	0.9	2.3	1.1	0.2	11.1	1.2	0.0	0.7	0.0	0.5	1.9	5.2	1.3	3.4	0.8	1.5	8.6	0.0	2.5	2.1	19.5	0.2	3.2	0.5	3.8	0.8	0.0	3.4	2.2	0.4	0.2	0.1	0.1	2.7	2.2	1.2	0.3	0.2	3.1	0.2	6.5	0.0	0.2	0.3	9.0	0.0	0.0	4.1	3.6	3.4	0.1	0.1	5.8	13.3	0.7	2.5	0.0	2.3	4.2	1.8	0.4	3.4	2.5	0.1	0.1	5.1	1.9	2.4	0.0	0.9	2.0	0.3	0.3	0.0	0.0	0.5	1.1	0.3	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.8	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell line enriched"	"Detected in some"	18	"hTCEpi: 84.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		310000	310000	"Plasma membrane"	"Plasma membrane"	"HPA042550: AB_2678048, HPA059859: AB_2684145"	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.8	2.5	0.0	0.0	18.3	26.6	8.8	0.0	0.4	0.0	0.1	11.3	17.4	0.1	4.0	0.3	55.8	0.3	6.7	0.0	0.0	0.3	0.0	13.5	2.0	1.1	0.0	0.0	1.3	6.2	0.0	2.1	0.0	0.0	0.0	0.0	20.4	0.0	0.0	1.7	5.3	0.0	0.0	8.6	13.3	10.9	9.2	0.1	29.9	10.0	0.1	5.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0
PRSS22	"BSSP-4, hBSSP-4, SP001LA"	ENSG00000005001	"Serine protease 22"	Q9GZN4	16	2852727-2858170	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.6;MCF7: 12.4;RT4: 5.8;SK-BR-3: 13.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"cerebellum: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.6"	"Low region specificity"	"Detected in all"			HPA049161	Approved		Approved	Nucleoplasm	"Secreted in other tissues"			Nucleoplasm	Nucleoplasm	"HPA049161: AB_2680660"	"unprognostic (1.45e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.48e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.12e-1)"	"unprognostic (2.32e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	0.4	0.7	0.0	0.4	0.0	0.6	1.3	1.5	0.4	9.9	1.0	0.0	8.6	1.5	3.0	0.6	40.4	3.0	6.8	0.4	0.0	0.0	2.4	0.7	3.0	0.4	0.0	0.0	0.4	7.5	0.4	1.1	4.3	0.0	5.1	0.6	0.0	13.4	10.6	2.3	1.3	0.4	0.7	0.0	0.4	3.5	0.4	0.0	0.0	1.5	36.5	40.1	5.2	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	13.1	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRSS27	"CAPH2, MPN"	ENSG00000172382	"Serine protease 27"	Q9BQR3	16	2712418-2720551	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.4;SK-BR-3: 21.8;T-47d: 12.8;U-266/70: 4.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;myeloid DC: 1.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB024920, HPA028848"	Approved		Approved	Vesicles	"Secreted to digestive system"			Vesicles	Vesicles	"CAB024920: , HPA028848: "	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.28e-2)"	0.2	0.3	0.1	0.2	0.5	0.2	0.4	0.7	0.4	15.3	0.2	0.1	0.1	0.1	1.2	0.1	94.1	0.3	0.2	0.2	0.1	0.4	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.1	0.2	0.1	0.1	10.0	0.3	0.2	1.2	0.1	0.2	0.1	0.2	0.1	0.5	0.1	0.3	0.2	64.5	97.2	0.5	24.0	0.1	1.7	0.2	0.0	0.2	1.4	1.2	0.0	0.2	0.5	1.8	0.3	0.6	5.4	0.0	0.2	0.2	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.9	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.6	0.0	0.9	1.3	0.0	0.8	0.2	0.1	0.1	0.3	0.6	2.6	0.0	21.8	0.5	12.8	1.5	0.0	0.3	0.0	0.0	0.0	4.5	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	1.7	0.0	0.3	0.7	0.2	0.2	0.0	0.0	0.0	1.2	0.1	0.5	0.7	0.1	0.1	0.4	0.1	0.1	0.1	0.1
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682724	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.5;HeLa: 22.2;RT4: 31.8;SK-BR-3: 8.1"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	0.4	0.2	0.0	0.2	0.0	0.2	0.3	0.0	0.2	7.0	2.4	0.7	0.1	0.6	0.3	0.2	72.6	1.1	21.2	0.1	0.0	0.0	2.6	0.1	3.0	0.2	0.0	0.0	0.1	0.3	0.1	0.5	17.2	0.0	30.1	0.7	0.1	11.7	0.6	0.1	0.8	1.5	18.9	0.0	0.2	230.2	0.2	0.0	0.0	0.1	9.3	35.1	112.0	54.5	0.0	0.8	0.0	0.3	0.0	0.0	0.0	5.3	0.3	0.0	0.0	1.1	3.7	5.5	2.5	0.5	1.1	0.9	0.0	11.5	0.0	0.2	0.2	1.1	0.0	0.2	0.6	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.7	3.2	4.1	2.4	0.0	0.0	0.0	0.0	0.8	2.9	0.8	0.3	0.6	0.6	0.3	0.0	0.4	0.5	31.8	0.1	0.2	2.6	8.1	1.7	0.1	0.1	0.5	0.8	0.9	1.5	0.0	1.0	0.0	0.0	1.5	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.9;CAPAN-2: 26.2;HaCaT: 23.8;hTCEpi: 23.5;MCF7: 36.3;RT4: 33.0;SK-BR-3: 53.7;T-47d: 50.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	"Cell Junctions, Cytosol"	"CAB033645: AB_1128883, HPA010872: "	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	19.7	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	19.3	26.2	0.0	0.0	0.0	23.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	33.0	2.9	0.0	0.0	53.7	0.0	50.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 39.7;lymphoid tissue: 22.5;tongue: 19.8"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.5;HeLa: 21.4;hTCEpi: 15.5;SiHa: 7.4;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"			"Focal adhesion sites"	"Focal adhesion sites"	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	1.6	0.5	0.2	0.5	0.2	0.0	1.4	0.2	0.2	10.4	0.3	0.2	0.2	0.2	0.8	0.6	39.7	0.6	0.2	0.2	0.2	0.0	2.8	0.2	0.6	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.5	0.2	0.4	0.3	0.2	7.0	0.2	0.7	14.6	0.3	0.3	0.2	0.6	0.2	0.5	0.3	0.3	0.2	19.8	22.5	1.3	12.6	0.6	0.4	2.3	0.6	0.5	0.7	0.1	1.5	0.9	0.0	0.0	0.1	1.3	0.1	0.1	0.9	0.1	0.3	0.0	3.7	0.0	2.1	3.0	1.6	0.0	15.5	0.2	0.4	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.3	15.5	0.9	3.2	0.1	0.0	1.3	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.7	0.2	0.0	7.4	2.0	0.0	1.1	0.0	2.9	1.1	0.4	0.1	0.9	0.0	0.0	0.0	6.7	0.3	0.0	2.0	0.6	0.4	0.4	0.3	0.2	0.2	0.6	0.3	0.1	0.6	0.7	0.4	2.3	0.5	0.2	0.4	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.2;tongue: 18.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.9;hTCEpi: 18.3;SiHa: 9.0;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062673			Supported	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA062673: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.5	10.0	0.3	0.6	0.3	0.0	2.5	0.2	1.0	5.6	0.6	0.5	1.4	0.2	0.8	4.3	21.2	0.5	1.2	0.9	0.4	0.2	2.3	0.2	1.3	0.1	0.3	0.1	1.9	0.1	0.1	1.2	0.1	0.5	2.9	0.1	0.8	3.9	2.2	0.4	4.3	0.5	1.8	0.9	0.2	0.6	0.5	0.2	0.2	0.7	18.4	10.7	2.8	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	1.0	0.0	1.3	1.9	1.7	0.0	0.6	2.4	1.0	1.5	0.0	1.2	0.0	0.4	1.3	2.0	0.7	4.0	0.8	0.2	1.2	0.4	22.9	0.0	0.5	0.0	0.0	2.6	18.3	2.8	1.3	0.4	0.2	0.1	0.4	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.8	2.4	0.3	0.2	9.0	0.3	0.0	0.3	0.2	1.3	0.5	0.4	1.1	0.6	0.0	0.0	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.0	0.4	0.2	0.3	0.1	0.5	0.2
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.4;lymphoid tissue: 15.3;tongue: 25.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.1"	"Region enriched"	"Detected in single"	4	"amygdala: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavourable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	1.1	0.0	0.1	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0	0.3	0.0	31.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.5	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	25.1	15.3	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.8	0.0	19.3	0.5	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.9	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.3	0.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RAPGEFL1	Link-GEFII	ENSG00000108352	"Rap guanine nucleotide exchange factor like 1"	Q9UHV5	17	40177010-40195656	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 37.7;skin 1: 87.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 38.2;hTCEpi: 19.2;T-47d: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022895			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA022895: "	"prognostic favourable (8.43e-4)"	"prognostic favourable (3.28e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.64e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.46e-3)"	"unprognostic (8.84e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	1.5	1.3	15.9	2.7	17.2	1.8	4.1	8.2	22.7	8.9	19.5	1.8	0.9	18.8	1.6	4.3	37.7	2.9	5.9	1.1	11.2	6.2	0.6	1.7	1.6	1.1	2.8	20.2	0.8	1.6	0.8	2.7	1.2	5.5	3.4	17.7	1.3	5.7	3.2	4.6	87.1	15.5	2.0	1.9	1.4	12.6	2.4	2.9	0.2	0.9	13.3	10.7	6.5	19.4	0.1	0.9	2.9	0.4	0.0	0.6	0.0	2.1	1.0	5.7	4.2	0.6	1.4	2.7	0.8	0.6	1.1	1.3	2.4	3.1	1.7	0.8	1.1	38.2	1.1	1.3	1.6	3.1	2.8	1.0	1.2	2.3	0.7	2.0	3.5	1.6	19.2	1.1	0.5	1.7	0.7	1.1	0.8	5.8	1.9	2.5	1.7	1.0	3.5	0.6	1.0	0.7	11.2	11.0	2.2	1.3	13.0	0.5	33.4	1.5	3.2	1.4	2.9	1.4	1.2	1.9	1.8	1.4	3.3	1.2	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.1	0.2	2.9	0.0	0.4	0.2	0.0	0.0	15.9	17.2	8.2	22.7	11.2	6.2	2.8	20.2	5.5	2.9
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 49.4;skin 1: 52.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;MCF7: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 5.6;T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053883	Supported		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	4.8	5.0	2.7	7.0	3.6	1.3	10.8	6.3	3.8	26.8	6.3	1.8	7.3	1.0	14.6	6.0	49.4	10.6	8.6	6.9	3.0	1.4	3.7	1.9	7.4	6.7	2.4	2.3	12.6	2.7	4.2	2.8	4.4	1.6	11.3	3.4	10.3	9.5	10.6	2.6	52.1	3.0	9.7	1.5	4.7	6.0	3.9	1.7	2.3	7.3	30.6	26.8	10.9	19.8	1.8	5.6	1.5	2.5	1.7	17.0	2.9	7.2	8.0	1.8	16.9	18.8	16.2	0.5	7.6	16.6	10.0	7.8	2.7	33.2	0.1	4.1	30.5	24.4	6.1	14.6	2.5	1.9	3.1	1.0	6.1	2.3	7.9	0.0	3.0	11.9	21.4	9.5	2.1	4.2	0.2	3.2	3.9	35.0	0.4	0.3	5.4	14.1	2.3	0.6	5.8	2.9	12.0	1.5	7.6	15.4	16.7	10.1	14.5	0.4	4.5	12.0	5.6	7.9	0.4	1.5	0.8	0.5	14.7	1.2	16.9	1.5	2.5	0.7	6.6	0.8	17.0	1.8	5.7	4.8	5.6	0.6	4.8	4.1	0.0	1.7	0.0	0.4	1.5	2.9	2.7	3.6	6.3	3.8	3.0	1.4	2.4	2.3	1.6	1.7
RASSF10		ENSG00000189431	"Ras association domain family member 10"	A6NK89	11	13009577-13012106	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.3"	"Group enriched"	"Detected in some"	5	"A549: 9.3;CAPAN-2: 8.3;HaCaT: 12.8;HMC-1: 6.4;RPTEC TERT1: 13.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA040406			Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA040406: AB_2732485"	"unprognostic (6.71e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.41e-3)"	"unprognostic (6.25e-3)"	"prognostic favourable (2.76e-4)"		"unprognostic (3.43e-3)"	"unprognostic (8.04e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (4.12e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.65e-2)"	0.2	0.0	0.4	0.2	1.0	0.0	3.9	0.0	1.7	1.1	1.4	1.0	0.0	1.8	0.0	1.3	9.3	5.2	2.5	0.2	1.0		4.7	0.0	1.8	0.0	0.0	0.6	1.2	0.0	3.8	0.1	0.0	0.6	1.6	0.5	0.4	8.0	0.1	0.8	4.1	0.6	0.0	0.1	0.0	5.6	2.4	1.0	1.1	0.1	8.1	7.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	9.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.3	0.0	0.6	0.0	12.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.0	13.0	1.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RHBDL2	FLJ20435	ENSG00000158315	"Rhomboid like 2"	Q9NX52	1	38885807-38941799	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 26.0;HaCaT: 13.5;RT4: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043807	Approved									"HPA043807: AB_10961118"	"unprognostic (3.34e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.57e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.47e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.20e-2)"	1.4	0.0	2.9	6.7	2.7	0.0	1.5	0.4	4.0	5.5	14.9	1.7	0.4	0.7	1.9	0.7	18.9	0.7	6.9	4.9	4.2	2.1	0.5	0.4	2.1	1.5	4.9	0.7	1.2	2.4	0.0	0.4	1.0	1.6	3.1	14.7	0.8	8.2	0.4	0.4	13.4	0.9	0.9	7.9	0.6	12.3	8.4	0.4	1.3	0.4	12.2	16.4	6.9	8.2	1.7	2.1	5.3	1.7	0.9	0.9	0.7	8.0	3.2	0.2	0.1	0.1	1.0	0.9	0.4	0.1	0.6	0.0	0.5	26.0	0.2	1.9	3.7	13.5	0.0	4.8	0.3	0.1	0.1	0.1	2.0	1.7	0.5	0.0	0.3	0.6	0.6	3.9	0.0	0.8	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.7	0.1	0.1	0.0	0.0	26.1	0.2	0.1	2.8	6.6	0.2	3.4	0.2	0.5	2.9	0.3	0.2	0.2	0.2	0.3	0.3	2.5	0.4	0.1	3.6	1.7	1.1	0.8	1.1	0.4	1.7	0.6	0.5	1.9	1.1	0.7	0.7	5.3	0.9	0.7	2.1	0.9	0.7	2.9	2.7	0.4	1.5	4.2	2.1	4.9	0.7	1.6	0.4
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;hTCEpi: 4.4;RT4: 4.4;SK-MEL-30: 2.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced									"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	4.4	0.3	0.3	0.8	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0
RHOV	"ARHV, Chp, WRCH2"	ENSG00000104140	"Ras homolog family member V"	Q96L33	15	40872214-40874289	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 74.8;skin 1: 31.5;tongue: 29.2"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 82.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 91.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA053343	Enhanced									"HPA053343: AB_2682122"	"unprognostic (1.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.29e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (3.29e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.63e-3)"	0.2	0.0	0.4	0.4	0.4	0.0	7.8	0.8	0.9	8.8	0.9	0.2	0.5	0.1	0.6	4.8	74.8	1.2	0.6	0.2	0.4	0.3	1.9	0.2	1.9	0.2	0.2	0.5	0.2	7.4	0.4	0.7	7.3	1.2	4.2	1.1	0.2	12.6	1.1	0.2	31.5	0.5	0.7	0.3	0.3	0.3	0.8	0.3	2.0	0.2	29.2	27.9	5.2	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.0	0.9	1.1	0.0	0.6	0.0	19.3	1.1	0.1	0.0	2.5	3.1	0.1	2.7	0.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.1	0.0	6.5	0.1	0.5	0.4	0.9	0.9	0.1	0.4	1.2	8.4	1.0	0.2	1.9	82.5	0.0	10.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.8	0.9	0.4	0.3	0.2	0.5	1.2	0.3
RIPK4	"ANKK2, ANKRD3, DIK, PKK, RIP4"	ENSG00000183421	"Receptor interacting serine/threonine kinase 4"	P57078	21	41739369-41767106	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.3;HaCaT: 24.0;hTCEpi: 16.2;PC-3: 13.4;RPTEC TERT1: 14.5;RT4: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"naive CD4 T-cell: 1.5;neutrophil: 2.2"	"Group enriched"	"Detected in many"	17	"granulocytes: 2.2;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA030942	Enhanced									"HPA030942: AB_2732462"	"unprognostic (8.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.32e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.22e-5)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (9.98e-2)"	"prognostic favourable (6.52e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.78e-2)"	1.0	0.2	0.2	0.8	0.2	0.1	3.3	0.2	0.2	6.7	9.4	0.3	12.0	6.8	1.7	6.5	42.1	4.2	17.1	1.1	0.4	0.2	10.8	17.3	5.4	0.4	0.2	0.1	1.8	14.4	4.7	6.8	2.8	1.1	10.6	1.3	4.8	10.2	14.8	0.2	11.7	11.6	2.0	0.3	0.2	11.2	2.7	0.0	8.1	13.6	12.3	26.6	5.2	11.0	0.0	0.0	2.2	0.1	0.0	1.5	0.2	7.0	4.5	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.1	11.7	16.3	0.0	6.9	1.4	24.0	0.3	9.7	0.0	0.0	4.8	0.0	3.3	4.3	0.0	0.0	0.0	0.0	16.2	0.1	2.2	0.0	0.0	0.0	0.0	5.1	0.9	0.0	0.4	13.4	0.0	0.0	1.1	14.5	15.5	2.3	0.1	7.8	8.0	7.3	4.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	2.1	0.0	6.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.1	2.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.1	1.1	0.0
RNASE7	RAE1	ENSG00000165799	"Ribonuclease A family member 7"	Q9H1E1	14	21042226-21044234	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 38.3;lymphoid tissue: 41.0;tongue: 21.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.0;hTCEpi: 6.5;hTERT-HME1: 32.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005690, CAB062560, CAB068225"	Enhanced				"Secreted in other tissues"					"CAB062560: AB_2665595, CAB068225: , HPA005690: AB_1079819"	"unprognostic (1.13e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.42e-1)"	0.1	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.3	38.3	0.0	4.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.5	0.2	0.0	3.5	0.2	0.2	14.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.3	0.1	21.4	41.0	0.6	7.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
RNF222		ENSG00000189051	"Ring finger protein 222"	A6NCQ9	17	8390704-8397826	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 15.7;lymphoid tissue: 9.4;tongue: 13.6"	"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 12.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048916	Uncertain									"HPA048916: AB_2680555"	"unprognostic (2.49e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.19e-4)"	"unprognostic (2.81e-1)"	"unprognostic (5.30e-2)"		"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.97e-2)"	0.1	0.0	0.1	0.1	0.1	1.8	0.5	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.6	0.1	15.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	1.8	0.1	0.1	6.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.6	9.4	0.1	5.5	0.4	0.5	2.0	0.5	0.2	1.0	0.1	1.1	0.0	0.0	0.2	0.1	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	12.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.6	0.5	1.0	0.3	0.2	0.2	0.2	0.3	0.1	0.1	0.4	0.6	1.0	2.0	0.2	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
RNF223		ENSG00000237330	"Ring finger protein 223"	E7ERA6	1	1070966-1074307	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"A-431: 11.7;CAPAN-2: 8.8;HaCaT: 5.5;MCF7: 18.7;SK-BR-3: 12.8;T-47d: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"unprognostic (4.71e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (8.08e-5)"	"unprognostic (3.50e-1)"	"unprognostic (6.50e-2)"		"unprognostic (1.43e-3)"	"unprognostic (3.91e-1)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-1)"	"unprognostic (9.52e-3)"	0.0	0.0	0.0	1.4	0.0	0.4	0.8	0.0	0.5	8.3	1.4	0.0	0.0	0.4	1.0	0.3	28.8	0.2	1.9	0.0	0.0	0.0	0.6	0.3	0.9	0.1	0.0	0.0	0.0	1.0	0.1	0.0	6.5	0.0	4.2	0.8	0.0	3.3	0.4	0.7	3.5	0.2	2.6	0.0	0.2	7.8	0.1	0.0	0.0	0.2	14.8	17.1	4.9	9.3	0.6	0.6	1.9	0.4	0.3	0.4	0.0	11.7	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	18.7	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	12.8	0.2	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.4	0.2	0.3	0.1	0.1	0.3	0.2	0.4	0.0	0.6	0.2	0.4	0.9	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF224		ENSG00000233198	"Ring finger protein 224"	P0DH78	9	137227271-137229638	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"esophagus: 4.8;pituitary gland: 7.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HeLa: 5.2;MCF7: 12.6"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.45e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.01e-4)"	"unprognostic (6.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.57e-2)"	"unprognostic (5.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.21e-1)"	0.0	0.6	0.5	0.1	0.7	0.3	0.0	0.2	0.9	0.3	0.0			1.0	0.4	0.1	4.8	2.0	1.0	0.3	0.5	0.5	2.8	0.0	1.1	0.4	0.1		0.0	1.5	0.2	7.7	0.0		0.9	0.0		4.6	0.0	0.1	1.5	1.6	0.0	0.1	0.4	1.2	1.2			1.0		0.1	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.5	0.7	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	7.2	0.2	0.3	0.0	3.4	0.0	0.1	0.0	2.5	0.6	0.0	5.2	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.0	12.6	0.1	0.2	0.6	1.6	0.8	0.3	0.3	0.1	0.8	0.0	1.6	0.7	2.7	0.1	2.8	0.3	0.2	0.3	0.2	1.6	0.0	0.9	0.2	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RNF225		ENSG00000269855	"Ring finger protein 225"	M0QZC1	19	58396090-58397079	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 31.6;lymphoid tissue: 16.5;tongue: 21.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;SCLC-21H: 1.1;T-47d: 3.2;U-266/84: 1.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (3.07e-1)"	"unprognostic (6.94e-2)"				"unprognostic (3.68e-3)"		"unprognostic (2.19e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.75e-3)"		"unprognostic (1.40e-1)"		"unprognostic (3.42e-1)"	"unprognostic (9.18e-2)"	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.0	0.0	0.0	3.1	0.0	0.0	0.1	31.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	1.4	0.0	0.0	1.9	2.1	0.0	6.2	0.0	0.4	0.0	0.1	0.1	1.1	0.0	0.0	0.2	21.8	16.5	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.3	0.9	1.1	0.3	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.7	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF39	"HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.3;skin 1: 26.4"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HEK 293: 2.6;U-266/84: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 8.0;hippocampal formation: 4.2"	"Group enriched"	"Detected in some"	6	"cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"				"Vesicles, Plasma membrane, Centrosome"	"Vesicles, Plasma membrane, Centrosome"	"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	0.3	0.2	0.1	0.3	0.3	0.4	5.1	0.3	0.9	7.3	0.7	0.0	1.1	0.9	0.8	0.3	28.3	0.8	1.1	0.2	0.2	0.1	0.3	0.3	3.6	0.3	0.2	0.0	0.6	2.3	0.4	0.4	9.7	0.3	8.1	0.4	0.6	10.2	0.6	0.4	26.4	0.4	1.0	0.2	0.2	4.3	0.8	0.0	0.3	0.4	10.1	11.7	7.8	12.4	0.0	0.0	1.3	0.0	0.2	0.0	0.0	2.9	0.0	0.7	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.6	0.0	1.4	0.0	0.5	2.6	1.1	0.3	0.0	0.0	0.1	0.3	0.0	1.9	0.0	0.2	0.0	0.7	0.6	0.0	1.0	0.0	1.3	0.0	0.0	0.3	0.4	0.0	1.9	0.3	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.5	0.6	0.0	0.3	1.9	8.0	0.7	0.6	0.1	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.2	0.1	0.2	0.0	0.3	0.0
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 485.8;esophagus: 373.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 485.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced					11000000	11000000			"CAB034320: AB_2183487, HPA042745: AB_2678142"	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	98.4	18.7	9.2	32.7	17.3	24.9	48.0	2.7	9.2	96.3	22.2	14.7	41.3	12.1	42.2	48.0	373.9	42.1	45.6	30.2	7.4	6.5	107.9	17.2	74.6	73.4	16.5	3.4	35.1	23.4	77.0	20.1	197.6	14.3	60.8	22.9	29.6	108.3	49.0	23.9	65.3	31.0	31.2	19.4	89.9	38.7	16.9	11.3	46.7	44.3	181.3	272.3	71.0	130.7	9.2	81.7	485.8	124.5	18.4	39.3	110.7	93.2	74.4	3.6	27.8	102.7	128.8	60.6	91.4	132.4	73.7	75.6	34.5	105.3	0.1	82.0	117.4	132.1	3.7	163.4	41.8	45.2	7.5	8.1	44.1	19.9	79.4	7.3	57.4	97.6	165.5	80.9	102.2	56.0	16.5	18.1	107.3	149.5	0.9	34.2	26.5	75.6	0.1	39.2	70.7	219.1	158.9	0.1	6.0	69.6	92.6	61.6	70.9	80.9	80.3	39.6	28.0	61.5	48.5	0.1	0.8	0.3	89.7	24.1	46.7	173.6	124.5	187.4	20.4	119.9	26.9	9.2	39.3	24.1	81.7	5.3	11.7	13.2	485.8	18.4	120.9	28.3	32.6	110.7	9.2	17.3	2.7	9.2	7.4	6.5	16.5	3.4	14.3	11.3
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Group enriched"	"Detected in some"	10	"A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		110000	110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"	"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.8	11.4	0.0	0.1	0.0	86.8	0.0	123.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	183.4	0.0	1.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	4.1	0.0	0.0	0.1	129.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 118.0;SK-BR-3: 143.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		92000	92000	Cytosol	Cytosol	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (3.18e-4)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.5	27.2	1.4	3.2	9.4	35.7	3.7	32.4	29.8	26.6	23.7	25.5	31.6	0.0	52.0	48.4	41.5	0.0	72.6	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	118.0	0.7	0.0	58.5	75.0	0.0	0.1	6.0	73.7	0.0	16.4	0.1	100.3	20.3	0.0	0.1	23.8	143.0	4.7	44.4	0.3	63.3	16.0	25.7	15.4	73.1	0.0	0.2	0.1	47.6	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.3;SK-BR-3: 16.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"	17000000	17000000	Cytosol	Cytosol	"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	7.3	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.8	16.9	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	530000000	530000000	"Intermediate filaments"	"Intermediate filaments"	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	1400000000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"	"Nucleoplasm, Cell Junctions, Cytosol"	"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	12.2	1.6	0.4	0.1	5.5	7.0	0.1	4.8	20.1	23.0	30.5	0.1	13.6	5.1	7.6	11.8	14.5	0.0	4.4	7.8	17.4	0.6	7.4	8.2	0.0	2.5	8.3	10.4	3.1	6.4	7.6	2.1	3.4	0.5	12.8	4.8	0.0	12.3	6.8	0.0	3.5	4.1	4.1	5.8	0.1	1.5	2.0	0.2	3.7	1.4	3.9	0.4	4.1	14.8	5.4	1.9	16.1	2.6	7.6	1.4	4.7	5.6	4.9	5.3	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.7;ASC TERT1: 34.4;HSkMC: 46.5;U-2197: 16.0;U-87 MG: 37.7"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"	62000000	62000000	Vesicles	Vesicles	"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.7	34.4	0.0	1.5	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.5	2.5	9.3	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	5.8	1.2	16.0	0.4	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 beta subunit"	P51168	16	23278231-23381299	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.4"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 19.0;RT4: 10.1;U-266/70: 31.3;U-266/84: 10.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 26.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015612	Uncertain									"HPA015612: AB_1856629"	"unprognostic (7.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.74e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (2.09e-6)"	"unprognostic (2.32e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-2)"	35.1	0.2	0.1	4.0	0.2	0.0	21.2	1.1	0.1	28.3	27.2	0.0	1.3	1.3	2.9	2.5	42.4	1.3	3.3	0.6	0.0	0.0	13.0	0.0	31.1	1.3	0.0	0.0	2.0	0.8	0.3	1.6	25.2	0.3	5.7	19.7	0.5	29.7	2.4	3.9	13.2	1.7	4.2	0.1	1.9	8.9	1.6	0.0	0.6	16.2	17.8	15.5	5.6	19.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	3.9	0.0	0.0	4.8	0.0	10.1	0.1	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	31.3	10.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 19.9;HaCaT: 9.9;hTCEpi: 16.4;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced									"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favourable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.0	0.0	0.0	9.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.4	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2842006	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2;lymphoid tissue: 108.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;U-937: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"		49000000	49000000	"Cytoplasmic bodies"	"Cytoplasmic bodies"	"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	11.4	15.1	3.5	13.4	7.0	75.8	6.4	2.9	3.3	25.1	23.6	5.7	5.3	26.0	6.6	8.6	119.2	7.6	18.1	8.3	3.5	3.9	11.4	36.9	32.6	37.4	7.5	1.8	7.8	66.7	8.3	10.4	11.9	6.2	6.5	16.7	6.7	23.5	3.6	21.8	4.4	49.2	5.6	6.8	34.8	18.0	3.9	5.3	9.4	14.0	98.9	108.0	7.2	20.8	12.8	38.3	48.5	49.6	21.7	16.7	38.7	12.9	15.1	0.8	0.1	3.3	7.0	13.1	3.8	10.9	4.5	8.2	14.2	37.5	0.1	27.5	8.0	8.2	1.5	3.4	3.4	18.5	2.7	22.8	5.1	10.9	12.0	4.0	14.7	8.7	5.9	2.3	1.0	14.8	8.1	3.1	4.0	6.0	0.5	10.5	1.5	7.2	1.2	0.1	13.2	15.5	2.8	2.9	1.6	8.7	3.4	18.9	1.7	12.9	9.1	1.5	3.6	3.2	1.1	0.0	0.6	0.1	5.5	42.6	0.7	27.1	49.6	28.5	16.1	25.7	14.5	12.8	15.6	14.8	38.3	9.6	16.1	16.1	48.5	21.7	19.5	14.8	16.7	38.7	3.5	7.0	2.9	3.3	3.5	3.9	7.5	1.8	6.2	5.3
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903890	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.6;placenta: 222.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 79.8;U-138 MG: 95.5;U-2197: 145.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 16.3;eosinophil: 7.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.3"	"Region enriched"	"Detected in single"	14	"cerebellum: 2.9"	"Low region specificity"	"Detected in all"			HPA015480	Supported				"Intracellular and membrane"	110000	110000			"HPA015480: AB_1855456"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (1.55e-5)"	6.0	0.0	0.1	2.9	0.2	8.7	2.6	0.2	0.1	6.4	0.8	0.1	0.1	0.0	0.7	0.4	70.6	3.1	0.1	0.4	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.6	0.3	0.0	0.1	222.1	0.2	0.3	0.0	0.1	11.3	0.2	0.3	25.7	0.2	0.3	0.1	0.3	0.1	0.2	0.1	0.9	0.2	49.0	37.7	1.1	13.8	0.0	0.2	16.3	3.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.4	20.6	0.7	1.5	0.1	0.0	0.0	0.0	0.6	79.8	0.0	16.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	9.5	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.5	95.5	0.0	145.1	0.0	0.0	0.0	0.0	2.5	0.2	11.1	16.3	3.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	660000	660000	Vesicles	Vesicles	"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavourable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavourable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	143.8	0.0	47.4	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	99.9	0.0	25.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	10.5	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"	54000000	54000000	Cytosol	Cytosol	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SLC7A1	"ATRC1, CAT-1, ERR, HCAT1, REC1L"	ENSG00000139514	"Solute carrier family 7 member 1"	P30825	13	29509410-29595688	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 42.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039721	Approved									"HPA039721: AB_10672893"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (3.20e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.37e-3)"	5.7	4.5	8.5	9.0	11.7	8.6	7.0	8.7	19.6	8.1	8.7	10.7	7.5	9.0	7.3	9.6	42.8	6.9	4.8	6.2	12.2	10.4	4.3	2.4	4.4	7.1	11.4	7.7	5.3	26.6	2.9	6.4	12.9	20.0	7.2	6.8	6.1	16.2	12.6	2.1	14.8	12.9	8.1	11.9	5.7	10.0	8.8	6.9	5.3	8.6	27.7	16.2	6.4	8.3	2.0	3.7	0.5	2.8	0.8	3.3	1.7	12.1	9.9	8.7	17.5	4.5	8.9	9.9	26.1	17.5	22.6	16.9	19.9	21.6	24.2	7.1	39.7	56.1	15.1	18.5	29.9	22.7	9.0	18.1	10.8	10.7	23.4	26.4	12.0	11.3	39.5	25.1	29.8	11.1	11.5	11.3	9.4	16.4	19.2	7.1	8.3	6.6	13.3	17.9	13.9	14.3	8.1	29.7	14.1	14.8	14.6	23.6	6.4	22.4	10.4	17.9	12.5	15.6	18.6	12.8	9.2	27.6	14.2	10.7	18.0	0.0	1.1	0.5	3.3	1.2	2.7	2.0	2.4	2.7	1.8	1.4	1.9	3.1	0.0	0.8	2.8	3.7	1.9	1.7	8.5	11.7	8.7	15.9	12.2	10.4	11.4	7.7	20.0	6.9
SLURP2		ENSG00000283992	"Secreted LY6/PLAUR domain containing 2"	P0DP57	8	142764338-142769844	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"esophagus: 112.1;lymphoid tissue: 60.7;tongue: 105.8"	"Cell line enriched"	"Detected in some"	4	"HaCaT: 24.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																							0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	112.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	105.8	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.1	5.4	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270890	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	7.5	6.9	0.9	11.3	1.7	0.9	26.3	1.1	1.3	13.1	22.6	0.9	5.3	6.9	8.0	13.6	53.4	3.2	21.8	6.0	1.0	1.0	10.9	4.3	17.6	14.2	1.5	0.4	5.2	14.9	4.6	1.9	50.0	3.0	4.8	24.3	2.6	10.2	6.9	3.6	12.6	8.5	3.4	4.3	11.5	14.1	4.8	0.7	1.2	4.2	28.7	33.1	7.9	24.6	22.5	2.6	8.6	3.7	12.3	9.5	3.5	24.7	7.6	0.9	0.8	3.4	13.5	41.9	19.1	19.3	9.8	6.1	15.1	26.1	0.3	3.4	11.8	8.8	5.4	7.4	13.7	1.2	4.4	3.3	0.9	5.0	9.4	0.8	3.2	8.7	5.7	21.2	19.2	23.5	2.6	1.4	15.7	21.8	4.0	3.0	3.9	29.6	0.2	0.3	0.9	14.2	5.7	1.0	1.2	4.1	16.8	3.0	14.5	1.2	8.1	10.9	10.4	0.5	11.6	0.5	0.7	0.5	16.1	8.2	5.9	1.9	3.7	6.4	9.5	2.4	6.1	22.5	4.2	6.9	2.6	17.6	3.9	7.0	8.6	12.3	2.6	1.5	2.7	3.5	0.9	1.7	1.1	1.3	1.0	1.0	1.5	0.4	3.0	0.7
SMCO2	"C12orf70, LOC341346"	ENSG00000165935	"Single-pass membrane protein with coiled-coil domains 2"	A6NFE2	12	27466810-27502185	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.3;testis: 3.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;HDLM-2: 5.4"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014366	Uncertain									"HPA014366: AB_1845544"	"unprognostic (2.64e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.86e-3)"	"unprognostic (5.44e-3)"	"unprognostic (2.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.69e-1)"	0.2	0.3	0.2	1.7	0.1	0.1	0.4	0.3	0.5	0.1	0.4			0.0	0.1	0.0	2.3	0.0	0.8	0.0	0.3	0.4	0.0	0.7	0.4	0.5	0.2		0.0	0.0	0.0	0.0	0.3		0.1	0.0		0.5	0.0	0.1	2.1	0.0	0.4	0.0	0.0	1.5	3.1			0.0		1.9	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.2	0.1	0.0	0.2	2.5	0.2	0.1	0.1	1.8	0.0	3.8	0.0	0.9	0.0	0.6	0.2	0.6	1.1	5.4	0.0	0.2	0.9	0.0	0.0	2.0	0.4	1.1	0.6	0.7	3.1	1.9	0.0	1.6	0.0	0.3	0.9	2.2	1.0	1.9	0.9	0.0	0.0	0.6	0.8	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.7	1.6	0.7	1.8	3.0	0.1	0.3	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	28000000	28000000	Vesicles	Vesicles	"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINK7	"ECG2, ECRG2"	ENSG00000145879	"Serine peptidase inhibitor, Kazal type 7 (putative)"	P58062	5	148312419-148315922	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 161.8;tongue: 124.0;vagina: 79.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.9;HeLa: 2.1;hTCEpi: 3.9;PC-3: 3.1;SiHa: 1.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 4.5;head and neck cancer: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036294	Enhanced				"Secreted - unknown location"	90000	90000			"HPA036294: AB_10671243"		"unprognostic (2.82e-1)"				"unprognostic (8.99e-3)"		"unprognostic (8.52e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.12e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.24e-2)"	"unprognostic (4.22e-2)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	39.1	0.1	0.0	0.0	0.1	2.8	0.1	161.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	16.9	0.1	0.2	1.1	0.1	0.1	0.0	0.1	1.3	0.1	0.0	0.6	0.1	124.0	30.6	0.2	79.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPNS2		ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498838-4539035	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.7;RPTEC TERT1: 56.6;SK-BR-3: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;NK-cell: 1.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;NK-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain									"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	9.8	2.1	10.3	5.8	13.6	7.9	8.6	5.3	19.5	8.2	4.9	22.6	0.0	13.1	5.4	2.1	45.9	4.6	13.8	7.2	11.0	7.8	31.2	3.3	16.1	5.4	21.3	10.9	1.8	7.3	2.3	1.3	9.0	25.0	3.2	3.2	11.6	11.2	3.2	5.0	13.8	8.5	5.8	12.3	9.1	21.7	2.0	15.7	0.0	5.2	10.9	15.7	8.4	13.1	0.0	0.2	1.2	0.0	1.2	0.2	0.0	3.2	0.4	0.0	0.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.1	2.7	0.1	4.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.2	0.0	5.6	0.0	0.1	0.2	0.0	0.1	56.6	0.2	1.8	0.0	0.0	26.3	0.0	0.9	2.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	1.2	0.0	0.0	0.0	0.0	10.3	13.6	5.3	19.5	11.0	7.8	21.3	10.9	25.0	15.7
SPRR1B	"GADD33, SPRR1"	ENSG00000169469	"Small proline rich protein 1B"	P22528	1	153031202-153032900	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 264.7;lymphoid tissue: 188.6;tongue: 618.5"	"Cell line enriched"	"Detected in some"	9	"hTCEpi: 89.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 468.6;head and neck cancer: 1812.5;melanoma: 425.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (1.73e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.59e-2)"		"unprognostic (9.68e-2)"		"prognostic unfavourable (7.66e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (7.64e-5)"			"unprognostic (5.71e-2)"		"unprognostic (2.15e-1)"	"prognostic unfavourable (7.28e-4)"	0.1	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	94.9	0.1	0.1	0.1	0.1	9.5	0.2	264.7	0.2	2.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	48.7	0.1	0.2	33.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.9	0.1	618.5	188.6	0.2	113.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	9.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	89.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPRR2E		ENSG00000203785	"Small proline rich protein 2E"	P22531	1	153093135-153106184	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 210.2;skin 1: 94.0;tongue: 291.9"	"Cell line enriched"	"Detected in some"	11	"hTCEpi: 19.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 612.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (2.27e-1)"				"unprognostic (3.86e-2)"		"unprognostic (5.04e-2)"	"unprognostic (3.40e-1)"								"prognostic unfavourable (9.47e-4)"	0.3	0.0	0.3	0.3	0.3	0.0	5.7	0.3	0.3	25.9	0.3	0.3	0.3	0.0	0.6	0.3	210.2	0.0	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	26.8	0.3	0.3	94.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.4	0.3	291.9	54.7	0.3	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SPRR3		ENSG00000163209	"Small proline rich protein 3"	Q9UBC9	1	153001747-153003856	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;hTCEpi: 10.9;RT4: 13.9;TIME: 3.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 423.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044467	Enhanced					15000	15000			"HPA044467: AB_2678952"		"unprognostic (2.78e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.77e-2)"		"unprognostic (7.50e-3)"		"unprognostic (9.67e-3)"	"unprognostic (2.36e-1)"		"prognostic unfavourable (6.27e-5)"			"unprognostic (9.70e-2)"	"unprognostic (4.66e-2)"		"unprognostic (1.58e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	157.6	0.2	0.0	0.0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	1.2	0.0	0.2	0.2	0.0	93.4	0.2	0.4	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.2	389.6	537.4	0.6	163.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	6.7	3.5	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.2	0.0	0.0	10.9	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	13.9	0.0	0.0	0.4	3.2	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;CAPAN-2: 34.1;MCF7: 20.9;T-47d: 17.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB033013, HPA041724, HPA043539"	Approved		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB033013: AB_661450, HPA041724: AB_2677638, HPA043539: AB_2678540"	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	5.6	7.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	34.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.0	3.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	20.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	2.9	0.1	17.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364202	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.0;esophagus: 33.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;RPTEC TERT1: 8.3;SCLC-21H: 28.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7"	"Lineage enriched"	"Detected in single"	66	"T-cells: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA058296: AB_2683672"	"unprognostic (2.90e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (4.28e-4)"	"unprognostic (2.12e-1)"	"unprognostic (7.01e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.82e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.51e-6)"	"unprognostic (3.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.11e-2)"	0.8	5.2	15.9	1.5	33.0	0.9	8.1	9.9	21.3	3.4	0.9	4.0	4.7	1.5	0.9	24.3	33.8	3.6	1.3	9.6	30.6	14.6	13.7	4.0	3.2	1.9	6.8	12.8	27.8	7.6	8.3	16.5	1.0	6.6	4.4	0.8	1.2	13.2	5.7	1.2	3.5	0.9	0.9	2.4	0.8	7.6	5.1	3.8	0.3	1.5	8.1	13.8	2.7	9.1	0.0	0.0	0.0	0.1	0.1	11.7	1.8	4.2	0.4	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.7	0.5	4.4	1.3	0.0	1.4	0.1	7.0	0.2	1.0	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.4	0.0	0.3	3.2	3.0	0.0	0.1	0.8	0.0	0.1	0.0	8.3	1.9	28.5	0.3	0.0	2.3	0.0	1.8	0.2	0.0	1.2	5.1	0.0	2.5	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.3	0.1	6.0	0.0	7.4	1.9	0.0	0.0	11.7	2.1	0.0	0.1	0.0	0.0	1.0	1.8	15.9	33.0	9.9	17.9	30.6	14.6	6.8	12.8	6.6	3.8
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell line enhanced"	"Detected in some"		"A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	74.1	0.0	0.0	0.1	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	100.5	0.0	9.7	6.3	100.7	0.0	18.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	1.1	4.2	0.0	0.1	0.0	15.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	13.5	34.8	0.0	0.0	3.2	26.8	0.1	17.5	0.1	4.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8										
TBX6		ENSG00000149922	"T-box 6"	O95947	16	30085793-30091887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"RT4: 10.0;U-266/70: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA062498: AB_2732686"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.2	1.4	1.4	1.0	1.5	0.6	0.9	0.9	1.5	2.7	1.2	0.9	0.9	1.8	0.9	1.0	22.8	1.6	1.3	0.9	1.5	1.0	1.8	1.2	1.2	1.2	1.7	0.9	1.9	19.8	3.2	2.3	0.9	2.1	3.2	0.3	2.3	3.9	2.2	2.8	5.0	1.7	0.9	1.5	1.8	7.8	2.4	1.2	1.6	2.3	5.1	16.3	5.5	8.6	4.4	1.3	3.3	2.6	1.3	1.9	1.1	0.9	1.1	0.6	1.2	1.5	0.8	0.8	0.3	0.2	0.0	0.2	1.3	4.3	1.9	2.3	0.2	1.3	0.5	0.9	0.0	1.4	0.8	1.2	1.7	1.0	1.1	0.2	2.6	0.3	1.2	0.3	0.5	0.6	0.1	4.3	0.1	3.7	0.7	0.5	0.9	0.9	2.8	0.1	3.2	0.0	10.0	1.4	2.1	0.2	0.9	1.2	1.8	1.7	0.5	1.2	0.7	0.6	0.0	10.5	2.4	0.3	1.2	1.8	0.4	3.1	2.6	0.8	1.8	2.3	1.2	1.3	0.9	1.3	1.3	4.4	1.9	1.7	3.3	1.3	0.8	1.1	1.8	1.1	1.4	1.5	0.9	1.4	1.5	1.0	1.7	0.9	2.1	1.2
TGM5	TGX	ENSG00000104055	"Transglutaminase 5"	O43548	15	43232595-43266857	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.7;lymphoid tissue: 10.4;skin 1: 24.3;tongue: 13.1"	"Cell line enriched"	"Detected in some"	7	"HEL: 19.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"cerebellum: 2.9"	"Not detected"	"Not detected"														"unprognostic (3.17e-2)"	"unprognostic (1.03e-2)"		"unprognostic (5.92e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-2)"		"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.44e-15)"	"unprognostic (1.94e-1)"	"unprognostic (3.14e-1)"	"unprognostic (7.22e-3)"	"unprognostic (5.71e-2)"	0.3	0.0	0.1	0.1	0.1	0.2	2.1	0.1	0.1	2.6	0.1	0.1	0.1	0.0	0.7	0.1	9.7	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.6	0.0	0.1	2.8	3.4	0.1	24.3	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	13.1	10.4	0.8	4.7	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.4	0.0	0.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TICRR	"C15orf42, FLJ41618, MGC45866, SLD3, Treslin"	ENSG00000140534	"TOPBP1 interacting checkpoint and replication regulator"	Q7Z2Z1	15	89575482-89631056	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 9.0;lymphoid tissue: 21.7;tongue: 9.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046746, HPA049454"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA046746: AB_2732533, HPA049454: AB_2680773"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (3.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-5)"	"unprognostic (7.73e-3)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (1.64e-1)"	"unprognostic (1.31e-4)"	"unprognostic (5.87e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.54e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.59e-2)"	0.9	0.4	0.3	3.5	0.4	6.9	0.6	0.1	0.4	1.0	2.5	0.1	0.1	2.2	1.0	0.1	9.0	0.7	0.5	0.3	0.2	0.3	0.3	0.2	0.7	2.9	0.4	0.1	0.9	0.1	0.0	0.3	3.9	0.1	0.5	2.6	0.2	1.2	0.1	0.1	1.0	3.2	0.4	0.2	2.9	0.9	7.7	0.1	21.7	0.4	9.5	12.2	0.8	2.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	7.0	9.7	12.6	7.2	0.5	1.0	7.1	5.2	2.4	7.3	7.7	10.5	5.5	9.4	2.8	1.7	14.1	17.3	4.6	6.7	4.7	16.6	14.0	9.4	5.5	0.0	9.9	5.1	0.3	0.3	6.0	4.4	3.6	13.3	11.0	4.2	6.6	8.7	8.4	8.4	5.0	12.5	11.4	7.5	1.7	10.0	5.4	5.3	12.3	7.0	2.1	5.2	6.7	2.1	8.0	10.0	16.2	10.5	2.6	4.9	8.1	2.7	8.5	4.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.4	0.1	0.3	0.2	0.3	0.4	0.1	0.1	0.1
TMEM154	FLJ32028	ENSG00000170006	"Transmembrane protein 154"	Q6P9G4	4	152618632-152680165	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.3;HMC-1: 28.0;Karpas-707: 21.8;U-266/70: 27.3;U-937: 21.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 75.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA019184, HPA055411"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA019184: AB_2670088, HPA055411: "	"unprognostic (1.09e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	1.4	0.7	0.8	12.5	0.8	8.3	2.0	0.7	0.7	5.0	1.4	1.3	0.9	1.0	1.1	1.2	36.1	1.1	2.4	1.7	0.8	0.8	1.0	4.8	7.9	20.4	1.3	0.1	0.7	0.8	0.1	3.5	3.5	0.8	3.9	1.1	0.5	16.1	2.5	1.3	28.7	3.0	2.2	1.2	16.2	2.7	0.6	0.1	8.2	1.5	26.0	38.0	7.1	6.3	8.3	2.9	75.4	6.0	0.1	3.4	2.2	12.0	0.0	0.1	0.0	0.2	3.5	5.5	3.0	11.3	3.3	6.4	0.1	1.6	12.4	1.3	2.8	8.8	0.0	24.3	6.2	0.0	0.0	0.6	0.1	0.0	3.6	9.5	28.0	3.3	11.7	10.7	9.3	8.3	0.0	21.8	0.2	0.8	3.7	2.9	0.6	2.9	0.4	0.0	0.0	19.2	7.4	0.0	0.5	0.7	2.4	0.4	0.3	6.7	3.3	0.4	2.0	0.3	4.2	27.3	9.2	6.8	4.6	21.7	2.5	49.8	5.8	44.8	0.8	5.9	1.5	8.3	1.8	1.3	2.9	7.2	1.8	1.2	75.4	0.1	6.0	0.3	3.4	2.2	0.8	0.8	0.7	0.7	0.8	0.8	1.3	0.1	0.8	0.1
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.2;intestine: 39.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 14.9;RT4: 16.9;SCLC-21H: 17.4;SK-BR-3: 27.0;T-47d: 23.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA053790, HPA071312"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.1	0.2	3.5	0.2	0.1	1.6	0.2	0.3	8.6	15.6	0.2	8.0	15.1	1.7	2.9	40.2	4.4	9.6	0.2	0.2	0.1	5.3	18.0	1.5	0.2	0.2	0.3	0.9	24.7	3.1	5.4	14.3	0.4	5.1	4.0	0.3	10.3	12.0	2.3	17.9	39.3	1.2	0.2	0.2	7.5	3.8	0.2	0.5	0.3	22.9	31.9	10.0	15.8	0.8	0.8	2.0	0.5	0.4	0.5	0.0	9.5	6.4	0.0	0.0	0.0	0.0	2.1	0.3	0.1	0.4	0.0	8.7	11.4	0.2	3.4	0.1	7.4	0.0	4.3	0.1	0.1	0.2	0.0	5.9	4.0	0.1	0.0	0.0	0.0	4.2	0.1	3.8	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.3	8.4	0.2	0.0	4.6	3.3	16.9	17.4	0.0	2.8	27.0	0.0	23.9	0.0	0.0	0.0	3.6	4.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.2	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.8	0.4	0.3	2.0	0.4	0.2	0.8	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.4	0.2
TMEM40	FLJ11036	ENSG00000088726	"Transmembrane protein 40"	Q8WWA1	3	12733525-12769457	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 72.0;hTCEpi: 16.2;hTERT-HME1: 20.5;RT4: 10.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA044165	Enhanced		Approved	Cytosol		7000000	7000000	Cytosol	Cytosol	"HPA044165: AB_10961279"	"unprognostic (2.51e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.15e-4)"	"unprognostic (5.96e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.77e-2)"	0.0	0.0	0.0	0.0	0.2	1.4	1.8	0.0	0.0	11.7	0.0	0.0	0.4	0.0	0.9	0.6	62.9	1.6	0.1	1.6	0.0	0.0	0.3	0.0	1.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	53.6	0.1	2.3	0.0	0.0	6.6	1.4	0.4	24.0	0.0	0.7	0.0	1.1	0.0	0.4	0.0	0.4	0.0	40.5	41.8	10.6	18.6	0.0	0.5	4.5	0.6	0.0	0.3	21.1	7.2	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.3	0.4	0.2	1.1	0.0	0.0	0.0	2.1	0.0	72.0	1.4	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	16.2	0.0	20.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.4	10.1	0.0	0.0	0.0	9.0	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.6	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.5	0.0	0.0	0.5	0.0	21.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
TMEM79	"FLJ16057, FLJ32254, MATT, MGC13102"	ENSG00000163472	"Transmembrane protein 79"	Q9BSE2	1	156282935-156293185	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 47.5;skin 1: 35.7;tongue: 37.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.5;SK-BR-3: 17.8;T-47d: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA055214	Enhanced		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA055214: AB_2682741"	"unprognostic (3.12e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.51e-2)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (2.61e-5)"	"unprognostic (6.37e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-3)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.37e-1)"	1.2	1.3	2.4	1.2	5.1	2.0	3.4	3.4	3.7	12.5	1.2	3.6	1.9	1.8	1.3	1.9	47.5	1.5	1.9	1.0	2.0	1.1	1.1	1.4	1.0	1.8	5.6	1.4	1.5	1.0	3.8	2.5	4.5	3.1	19.0	1.1	1.2	9.4	2.1	1.9	35.7	1.3	1.1	3.2	1.6	1.6	0.9	5.2	3.7	1.5	37.2	24.2	3.3	20.5	5.2	4.1	7.8	4.1	3.0	5.2	3.1	8.0	4.8	1.7	3.1	1.2	1.3	4.0	2.4	0.9	4.3	1.7	5.6	2.3	1.5	5.2	0.6	7.2	1.8	3.6	1.8	5.4	2.7	1.5	1.9	1.6	2.3	1.6	2.3	1.3	21.5	3.2	3.3	0.9	6.8	10.1	2.0	9.6	4.7	2.6	2.5	3.8	5.6	1.6	3.2	0.8	2.5	2.9	3.2	2.9	17.8	4.6	19.0	4.9	2.3	8.0	2.7	2.8	6.2	7.8	8.2	3.4	5.5	4.0	6.0	0.0	4.1	5.6	3.9	1.4	3.9	3.7	3.4	4.0	3.2	5.2	4.4	5.2	7.8	3.0	2.6	4.1	4.0	3.1	2.4	5.1	3.4	3.7	2.0	1.1	5.6	1.4	3.1	5.2
TMPRSS11A	ECRG1	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909385-67964140	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 19.5;esophagus: 48.4;lymphoid tissue: 18.7;tongue: 47.6"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.5"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	47.6	18.7	0.3	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11B		ENSG00000185873	"Transmembrane serine protease 11B"	Q86T26	4	68226653-68245720	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 138.8;lymphoid tissue: 57.0;tongue: 44.0"	"Low cell line specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"cervical cancer: 2.6;head and neck cancer: 2.6;stomach cancer: 1.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (4.24e-2)"				"prognostic favourable (6.91e-4)"				"unprognostic (2.92e-1)"				"unprognostic (3.96e-1)"				0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	11.2	0.1	0.0	0.0	0.1	0.5	0.1	138.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	13.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.1	44.0	57.0	0.1	23.2	0.7	0.6	2.4	0.5	0.4	0.7	0.0	0.3	1.4	0.8	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.3	0.8	0.4	1.3	0.1	0.4	1.0	0.2	0.1	0.0	0.1	1.5	0.8	1.8	2.0	0.1	1.1	1.3	0.5	0.2	0.0	0.1	0.0	0.7	2.0	0.1	0.7	0.5	1.3	0.1	1.0	0.6	0.6	0.5	0.2	1.4	0.8	0.3	0.1	0.2	0.1	0.4	0.2	1.3	1.0	0.3	0.5	0.1	0.2	0.9	0.7	0.3	1.0	0.1	0.3	0.4	0.2	0.4	0.1	0.3	0.3	0.3	0.4	0.0	0.7	0.3	0.7	2.4	0.4	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11E	"DESC1, TMPRSS11E2"	ENSG00000087128	"Transmembrane serine protease 11E"	Q9UL52	4	68447449-68497604	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6"	"Group enriched"	"Detected in some"	6	"HaCaT: 5.8;HBEC3-KT: 2.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051062	Enhanced				"Intracellular and membrane"					"HPA051062: AB_2681329"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.14e-2)"		"unprognostic (5.03e-2)"		"prognostic unfavourable (6.73e-4)"	"unprognostic (2.22e-1)"		"unprognostic (9.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	28.9	0.0	0.0	1.2	0.0	1.1	10.5	103.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	1.4	0.0	0.0	13.6	0.5	0.0	1.6	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	40.5	39.1	2.6	36.6	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	5.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS11F	FLJ16046	ENSG00000198092	"Transmembrane serine protease 11F"	Q6ZWK6	4	68053198-68129880	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 18.3;lymphoid tissue: 11.4;skin 1: 10.9;tongue: 13.1"	"Group enriched"	"Detected in some"	8	"HEL: 2.4;K-562: 5.4;Karpas-707: 1.6;U-266/70: 1.6"	"Group enriched"	"Detected in some"	7	"cervical cancer: 1.6;head and neck cancer: 2.1;lung cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026911	Uncertain									"HPA026911: AB_2205589"		"unprognostic (9.46e-2)"			"unprognostic (5.30e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.79e-3)"	"unprognostic (1.09e-1)"			"unprognostic (2.40e-1)"			"unprognostic (1.22e-1)"	"unprognostic (5.08e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.1	0.0	0.0	1.4	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	13.1	11.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	44.9	0.0	1.7	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	31.5	39.3	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0
TP53AIP1	p53AIP1	ENSG00000120471	"Tumor protein p53 regulated apoptosis inducing protein 1"	Q9HCN2	11	128934731-128943399	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5"	"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SK-BR-3: 2.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.9"									"HPA044300, HPA048797"	Uncertain									"HPA044300: AB_2678888, HPA048797: AB_2680524"	"unprognostic (4.12e-7)"	"unprognostic (3.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.57e-6)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.78e-2)"	0.1	0.3	0.3	0.1	0.3	0.2	1.6	0.3	0.3	4.6	0.1	0.2	4.2	0.0	0.4	8.9	19.6	3.2	0.1	0.1	0.3	0.6	0.5	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.1	1.2	0.1	0.1	3.0	1.2	0.9	22.5	0.2	0.1	0.1	0.1	0.2	0.6	0.1	15.2	0.1	31.5	6.7	0.2	11.0	0.4	0.1	1.9	0.2	0.2	0.3	0.1	0.4	0.0	0.2	0.5	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.4	0.4	0.5	0.0	0.1	1.6	0.0	0.1	1.0	0.0	0.8	0.6	0.0	0.4	0.0	0.0	3.4	1.1	0.1	0.0	2.3	0.0	0.7	0.0	0.0	0.7	0.7	0.5	0.4	0.0	0.0	0.4	0.0	0.2	0.1	1.3	0.1	0.1	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	1.9	0.2	0.1	0.1	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.1	0.1	0.1
TPRG1	"FAM79B, FLJ41238, FLJ43694"	ENSG00000188001	"Tumor protein p63 regulated 1"	Q6ZUI0	3	188947214-189325304	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.3;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.5;HDLM-2: 12.2;Karpas-707: 6.2;T-47d: 5.5;U-266/70: 5.9;U-266/84: 4.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA044751, HPA060187"	Uncertain		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044751: AB_2679073, HPA060187: AB_2684217"	"prognostic favourable (5.43e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.52e-8)"	"unprognostic (8.50e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	16.1	1.0	0.3	0.9	0.8	0.0	14.4	1.7	0.8	19.7	1.2	0.1	1.0	0.0	5.0	1.6	43.3	5.2	1.6	2.4	0.2	0.2	0.6	5.1	2.7	0.3	0.3	0.5	1.9	0.3	0.0	0.8	1.0	0.5	2.5	0.0	0.8	3.7	0.7	5.0	14.5	0.5	1.9	0.3	0.7	0.4	2.6	0.3	7.9	0.8	25.5	32.9	2.3	17.8	0.2	0.7	1.3	2.3	0.0	6.3	1.3	1.2	0.2	0.5	0.1	2.8	2.3	0.0	0.0	0.0	0.1	0.1	1.4	2.9	1.8	4.5	0.2	0.3	0.0	0.1	0.0	12.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.0	6.2	0.2	0.5	0.0	0.0	0.9	0.4	0.0	0.0	2.2	0.1	2.4	0.0	0.0	0.3	0.7	0.0	5.5	0.8	0.1	0.2	0.4	0.0	0.4	5.9	4.6	0.5	0.1	0.1	0.1	0.0	2.3	0.0	6.0	1.8	0.9	0.2	4.9	6.3	0.7	0.0	1.0	2.5	1.3	0.0	1.6	0.1	5.4	1.3	0.3	0.8	1.7	0.8	0.2	0.2	0.3	0.5	0.5	0.3
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell line enhanced"	"Detected in many"		"A549: 64.1;HaCaT: 51.8;HeLa: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA023623: AB_1858273, HPA066431: AB_2685668"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	20.1	64.1	2.0	4.4	9.5	11.0	2.1	3.3	11.8	4.1	5.8	3.8	26.3	2.1	12.7	14.5	51.8	5.8	14.9	2.8	26.6	3.7	1.0	46.7	2.0	15.9	1.1	2.2	6.0	9.4	9.0	5.2	8.8	1.2	10.5	11.2	7.1	4.4	2.6	3.0	3.9	1.9	16.6	1.5	21.3	26.1	1.4	4.1	14.6	16.6	5.0	2.5	2.8	13.7	5.2	6.2	2.5	11.4	2.5	2.7	0.2	8.1	2.8	13.2	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111275-120185529	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 53.0;hTCEpi: 70.5;RT4: 27.9;SiHa: 39.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Region enriched"	"Detected in single"	8	"pons and medulla: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020053	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"				"Nucleoplasm, Intermediate filaments"	"Nucleoplasm, Intermediate filaments"	"HPA020053: AB_1858280"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	0.3	0.2	0.1	0.0	0.1	0.1	7.3	0.0	0.1	30.4	0.6	0.2	1.6	0.3	3.1	2.9	176.3	3.7	0.8	0.1	0.1	0.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.2	0.0	2.2	24.4	1.1	11.1	0.5	0.0	25.5	4.8	0.9	90.1	0.2	1.6	0.3	0.0	0.2	0.7	0.0	7.5	0.1	113.6	93.6	9.6	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.3	0.0	0.8	0.0	53.0	0.0	12.1	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	70.5	0.0	0.5	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.2	0.9	39.6	5.6	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"esophagus: 1.8;testis: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.4;LHCN-M2: 2.2;MCF7: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051120	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	1.8	0.6	0.0	0.0			0.4	0.0	0.2	0.0			0.3	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TTC22	FLJ20619	ENSG00000006555	"Tetratricopeptide repeat domain 22"	Q5TAA0	1	54779712-54801267	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 46.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.9;CAPAN-2: 11.0;HaCaT: 12.6;hTCEpi: 7.2;RPMI-8226: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA035072	Uncertain									"HPA035072: AB_10602252"	"prognostic favourable (2.06e-4)"	"unprognostic (8.52e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.08e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.21e-1)"	0.3	0.4	1.0	4.2	3.5	0.6	1.5	0.2	0.4	12.1	11.8	0.2	5.1	10.1	1.6	2.4	46.8	2.1	7.7	0.2	1.1	0.6	6.6	6.4	5.0	1.5	0.3	0.5	0.6	5.7	8.2	5.7	0.5	0.6	3.6	7.3	1.0	9.5	3.9	0.1	12.2	27.7	0.3	0.3	1.1	8.7	0.5	0.7	3.0	5.3	18.4	21.0	1.8	18.8	1.2	0.1	4.0	0.1	2.9	6.5	0.7	8.9	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	11.0	0.1	0.4	0.0	12.6	0.0	3.7	0.0	3.9	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.0	7.2	0.0	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.1	1.2	0.1	0.0	8.1	0.5	2.2	0.3	0.2	0.7	0.1	0.0	0.4	0.2	0.1	0.2	0.0	0.2	0.1	0.8	2.1	0.1	0.1	0.1	0.0	1.4	0.1	4.0	6.0	0.0	3.6	1.2	2.9	6.5	0.1	0.9	2.5	3.1	2.3	2.9	0.1	0.1	3.9	0.7	1.0	3.5	0.2	0.4	1.1	0.6	0.3	0.5	0.6	0.7
TTC9	"KIAA0227, TTC9A"	ENSG00000133985	"Tetratricopeptide repeat domain 9"	Q92623	14	70641787-70675360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.0"	"Cell line enhanced"	"Detected in many"		"A-431: 11.6;Daudi: 10.2;RH-30: 14.2;SK-BR-3: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.37e-2)"	"unprognostic (6.01e-2)"	"unprognostic (9.29e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (3.81e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.39e-1)"	"prognostic favourable (2.10e-8)"	"unprognostic (1.22e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.38e-2)"	1.3	1.7	7.6	4.2	11.0	1.3	4.3	6.3	9.7	4.0	1.3	1.5	2.2	1.3	1.8	2.0	42.0	10.8	3.9	2.4	7.5	6.5	2.3	1.5	4.8	8.9	4.6	10.3	0.6	1.4	2.1	3.2	5.8	9.8	3.1	1.4	1.5	9.8	2.2	6.5	5.4	2.0	1.4	2.9	5.8	4.4	1.0	1.5	1.2	4.6	7.2	18.6	3.2	9.0	3.4	0.2	2.3	3.5	0.0	3.4	0.7	11.6	1.3	4.4	0.2	0.0	0.0	4.8	0.2	0.0	0.3	1.5	0.2	5.8	10.2	1.6	0.1	4.3	3.3	0.4	0.2	0.3	1.2	1.4	0.4	3.3	0.0	0.0	2.9	0.4	0.8	0.0	0.1	0.0	0.0	0.9	4.8	5.7	0.2	0.1	2.4	1.5	2.4	14.2	0.0	7.3	2.6	2.7	1.3	1.3	24.1	0.0	8.4	0.4	0.0	0.0	2.2	0.0	0.2	0.0	0.1	3.2	0.0	0.2	0.1	0.0	0.0	1.5	1.1	0.7	2.5	1.8	2.0	1.5	0.2	3.4	3.4	1.9	2.3	0.0	3.5	0.0	1.0	0.7	7.6	11.0	6.3	9.7	7.5	6.5	4.6	10.3	9.8	1.5
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942000-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 10.8"	"Cell line enhanced"	"Detected in many"		"SiHa: 31.7;U-2197: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"gdTCR: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.5"									CAB018974	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"			"Vesicles, Plasma membrane"	"Vesicles, Plasma membrane"	"CAB018974: "	"unprognostic (2.09e-5)"	"prognostic unfavourable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	3.3	1.7	4.5	1.9	2.3	4.3	5.9	5.3	6.5	1.6	0.6	0.0	0.0	0.9	0.6	0.5	10.8	0.5	1.6	4.1	4.4	1.0	1.9	1.7	6.2	1.1	1.0	2.1	0.2	1.6	0.3	1.1	4.4	3.9	0.6	0.7	0.3	1.5	0.4	0.6	1.0	0.4	2.0	0.6	0.5	0.7	3.6	0.1	0.5	3.5	4.6	2.4	4.1	5.2	0.0	0.0	0.0	0.0	0.8	5.5	0.9	9.2	0.8	0.2	2.9	0.5	2.8	1.6	9.5	5.6	10.0	8.2	3.5	5.2	0.0	14.6	10.8	6.6	3.6	8.7	5.8	4.2	1.8	0.5	1.4	0.0	3.5	0.0	0.7	1.3	6.7	8.9	3.9	5.7	1.1	0.0	7.4	6.4	0.8	0.0	0.0	4.9	1.4	2.2	0.0	14.2	2.7	0.3	0.0	31.7	0.6	0.9	0.9	3.9	8.9	6.6	8.2	22.9	11.0	0.0	0.0	0.4	9.4	5.0	4.7	0.0	0.0	0.0	5.5	0.0	0.6	0.0	1.8	3.2	0.0	0.0	0.6	3.9	0.0	0.8	0.0	0.0	3.0	0.9	4.5	2.3	5.3	6.5	4.4	1.0	1.0	2.1	3.9	0.1
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;CAPAN-2: 27.8;HaCaT: 5.7;RT4: 19.0;T-47d: 15.9"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"									HPA010506	Approved									"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.8	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.2	2.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0
UPK3BL1	"UPK3BL, UPLP"	ENSG00000267368	"Uroplakin 3B like 1"	"B0FP48, E5RIL1"	7	102637025-102642791	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.1;lymphoid tissue: 34.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 47.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA011403	Supported									"HPA011403: AB_2668503"	"unprognostic (4.63e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.00e-1)"	"unprognostic (8.11e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.93e-2)"	3.0	2.2	2.1	3.3	2.7	7.9	3.0	4.5	2.1	6.5	2.9			3.6	3.4	1.7	45.1	3.7	1.0	2.2	3.0	1.9	4.6	4.0	3.4	7.1	2.1		3.7	3.8	3.4	4.3	1.7		5.9	1.5		7.7	23.7	6.5	5.1	4.6	0.9	2.0	8.8	3.0	1.3			13.1		34.6	11.8	15.1	5.3	6.8	13.6	5.9	7.1	9.6	4.7	7.2	5.7	3.7	1.6	1.5	0.2	5.1	0.0	0.8	0.8	2.1	0.9	4.0	1.1	1.4	0.9	47.8	1.1	5.3	0.6	6.5	8.4	1.1	2.4	1.7	0.5	1.9	1.9	3.2	6.9	0.0	1.3	6.7	2.8	4.0	2.4	16.6	2.9	15.9	1.7	1.7	2.9	2.0	6.0	6.8	5.8	2.5	5.8	9.9	2.6	2.4	0.8	2.9	2.3	14.2	6.1	5.0	2.8	4.2	1.9	0.6	3.0	4.4	2.3	13.6	5.9	8.5	9.6	5.2	4.4	5.3	5.0	4.7	6.8	4.9	6.3	4.8	7.1	7.1	1.7	6.8	7.9	4.7										
UPK3BL2		ENSG00000284981	"Uroplakin 3B like 2"	E5RIL1	7	102538417-102543849	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 12.2;lymphoid tissue: 12.8"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011403	Approved									"HPA011403: AB_2668503"																		0.8	0.0		1.5		6.5	1.0		0.3	0.0	0.6			1.0	0.7	0.4	12.2	0.9	0.6	0.0			0.0	0.1	0.8	3.4			0.4	0.7	0.2		0.3		1.2	0.8		1.5	3.6	2.7	2.8	0.9	0.1		3.2	0.4	0.0			4.5		12.8	2.5		5.0	8.4	6.1	3.7	1.0	7.9	1.3	5.7	8.9	3.8	6.7	1.8	0.6	13.2	10.5	13.2	13.3	16.5	3.0	9.7	6.5	5.3	4.0	18.7	0.4	5.0	3.7	7.2	10.9	2.3	14.6	5.2	7.7	5.6	7.2	6.4	7.3	3.8	3.6	6.0	6.0	15.1	4.8	23.5	6.3	9.5	1.5	1.8	4.9	2.1	9.5	7.5	22.6	4.9	5.4	5.9	2.9	5.3	3.1	5.3	2.7	7.1	3.2	4.5	4.2	15.1	4.8	4.0	2.0	10.2	5.1	0.2	3.7	2.6	7.9	1.9	2.9	4.7	3.1	2.5	1.5	5.0	5.6	2.8	6.1	1.0	2.0	8.4	3.0	1.3										
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916084-74923256	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.9;epididymis: 11.4;esophagus: 11.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.7;hTCEpi: 4.3;K-562: 3.2;MCF7: 5.0;U-2 OS: 2.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Region enriched"	"Detected in single"	20	"cerebellum: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"olfactory region: 12.1"	"Low region specificity"	"Detected in some"			HPA024360	Uncertain									"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	1.4	0.0	0.0	0.4	0.3	0.0	13.9	0.2	1.4	0.0	0.0	1.1	0.3	1.9	11.4	11.8	0.2	0.0	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.5	0.1	0.0	1.3	0.9	0.1	0.0	4.2	0.7	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	0.8	0.5	1.7	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	4.7	1.0	0.2	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	4.3	0.0	0.0	0.1	3.2	0.4	0.0	5.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.5	0.0	0.7	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.9	0.2	0.7	0.0	0.0	0.0	0.5	0.0
ZBTB7C	"ZBTB36, ZNF857C"	ENSG00000184828	"Zinc finger and BTB domain containing 7C"	A1YPR0	18	48026673-48410752	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 38.6"	"Cell line enriched"	"Detected in some"	4	"RT4: 30.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"prognostic favourable (1.59e-4)"	"unprognostic (2.83e-3)"	"unprognostic (6.60e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.52e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.89e-2)"	3.3	6.8	1.7	4.9	1.8	0.1	4.5	0.8	4.9	10.4	10.2	1.9	7.3	1.2	3.0	13.5	38.6	10.3	18.2	3.0	1.8	2.7	1.6	1.3	5.8	0.2	2.9	2.1	10.8	1.1	6.1	2.8	3.5	3.8	3.6	9.6	5.9	12.8	5.7	1.6	19.2	2.7	3.0	4.9	8.7	9.9	6.5	1.5	0.0	15.7	22.9	20.8	6.7	14.9	1.5	1.1	3.2	2.2	0.7	1.3	0.2	0.0	0.0	1.0	0.8	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	2.0	0.1	0.2	0.1	0.2	0.9	0.1	2.3	0.0	0.0	0.1	0.4	0.1	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.5	1.3	0.3	0.4	0.1	0.1	0.0	6.7	0.9	30.0	4.0	5.0	0.4	0.2	0.0	0.7	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.2	0.1	1.9	0.1	0.2	3.2	0.8	0.7	1.3	0.9	0.6	0.3	0.6	1.1	0.0	1.5	0.5	0.9	1.1	0.7	2.2	1.1	0.3	0.2	1.7	1.8	0.8	4.9	1.8	2.7	2.9	2.1	3.8	1.5
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		5400	5400	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
ZNF750	"FLJ13841, Zfp750"	ENSG00000141579	"Zinc finger protein 750"	Q32MQ0	17	82829435-82840578	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 59.3;lymphoid tissue: 54.2;skeletal muscle: 84.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.0;hTCEpi: 6.3;MCF7: 4.5;SK-BR-3: 12.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021573, HPA023012"	Enhanced									"HPA021573: AB_1859438, HPA023012: AB_1859439"	"unprognostic (3.46e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.33e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.30e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-2)"	0.4	0.1	0.1	0.1	0.1	0.1	3.0	0.1	0.1	14.0	0.1	0.0	9.0	0.2	0.9	3.8	59.3	0.4	0.2	0.2	0.1	0.1	0.2	0.1	2.3	0.1	0.1	0.0	0.1	0.1	0.6	2.2	19.5	0.0	3.2	0.1	0.0	38.3	13.2	84.2	46.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	3.4	6.7	44.1	54.2	3.2	16.8	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.1	1.0	0.0	12.7	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
